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Abstract 
Background 
Outcomes are measured to establish what works, in the context of evaluative research, and 
to improve the quality of care that is offered. Traditional outcomes focus upon biomedical 
endpoints, but there is an increased interest in patient based outcomes, which measure the 
impact of illness or healthcare interventions on the individual and how they live their day to 
day life. There are reasons to expect that the application of patient based outcomes would 
be especially relevant to the discipline of psychiatry. 
Aims 
To explore the measurement of outcome in psychiatric research and practice, with particular 
reference to patient based outcomes. 
Methods 
1. A critical literature review of the outcomes movement in health care. 
2. A survey and systematic review of the methods used to measure outcome in 
evaluative psychiatric research (randomised trials and outcomes research) 
3. A survey of the use of outcomes measures by UK psychiatrists in their day-to-day 
practice. 
4. A systematic review of the effectiveness of routine outcomes measurement in 
improving the quality of care for those with common psychiatric disorders. 
Results 
An outcomes movement has emerged in healthcare, which can be understood in social, 
political and economic terms. 
Outcomes measurement in psychiatric research is dominated by the measurement of 
psychiatric symptoms, with little reference to patient based measures. 
Practising UK psychiatrists rarely measure outcomes. There are substantial practical and 
attitudinal barriers to the use of outcomes instruments in NHS mental health services. 
There is little evidence to support the potential for routine outcomes measures to improve the 
quality of mental healthcare. 
Discussion 
Current mental health policy places great emphasis on the measurement of outcomes, and 
is likely to fail. The potential for patient based outcomes to be adopted in psychiatric 
research and practice has yet to be realised. The need for important research into the 
suitability and value of patient based outcomes measures in mental health research and 
practice is identified. 
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The past 30 years have seen a rise in interest in the measurement of the outcomes 
of medical care - to the extent that an 'outcomes movement' has been described, 
which has been labelled 'a [third] revolution in healthcare' (Reiman, 1988). A 
feature of this outcomes movement is an interest in the measurement of outcome 
from the patient's perspective, with attempts to measure the impact of healthcare 
and illness on the individual, in terms of how they live their day-to-day life. 
Clinicians are urged to measure these outcomes of patient care in the context of 
their day-to-day practice - in a quest to improve the quality of this care. 
The purpose of this thesis is to explore the measurement of outcome within the 
speciality of psychiatry, with particular reference to patient based outcomes, and the 
use of outcomes measurement in the context of both clinical practice and evaluative 
research. The research presented within this thesis forms four distinct, but inter- 
related sections that are summarised below. 
Section 1- Outcomes measurement in healthcare 
The measurement of outcome, and in particular patient-based outcome has been 
studied by a variety of disciplines and from a number of perspectives. The reasons 
for the increase in emphasis in outcome measurement are social, political and 
economic. A pre-requisite to a study of the measurement of outcome in psychiatry 
is an understanding of these perspectives and an examination of the often-confusing 
terminology used in the measurement of outcome in general. 
The first section aims to: 
0 Clarify the terminology and main theoretical perspectives that are used in 
discussing outcome and patient based outcome. 
a Provide a brief review of the origins of the outcomes movement in wider 
healthcare. 
The method adopted in this section of the thesis is a narrative overview or scoping 
review, summarising a diverse and disparate literature examined in preparation of 
the thesis. 
10 
Section 2- Outcomes measurement in contemporary psychiatric research 
The outcomes movement in healthcare has laid emphasis on the methods used to 
measure outcome, such that it is more patient-centred and reflects not just 
biophysical markers of disease, but wider'quality of life'. The degree to which 
patient-based outcomes measures have been used in psychiatry is not known, and 
neither is the value of this approach when compared to traditional outcomes 
measurement. 
The second section aims to: 
0 Describe methods used to measure outcome in contemporary psychiatric 
research, with special reference to clinical trials and outcomes research. 
The methods adopted in this phase of the thesis are empirical survey and 
systematic review. 
Section 3- Outcomes measurement in psychiatric practice 
Whilst the previous sections focus on outcome measurement in evaluative research, 
a cornerstone of the outcomes movement is the encouragement of clinicians to 
measure the outcome of their patients in the context of routine day-to-day care, in 
order to improve the quality of this care. This emphasis has been made explicit in 
recent UK mental health policy statements (Secretary of State for Health, 1999). 
The degree to which this approach has been adopted by clinicians has yet to be 
charted in UK mental health services. Similarly, the measurement of outcome for 
each and every patient represents a health care intervention ortechnology'. The 
adoption of this approach by the UK National Health Service will consume 
substantial resources, and should therefore be justified by an empirical 
demonstration of some benefit, to both the clinician and the patient; i. e. it should be 
both clinically and cost effective. 
The third section aims to: 
0 Examine the actual use of standardised outcomes measure by practising UK 
clinicians, and to identify barriers and advantages to their use. 
0 Establish the research evidence that exists to support the use of routine 
outcome measurement in the day-to-day care of patients with mental health 
problems. 
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The methods adopted in this phase of the thesis are cross sectional survey and 
systematic review: 
A cross sectional survey of practising UK psychiatrists will be presented. 
A systematic review of randomised studies will be presented to examine the 
value of the implementation of routine outcomes measurement in improving the 
quality of healthcare for those with mental health problems. 
Section 4- Discussion of the thesis 
The final section will draw together the questions and research findings of sections 
1-3. The findings of the thesis will be discussed with reference to research, practice 
and policy within psychiatry. 
12 
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Section 1- Outcomes measurement in healthcare 
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Chapter 1 Introduction to the review of outcomes measurement in 
healthcare 
The past 30 years have seen a rise in interest in the measurement of the outcomes 
of medical care - to the extent that an 'outcomes movement' has been described, 
which has been labelled 'the third revolution in healthcare' (Relman, 1988). A 
feature of this outcomes movement has been an increased interest in the 
measurement of outcome from the patients' perspective, with attempts to measure 
the impact of healthcare and illness on the individual, in terms of how they live their 
day-to-day life. Terms such as 'health status' and 'quality of life' have entered 
medical vernacular and instruments have been developed with which to measure 
these constructs as actual outcomes of medical care ('patient based outcomes 
measures'). This thesis sets out to explore in detail the measurement of outcome 
within psychiatry, with particular reference to how and in what way psychiatry has 
adopted a more patient based approach to outcome measurement in clinical 
practice and research. However, any examination of this topic within psychiatry 
requires a knowledge and understanding of the core concepts, areas of controversy 
and debate and methods used in the measurement of outcome in wider healthcare. 
Section 1 of this thesis presents such an overview. 
Aims of the review 
The aims of the introductory overview were to outline: 
0 The historical origins of outcomes measurement in healthcare; 
0 The methods that have been employed in measuring outcome in healthcare, 
with special reference to patient based outcomes measurement; 
e The uses to which outcomes measures have been put in healthcare; 
0 Possible social and political explanations for any increased interest in 
outcomes measurement. 
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Chapter 2 Review method 
The introductory overview that follows summarises a broad body of literature 
surveyed in a scoping or conceptual review. 
The scoping review borrows and adapts methods that are used in the conduct of a 
systematic review - such as the use of electronic literature searches. However, the 
term systematic review implies the use of specific techniques to identify and 
summarise an empirical literature in order to answer specific research questions (or 
hypotheses) (NHS Centre for Reviews and Dissemination, 2000). The use of a 
scoping review in this context and the methods employed will now be discussed in 
more detail. 
Conceptual review versus systematic review 
Reviews of the literature now increasingly adopt the methods of 'systematic review' 
- where a systematic review has been defined as one which seeks to 7ocate, 
apprise and synthesise evidence from scientific studies in order to provide empirical 
answers to scientific questions'(NHS Centre for Reviews and Dissemination, 2000). 
This method will be described and used in subsequent sections of the present 
thesis, however, the primary purpose of the introductory review was to produce a 
broad overview of outcome measurement in wider healthcare. The method of 
systematic review was not appropriate for this topic for three main reasons: Firstly, 
because a different literature from that normally synthesised in systematic reviews 
was the main focus of this study - i. e. textbooks, opinion pieces and traditional 
narrative review articles. Secondly, the topic of study was not one that can be 
considered a'scientific question'to which'empirical answers' can be sought. Rather 
the purpose of the study was to produce a coherent narrative that summarises a 
large body of literature and provides (and demonstrates) a greater understanding of 
a topic. Thirdly, it was impossible to review all the literature that has ever been 
written on 'outcome measurement' in all areas of healthcare within the time frame of 
the study (see on for a fuller discussion of this issue). 
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Core issues addressed in the review 
A core body of research was consulted in deciding upon the scope of the review. 
This consisted of approximately 200 key articles and key textbooks, known to the 
author and supervisors. The following topics were identified as being key to gaining 
an understanding of how and why outcome is measured in wider healthcare, and in 
understanding what methods might be used in measuring outcome in psychiatry (the 
topic of the thesis). 
" What (if any) are the historical precedents in the measurement of outcome? 
" Why has there been a rise in the prominence of outcome measurement in 
recent years? 
" What is meant by outcome, when this term is used in the medical literature? 
" What is meant by 'measurement', when this term is applied to outcomes? 
" What are 'patient based' outcome measures? 
What is the origin of the measurement of patient based outcomes? 
What is meant by common synonyms for patient based outcome 
measurement - such as quality of life and health status? 
What specific types of patient based outcome measurement instrument are 
there? 
To what uses are outcome measures put? 
Having stipulated the core areas of the scoping review - further literature was 
sought to examine each of these areas in more depth. An inclusion criterion for 
articles was broadly defined as being directly relevant to any one of the topics 
outlined above. The bulk of this literature was expected to be review articles and 
opinion pieces from journals. Primary empirical research was only ordered and 
judged for inclusion if it was likely to discuss the measurement of outcome in some 
depth and some substance - rather than just reporting how outcome was measured 
within a specific study. 
Literature search methods 
Systematic reviews explicitly set out to 7ocate, apprise and synthesise evidence 
from scientific studies in order to provide empirical answer's to scientific questions' 
(NHS Centre for Reviews and Dissemination, 2000). In the first of these functions, 
locating research, electronic literature searches are often employed as the most 
efficient method of locating literature. 
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It was decided at an early stage that the explicit electronic search methods of a 
systematic review were not appropriate for the literature review presented in the 
introductory section (section 1). The primary reason for this being that the volume of 
literature on the topic of 'outcome measurement' and 'patient based outcome 
measurement' which is identified through electronic literature searches is so vast as 
to make it impossible to view all relevant literature and screen it for inclusion within 
the review. Similarly, the ubiquitous nature of likely search terms (such as outcome) 
in primary research articles would have resulted in large volumes of literature being 
identified that are of no relevance to the review - i. e. electronic searches will lack 
'specificity' or'precision' (McKibbon & Walker-Dilks, 1995), 
For example, a Medline search for the years 1966-99 using the term 'outcome' 
yields 192,570 references, which are likely to contain large volumes of literature, 
which are of no direct relevance to the topic. Literature searches using more 
specific terms, such as 'quality of life' yield similar volumes of literature (36,905 
individual references). Consultations with an experienced information officer were 
similarly unable to refine search strategies such that they were able to produce 
manageable volumes of literature, which could be usefully screened within the time 
frame of the research programme. Thus more specific methods to identify key 
papers of relevance to the scoping literature review were adopted from the outset 
and are identified below. 
'Bootstrapping' from reference lists 
From the reference lists of known papers and books, a further 246 references of 
direct relevance as source material were identified. This was the most productive in 
terms of identifying important literature for the review. 
Searches using author names 
Some authors (for example John Ware, author of the Short Form 36, and Avedis 
Donabedian, author of influential theoretical articles on outcome measurement) 
have published extensively on the topic of outcome measurement. A search using 
10 key authors, yielded a further 60 articles for inclusion, in addition to those 
identified above. 
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Hand searching of key journals 
Some journals have published relatively large numbers of articles discussing the 
measurement of outcome. These include the Journals, Medical Care, Quality in 
Health Care; Quality of Life; Journal of Clinical Epidemiology (formerly Journal of 
Chronic Diseases). These journals were hand searched over the past 20 years, and 
a further 72 articles, in addition to those identified above were identified. 
Synthesis of the literature 
A narrative overview of the main themes and issues revealed in the literature is 
presented. This document does not summarise or include every argument or 
theoretical viewpoint expressed. Rather it is intended to summarise the major 
arguments and positions that are advanced. The narrative nature of the literature 
does not lend itself to a quantitative summary in the way in which research is often 
presented in systematic reviews. 
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Chapter 3 Historical precedents in the measurement of outcomes 
The term 'outcome', in its contemporary use can be traced back to Donnabedian, 
who presented a tripartite evaluation of healthcare: structure, process and outcome. 
He defined health outcome as; 
'.... a change as a result of antecedent healthcare' (Donabedian, 1966) 
And identified the need for, 
'the improvement of methods for identifying key features of medical care that are 
associated with favourable outcomes, so that these features can be preserved 
despite the constraints imposed by an increasingly cost conscious healthcare 
environment' 
Several writers have commented that this focus was nothing new (e. g. Brookes, 
1995; Lohr, 1988; Scroeder, 1987). What Donabedian was in fact reflecting was a 
resurgence of attention to the results of medical care, For example, Davies, et al., 
(1994) suggest that; 
'For generations we have used indicators of mortality, morbidity and expenditure 
when describing and evaluating the performance of individual clinicians, provider 
groups, hospitals and healthcare organisations, and the healthcare system in 
general. We have measured, tracked, reported and often attempted to alter rates of 
death, disease and expenditure. ' 
Important historical contributions to the measurement of health outcome and quality 
improvement from Florence Nightingale working in the Crimea, Ernest Codman in 
Boston ,J Allison 
Glover in the UK, are identified by a number of authors (Brookes, 
1995; Donabedian, 1989; Eisele, et a/., 1956; Rosser, 1983; Rosser, 1993; 
Scroeder, 1987). 
Nightingale, upon her return from the Crimea described her concern with the quality 
of care in hospitals, the need for hospital data and the importance of cost 
effectiveness and accountability. In her Notes on Hospitals (Nightingale, 1863) she 
writes, 
V am fain to sum up with an urgent appeal for adopting this or some uniform system 
of publishing the statistical records of hospitals. There is a growing concem that in 
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a// hospitals, even in those which are best conducted, there is a great and 
unnecessary waste of life. In attempting to arrive at the truth, I have applied 
everywhere for information, but in scarcely an instance have I been able to obtain 
hospital records fit for any purpose of comparison. If they could be obtained, they 
would enable us to decide many other questions besides the ones alluded to. They 
would show subscribers how their money was being spent, what amount of good 
was being done with it or whether the money was not doing mischief rather than 
good' 
She recommended that for individual patients, their outcome of care be classified as 
dead, relieved or unrelieved. Further, Florence Nightingale was the first to achieve 
changes as a result of her outcome measurement, for example she influenced 
hospital design and her'accounting methods'were adopted by many teaching 
hospitals and some continued to use them until the Hospital Activity Analysis was 
introduced in the 1950s (Rosser, 1983). 
Ernest Codman, a Boston surgeon working at the beginning of this century 
advocated ideas that predate Donabebian's idea of outcome, which he termed the 
'end result' (Codman, 1914; Donabedian, 1989). Further, he advocated a process 
that we would now recognise as 'quality assurance' and 'audit. The 'end result' idea 
was that a hospital should follow every patient long enough to determine whether 
treatment had been successful or not, and to question the adequacy of care given to 
those with an unsuccessful 'end result'. His system involved analysis of each 
patient's diagnosis, treatment and results in the years subsequent to inpatient 
intervention. This allowed representative 'efficiency boards' to redirect policy, 
organisation, and operation of the hospital into more efficient channels. Positive 
outcome or'end result'was specified as a 'satisfied or relieved patent'. He believed 
that his end result data would be useful in monitoring quality, advocating clinical 
science, establishing accountability and allocating resources. 
In a similar vein, J Allison Glover (Glover, 1938; Glover, 1948), a community medical 
officer working in the UK in the 1930's observed massive variations between doctors 
and between geographical areas in the use of tonsillectomy for school children. 
Aside from documenting important differences in clinical practice, he was able, 
through the use of population morbidity statistics to demonstrate that higher 
operation rates made little impact on the natural history and outcome of childhood 
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middle ear disease. Glover's work predates that of Jack Wennberg in the USA 
(Wennberg & Gittelsohn, 1973; Wennberg & Gittelsohn, 1982), who studied small 
area variations in clinical practice and developed 'outcomes research' methods to 
study the consequences of these variations (Wennberg, 1991; Wennberg, et al., 
1980). The importance of Wennnberg's work as a cornerstone of the 'outcomes 
movement' in the US will be discussed in more detail below. 
More recently, but still nearly half a century ago, Paul Lembke, an early US health 
services researcher who pioneered the use of audit in the evaluation of surgical care 
stated that'the best measure of quality is not how well or how frequently a medical 
service is given, but how closely the result approaches the fundamental objectives 
I of prolonging life, relieving distress, restoring function and preventing disability. 
(Lembke, 1952) 
The conclusion that must be drawn from these selective historical examples is that 
the measurement of outcome (as it is defined by Donnabedian) extends back further 
than the past 20 years. An appreciation of the primacy of outcome over, for 
example, measures of process is seen. Further, outcome is measured with a 
purpose which we will see mirrors many contemporary themes - such as the 
improvement of the quality of healthcare; increasing the accountability of those who 
provide healthcare and increasing the relevance with which outcome is measured. 
What is less clear is why outcomes measurement came to popularity and developed 
the status of a 'movement' in the latter part of the twentieth century, rather than in 
the times of Codman and Nightingale. The ideas of Nightingale had only a limited 
effect on health planning and policy in the UK, since it was not until the 1950s that a 
more complex system of recording hospital outcomes was introduced (Rosser, 
1983). However, it is clear that her innovations were not further developed, or 
instituationalised. Similarly, Codman's ideas were not adopted in the US. In fact his 
pursuit of the 'end result' made him an outcast in the medical circles of turn of the 
century Boston and for his efforts, he was expelled form his post as chief of staff 
(Donabedian, 1989). 
A wider explanation of this recent rise in terms of social and political forces is 
therefore required. The reasons why an increased interest in outcome 
measurement has come about more recently will now be considered in some detail. 
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Chapter 4 What has stimulated the rise in outcome measurement? 
Given the historical precedents that are seen in the measurement of outcome in 
medical care, it is sensible to ask why the increased interest in outcome 
measurement has come about now, rather than, say earlier this century. Several 
overlapping drivers of the'outcomes movement' are seen - which reflect social, 
political and economic changes within society as a whole and within healthcare in 
particular. This section provides an overview of some of these changes, both from a 
UK and North American perspective. 
Effectiveness and efficiency 
The past 25 years has seen a revolution in the way in which healthcare has been 
evaluated. The publication of Archie Cochrane's 'Effectiveness and Efficiency' 
(Cochrane, 1972) heralded a growing interest in the importance of establishing 'what 
works' (through the use of rigorous evaluative studies such as the randomised 
controlled trial) and the use of only the most effective treatments, such that 
maximum health benefit can be obtained within given resources. The clear 
message of Cochrane is that in order to determine effectiveness, we need realistic 
measures with which to judge the success or otherwise of healthcare interventions 
and programmes. Although Cochrane does not explicitly refer to outcomes, the 
work is a plea for the need to measure outcomes (Opit, 1990). 
The drivers of effectiveness and efficiency have been political and economic 
(Doessel & Marshall, 1985; Epstein, 1990; Opit, 1990). The most conspicuous of 
these forces have been within the US healthcare system and include: (i) attempts to 
address the rising costs of healthcare, (ii) the demonstration of massive variations in 
clinical practice, and, (iii) the drive to improve the quality of healthcare (Brookes, 
1995). Further, there have been several landmark high cost initiatives that have 
facilitated the move towards outcome measurement. These will be outlined below 
with illustrative examples and parallels will be drawn between the US and UK 
healthcare system. 
Rising costs of United States healthcare and healthcare reform 
The US healthcare industry is amongst the most costly in the developed world. 
Escalating costs during the 1960s brought little extra benefit in terms of 
22 
t, 
corresponding improved healthcare, while significant proportions of the population 
continued to be excluded from receiving healthcare, through making it prohibitively 
expensive (Aday, et a/., 1998; Fuchs, 1974; Milio, 1983). The healthcare system 
was officially declared to be in crisis during a presidential address in 1969 (Ellwood, 
1988). In response to this, various healthcare reforms were proposed, which aimed 
to make US healthcare more universal in its coverage, more effective and more 
affordable (Thier, 1992). 
Efforts to contain the rising costs of healthcare were openly proposed and the 
measurement of outcome had several functions within this process. Epstein (1990) 
identifies three important factors that led to an increased emphasis on outcomes. 
Firstly, payers of healthcare costs were determined to find out'what works' 
(demonstrate effectiveness), such that they might cease to reimburse procedures 
that were ineffective, and to eliminate unnecessary and unexplained variations in 
medical practice. Secondly, changes in health coverage and reimbursement 
mechanisms generally meant a reduction in the volume and scope of medical care 
(in addition to that above) available to certain portions of society. Outcomes 
measures were required to provide a monitoring system aimed not so much at 
improving the quality of care, but to identify and monitor the adverse consequences 
of reforms. Thirdly, the setting up of collective providers of healthcare (such as 
Health Maintenance Organisations - HMOs) within the market based US healthcare 
system produced competition. HMOs were required to be able to demonstrate the 
clinical and cost effectiveness of their services to prospective purchasers of their 
healthcare (individuals and collective employee insurance schemes). 
A useful illustration of the major research initiatives prompted by the healthcare 
reforms of the 1970s is the US Health Insurance Experiment (HIE) carried out by the 
RAND Corporation (Brook, et al., 1983). The HIE was conceived in the 1970s to 
evaluate the potentially adverse consequences of cost containment strategies, such 
as user charges and other health payment systems (Wright, 1994b). Population 
samples of 4000 people were enrolled at six sites and were followed up for two 
years. The study showed that those enrolled in co-payment schemes made a third 
less health visits and were hospitalised a third less often than those receiving 
healthcare free at the point of delivery. In order to evaluate whether reduced 
healthcare utilisation was detrimental to health, a series of outcome instruments 
were developed which measured self assessed general health (physical functioning, 
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role functioning, mental health, social contacts, & health perceptions). The main 
results of the study were that for the majority of people, free care did not improve 
health status. However, co-payment mechanisms deterred a significant portion of 
the most disadvantaged patients from seeking care, to the detriment of their health - 
as evidenced by the comprehensive range of outcomes measures which were used 
to measure this. Of significance was the development of a battery of outcomes 
measures, which were subsequently refined and further developed in the Medical 
Outcomes Study (MOS) of the 1980s, and from which developed the now widely 
used Short Form 36 (SF-36) health status instrument (Ware & Sherbourne, 1992). 
Improving the 'quality' of healthcare in the United States 
The outcomes movement has also been inextricably linked with the drive to appraise 
and improve the quality of medical care (Aday, et al., 1998; Epstein, 1990). One 
manifestation of this has been the initiation of programmes such as 'Quality 
Assurance', the aims of which are succinctly described by Brook & Lohr (1985) as 
being 'to improve healthcare in terms of outcome, functional ability, patient well- 
being and consumer satisfaction and the use of resources by shaping health policy 
and practice'. 
The measurement of outcome in the pursuit of 'quality' represents a significant 
advance, since quality had hitherto been judged by the activities of clinicians, 
without reference to how these impacted on their patients. For example, Makover, 
working in the 1940s and early 1950s attempted to determine the quality of care 
offered by clinicians working for the the Health Insurance Plan (HIP) of New York. 
Makover sought 'to determine the quality of the end product - the actual medical 
services rendered - on the basis of clinical performance. '(Makover, 195 1). 
However, Makover's conception of clinical performance was the frequency with 
which procedures were carried out, rather then the impact of the procedure on the 
individual. 
The work of Makover dominated the methods by which healthcare was evaluated for 
the best part of the 1950s and early 1960s. According to Doessel & Marshall, 
(1985), the methods of Makover represented an 'indifference to the importance of 
medical care outcomes. 
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A contemporary of Makover's states that 'valid instruments for measurements of end 
results of medical care, such as amelioration of suffefing and promotion of well- 
being are unavailable' (Rosenfeld, 1957). Thus in the absence of such measures, 
quality was largely measured by (what Donabedian would later call) process. 
The contribution of Donabedian in separating structure, process and outcome 
should be seen in the context of a number of theorists who in the 1960s and 1970s 
decided to reformulate how quality should be conceptualised and measured. One 
such approach was that of 'Health Accounting' advocated by Williamson (1978), 
which adopted the methods of 'financial accounting' in pursuit of an improved 'end 
result'. Another key theorist was Robert H Brook (Brook & Appel, 1973), who called 
for an epidemiology of medical care; meaning the systematic investigation of the 
linkages between the components of medical care and patients' outcomes (Brook & 
Lohr, 1985). However, the work of Avedis Donabedian has been the most influential 
in facilitating the use of outcomes to evaluate the effects of healthcare practice and 
policy. Donabedian (1966) first offered a categorisation of the quality of medical 
care in terms of structure, process and outcome. 
Structure refers to the resources that are made available for medical care: in 
physical terms these are medical and other personnel, hospitals, clinics and 
technologies of all kinds. Structure also encompasses the ways in which resources 
are provided, including the organisation and the differing aspects of finance, and the 
skills and training of individuals. Process concerns the ways in which the structure 
is used in diagnosis and treatment, including the patient's own activities in seeking 
treatment, and the sorts of interventions that are offered and the way in which they 
are delivered. Outcome (as defined by Donabedian) focuses on the results of 
medical care processes for the health status of individuals and populations as the 
consequences of using the structure of resources. The influential framework 
proposed by Donabedian has had a number of consequences, including the raising 
of the profile of outcomes, when quality had previously been judged solely by 
process, or even structure in terms of equipment available and staff ratios etc. 
An illustrative example of the influence of Donabedian in the measurement of quality 
within the reformed US healthcare system is the way in hospital performance was 
measured. The US Joint Commission on Accreditation of Hospitals (JCAH) has for 




providing care for HMOs (including the federal Medicare programme), and has 
traditionally provided indicators of quality based upon indices of hospital activity. In 
the 1980s the JCAH took the controversial much-criticised step of rejecting these 
process based measures in favour of publishing outcomes in the form of mortality 
data in individual hospitals (O'Leary, 1987; Scroeder, 1987). 
Within the same vein, there have been initiatives to judge the 'appropriateness' of 
healthcare. Appropriateness has been variously defined and the following example 
given by the RAND Corporation illustrates the centrality of outcome: 
'Appropriate care means that the expected health benefit (i. e. increased life 
expectancy, relief of pain, reduction in anxiety, improved functional capacity) 
exceeds the expected negative consequences (ie mortality, morbidity, anxiety of 
anticipating the procedure, misleading or false diagnosis) by a sufficiently wide 
margin that the procedure is worth doing. '(Kahn, et al., 1988) 
Clearly the measures of benefit and dis-benefit implicit in judging approriateness in 
the above consideration require broad-based measures of outcome. Again the 
RAND Corporation, which has undertaken the Health Insurance Experiment (HIE) 
and Medical Outcomes Study (MOS), has also pioneered techniques to judge the 
'appropriateness' of various interventions (Brook & Lohr, 1985). 
Addressing variations in medical practice 
Linked to efforts to improve the quality of US healthcare has been the demonstration 
of massive regional variations in the rate and indications for various common 
medical procedures (Aday, et al., 1998). The implicit assumption is that unexplained 
variation in practice represents a poor quality and inappropriate healthcare. 
Wennberg and his colleagues have pioneered the small area variation study and 
have demonstrated regional variation in many common medical and surgical 
procedures (Wennberg & Gittelsohn, 1973; Wennberg & Gittelsohn, 1982; 
Wennberg, 1990). Most famously, Wennberg and colleagues demonstrated 
massive and inexplicable variations between New Haven and Boston in the 




Their supposition is that both over and under use of some procedures must 
represent 'inappropriate' care for a large portion of patients; ie errors of omission 
(failing to do necessary things) and errors of commission (doing unnecessary 
things). Wennberg's research has had a number of direct implications in terms of 
raising the profile of 'outcomes measurementi, particularly in the US, and deserves 
further discussion. 
Firstly, Wennberg has asserted that it is not sufficient to demonstrate practice 
variation, but it is also necessary to study the (potentially adverse) outcomes of 
these variations on patients - both in terms of traditional indices of outcome, such 
as mortality, but also in terms of the impact of illness on the individual in terms of the 
quality of life and health status (Wennberg, 1991; Wennberg, et a/., 1993). 
Secondly, outcomes research has used large-scale insurance claims databases as 
a source of primary data. This has in turn influenced the type of data that is 
routinely collected - making it more 'patient centred' (Wennberg, 1991). Lastly, 
Wennberg's work captured the political imagination of the time and culminated in the 
creation of the Agency for Health Care Policy and Research (AHCPR) and the 
funding of large scale'outcomes research' into common medical conditions (Patient 
Outcome Research Teams - PORTs) (Wennberg, et al., 1993). In 1989, the US 
Congress passed the Patient Outcome Research Act, which called for the 
establishment of a broad based, patient centred outcomes research programme. 
The research programme was allocated resources of $6 million in its first year, rising 
to $63 in 1991, with the purpose of using routine outcomes data to determine 
'outcomes, effectiveness and appropriateness of treatments' (Anderson, 1994).. 
The work of Wennberg was cited as central in the movement towards outcomes 
measurement, distilled in Paul Elwood's Shattuck lecture and manifesto of 
'outcome's management' (Ellwood, 1988) that came to be called the 'third revolution 
in healthcare (Relman, 1988) - an era where there is 'consensus on the need for 
accountability and for the assessment of outcome'. 
Ellwood (1988) describes the US healthcare system as: 
... an organism guided 
by misguided choices; it is unstable, confused and 
desperately in need of a central nervous system that can help it cope with the 
complexities of modern medicine. ' 
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The central nervous system he proposes is the measurement of outcome and the 
integration of these measures into health management strategies - 'outcomes 
management'. 
UK healthcare system 
Whilst the US healthcare system has provided much of the impetus behind the 
current interest in outcome in general, the UK healthcare system provides some 
interesting parallels and differences to that outlined above. Whilst Archie 
Cochrane's Effectiveness and Efficiency (Cochrane, 1972), was cited by Wennberg 
& Gittelsohn (1973) as of importance and influence to US thinking in the 1970s, it is 
clear that this text essentially evolved from the tradition of socialised medicine in the 
UK (Opit, 1990). 
The socialised model of healthcare enshrined within the UK National Health Service 
did not appear to suffer so much the problems of escalating cost and ensuing the 
financial crises that bedevilled the US healthcare system in the 1960s and 1970s. 
The primary reason being that it was (and is) a cash limited system (Klein, 1995). 
However, there has been a growing awareness that the system can be more 
efficient i. e. we can do not just'more', but we can deliver'better' healthcare, within 
given resources. Further, the arrival of various high cost innovations and treatments 
has forced a debate about how the NHS should respond and how the value of these 
treatments to patients and society should be determined (Sheldon & Faulkner, 
1996). The language of the UK NHS has been less about cost containment and 
more about how to measure health gain and cost effectiveness (Klein, 1995). Aside 
from the political differences between the UK and US, the practical and 
organisational differences between the two healthcare systems have meant that the 
raw data which has enabled the US'outcomes movementto grow, would not be 
readily available to researchers or developers in the UK. For example, the absence 
of large claims databases in the UK would make PORTs and outcomes research, as 
proposed by workers such as Wennberg impossible to apply generally (Black, 
1999). However, the rising awareness of the importance of 'outcome measurement' 
has none the less come about within the UK as evidenced by a number of initiatives 
The government's 1989 white paper Working for Patients (Department of Health, 
1989) explicitly called for the collection of 'outcomes', particularly within the remit of 
medical audit. The political emphasis of Working for Patients was one that 
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highlighted concepts such as choice, quality and standards. Associated initiatives, 
such as the Health of the Nation Strategy and the Patients' Charter gave a greater 
explicit role for patient and consumer involvement in healthcare decision making. 
This emphasis is in line with the rise in 'consumerism' within society as a whole 
(Klein, 1995). A role for outcome was also proposed in the 'market healthcare' 
emphasis of the white paper. For example, the purchaser-provider split allowed 
health authorities to think more about the needs of populations and how they should 
respond to these needs in their purchasing decisions (Jordan, et al., 1998). In 
common with the US healthcare system, a value for money rhetoric was adopted. It 
was proposed that providers of healthcare would seek to demonstrate the 
effectiveness and value of their services thorough the measurement of outcome, 
and thatpurchasing by outcome'would come about (Beckingham, 1994). 
Various initiatives can be seen to have arisen in response to the developing UK 
'outcomes agenda' - some of which predate the white paper and reflect an already 
emerging resurgence in outcome measurement. For example, confidential enquiries 
have been established into peri-operative deaths and suicides. These initiatives 
would fall under the broad approach of the examination of 'outcomes'. The Clinical 
Accountability Service, Planning and Evaluation (CASPE) study was initiated at the 
Freeman Hospital in Newcastle (Bardsley & Coles, 1992). The Department of 
Health commissioned a national centre - the UK Clearing House for the Assessment 
of Health Outcomes - which was charged with raising of the profile of 'outcome 
measurement' in general and US developed measures (such as the Short Form 36) 
in particular (Long, et a/., 1993). Various Royal Colleges responded to Working for 
Patients and the rise in profile of 'outcomes measures' by setting up workshops on 
how and why'outcome' should be measured (Hopkins & Constantin, 1990). The 
Colleges have also encouraged research units to develop measurement instruments 
with which to measure outcome, for example of the Health of the Nation Outcome 
Scale (HoNOS), developed by the Royal College of Psychiatrists (Wing, 1994). The 
Department of Health commissioned a series of working groups, under the auspices 
of a Central Outcomes Unit (Lakahni, 1994), charged with identifying outcomes 
indicators for use in routine care settings for ten common conditions - including 
severe mental illness (Carlwood, et al., 1999). 
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Audit as an activity 
One of the major mechanisms that have been proposed by which to measure 
outcome in the context of routine care has been 'clinical audit'. The white paper, 
Working for Patients, explicitly included the measurement of loutcomes, within the 
remit of audit, where processes had previously been measured. The purpose of 
audit, as proposed within the white paper was to encourage a move towards the 
'measurement of outcome' in the hope of assessing the benefits of healthcare and to 
help generate testable hypotheses on causal connections between process and 
outcome (Shanks & Frater, 1993). Comparisons of outcome between one clinician 
and another or one hospital and another would be possible in order to generate 
hypotheses for further research and to identify areas that might warrant further 
investigation. Further, standards of expected outcome might be set, against which 
performance or effectiveness would be judged. 
Audit has been heavily resourced and has contributed to raising the profile of 
outcomes measurement in the UK (Davies, 1997), despite concerns relating to its 
effectiveness as a way of improving the quality of healthcare (e. g. Walshe, 1995). 
Michael Power, Professor of Accounting at the London School of Economics, 
provides an interesting critique of the rise and role of all forms of audit within society, 
and places this recent preoccupation within a general movement towards greater 
accountability (Power, 1997). He describes an audit 'explosion', with wholesale 
importation of (US) accountancy-based notions of 'value for money' into diverse 
areas of human activity, including healthcare, policing and education. He goes on to 
describe 'rituals of verification', where there are checks and balances on all activities 
without forethought about the benefits or costs involved in this activity. The origins 
of this explosion date back to the demands for better governance and accountability, 
and a loss of trust in public services. 
Concluding comments 
The rise outcome measurement has come about through two interrelated but distinct 
influences - the quest to find what works (evaluation) and the quest to improve the 
quality of healthcare (accountability). Various social and political drivers to this rise 
have been described, which are both specific and common to the US and UK 
healthcare systems. 
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There is an implicit assumption that the measurement of outcome is a good thing, in 
that it will improve clinical practice, and therefore worth the effort and cost. At the 
micro level, clinicians will be keen to incorporate these data into their day-to-day 
practice, and at the macro level, that that they will be used in some meaningful way 
by hospitals. These issues, within the context of psychiatry, will be explored in more 
detail within this thesis (Sections 2 and 3). 
The term outcome is, however, one that is used imprecisely and with various 
meanings throughout the literature. The next chapter will highlight the imprecise 
nature of this term, and will seek to clarify the way in which this term will be used in 
the empirical studies of outcome in this thesis. 
31 
Chapter 5 What is meant by outcome? 
The preceding discussion highlights some of the diverse influences that have 
contributed to the rise of 'outcome' as an issue and topic of study. However, the 
term 'outcome' is used in different ways and with a diversity of meanings, which is in 
part a reflection of these various influences. Further, it has been endowed with a in 
the health, social and political spheres. 
Table 1 provides examples of the diversity of definitions for'outcome'. These reflect 
two related influences on outcome measurement outlined in the previous section; 
namely the quest to find out what works (evaluation) and the urge to improve the 
i quality' of medical care. They also reflect notions of 'change' over time, which may 
or may not be attributed to antecedent healthcare. Additionally, it is seen that 
implicit within many of these definitions are varying conceptions of how and what 
should be measured as an outcome. Only some of these include 'health' in its 
broadest sense. In some there are implicit assumptions about what constitutes 
health - where this can be negatively framed (death disease and disability'Lohr, 
1988) or can be positively framed ('the impact that changes in health have on quality 
of /ife'Seymour, et a/., 1993). The following sections will explore in more detail what 
is meant by'outcome' and will clarify in what sense the word outcome will be used in 
the rest of the present thesis. 
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Table 1: What is meant by outcome? 
,..., a change as a result of antecedent healthcare" (Donabedian, 1966; Donabedian, 1980). 
five Ds- death disease, disability, discomfort and dissatisfaction' (Lohr, 1988) 
'(The) results of health care processes. ' (Baumberg, et a/,, 1995) 
'All the possible results that stem from preventative or therapeutic interventions; all identified changes 
in health status arising as a consequence of handling of a health problem' (Last, 1994) 
'Outcome to the individual, essentially comes down to how comfortable, how accessible and how 
appropriate will be the care that is offered between the onset of mortal illness and death. ' (Best, 1988) 
'A measure of the quality of medical care, the standard on which is made the assessment of the 
expected end result of the intervention employed. ' (Glanze, 1990) 
'The attributable effect of an intervention or its lack on a previous health state. ' (Department of Health, 
1992) 
'The inter-relationship between health, health services and other factors in the social system are 
unclear. An improvement in 'health' may not be the outcome of health services. However, in this 
context it is measures of those aspects of health which are likely to be affected by changes in health 
services which are required as indicators of outcome. This concept of outcome implies both a measure 
of change in health status and an association with health service use/provision. ' (Hall, et al., 1984) 
'Outcomes are the effects of the utilisation of health services on the health status of the population. 
This definition implies both a measure of health status and the imputing of a change to the intervention 
of health services, i. e. a cause-effect relationship. ' (Hall, et al., 1986) 
'The end results of medical interventions and processes. These can be assessed in terms of mortality, 
morbidity, physiological measures and, increasing, more subjective patient-based assessments of 
health. ' (Jenkinson, 1994) 
'An outcome is a natural or artificially designed point in the care of an individual or population suitable 
for assessing the effect of an intervention, or lack of intervention, on the natural history of a condition. ' 
(McCallum, 1993) 
.a change in the health of an individual, group of people or population which is attributable to an 
intervention or series of interventions. ' (NSW Health Department, 1992) 
'Outcome is a relative value. It is a measure of change, the end point is compared with the situation at 
the start of the study period. ' (Pynsent, et al., 1993) 
'An important issue in health planning is the measurement and valuation of health outcomes. The 
former is concerned with description and the latter is concerned with the subjective perception of the 
impact that changes in health have on quality of life. ' (Seymour, et aL, 1993) 
'In education planning, this refers to any change in health status in a group or population that results 
from health promotion or health care utilised as measured at one point in time; a cross-sectional 
epidemiological study of health concerns or health status. A measure of the results of health 
activation, health education and health promotion. ' (Timmreck, 1992) 
'The dictionary definition of outcome is 'result or visible effect'. To be concerned with outcomes is 
simply to be concerned with the causal relationships between antecedent and subsequent conditions 
or events. But in the context of health and illness, outcome is usually defined in terms of the 
achievement of or failure to achieve desired goals. Relative to these goals, from a defined starting 
point, outcomes can be either positive or negative, ranging from complete health to death (or worse). ' 
(Wilkin, et al., 1992) 
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Attributing outcome to healthcare processes 
The frequently cited definition of health outcome given by Avedis Donabedian 
(1966) as a 'change as a result of antecedent healthcare' provides a useful starting 
point in seeking to examine what is meant when the term 'outcome' is used in the 
medical literature. From Donabedian's definition of 'outcome', there is an emphasis 
on both change and the attribution of this change to some healthcare intervention. 
Various criticisms have been levelled at this definition, particularly the assumption 
that any change can be attributed to healthcare its self, since there are many 
determinants of health, including cultural, environmental, economic and social 
factors (Shanks & Frater, 1993). 
In order to bring clarity to the idea of outcome in terms of the attribution that is 
implied, Shanks & Frater (1993) offer the following four distinctions: 
Outcome -a result 
Health outcome - an effect manifest as a change in health status 
Health care outcome -a result which is attributable and responsive to health care 
Health outcome of healthcare -a result evident in terms of health status which is 
attributable to and responsive to healthcare. 
The distinction between 'outcome' and 'health outcome' is conceptually clear, but 
difficult to apply in practice. It is true that many things are measured as important 
'outcomes' of healthcare, but which are not a direct measure of the patients 
underlying health state, such as aspects of service use, employment etc. Likewise 
change (or lack of change) is commonly attributed to a healthcare intervention, 
despite no clear establishment of causality. In using the word 'outcome', no clear 
link between outcome and healthcare process will be assumed. Where a causal link 
is explicitly demonstrated or inferred, this will be pointed out. 
What is measured as outcome. 
The definitions also reflect changing ideas about what should be measured as 
outcomes - from negatively framed biomedical endpoints ('death and disease'- 
Lohr, 1988), through to more recent trends in the measurement of positive aspects 
of health and the use of 'patient based' measures, which assess the patients' 
perspective in terms of the impact of disease processes on the individual (Greenfield 
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& Nelson, 1992). Some of the specific ways in which outcome has come to be 
measured, particular through the measurement of 'health status' and 'health related 
quality of life', will be studied in detail in the following chapter. In many cases, when 
the term 'outcome measure' is used, it is implied that this means the measurement 
of these broader'patient based outcomes. For conceptual clarity, the term 
'outcome'when used in this thesis will not presuppose what is measured as an 
outcome. When necessary, this will be explicitly stated and the use of terms such 
as 'patient based outcome'will be used where appropriate. 
'Temporal change' and outcome. 
The idea of 'temporal change' is central to the notion of 'outcome'- and the ability to 
detect change is a necessary (though often ignored) attribute of any instrument that 
is used to measure outcome (McDowell & Jenkinson, 1996). 
Change can only be measured over time and ideally requires the serial application 
of a measurement instrument or index. This instrument or index must be capable of 
measuring this change. The notion of 'temporal change'will be a key feature in 
considering when an instrument is being used appropriately as a 'measure of 
outcome' throughout this study. However, stipulating the serial application of a 
measurement instrument to infer change will exclude many examples of 'outcome 
measurement'. Where measurement only takes place once, in a scientific sense, it 
should only be considered a 'measure of outcome'when it is made during or at the 
end of some healthcare process and there is some implicit relationship inferred 
between the preceding process and this outcome. In this way, important categorical 
event-like 'outcomes', such as death, discharge from hospital or relapse can be 
recorded. 
What is meant by 'measurement'? 
Operation aI isation of 'outcome' in order that it can be measured requires a 
consideration of what is meant by the term 'measurement'. This necessarily 
requires a brief overview of measurement theory and the basic tenets of 
psychometrics (see Nunnally, 1967, for an overview). These are provided below. 
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Streiner and Norman (Streiner & Norman, 1995) outline two divergent traditions in 
the conceptualisation of 'measurement'; the categorical versus the dimensional. 
Categorical measurement stems from the medical tradition, where the world is 
construed in terms of diagnoses and treatments: either the patient has the disorder 
or does not and is prescribed a treatment or is not. Diastolic blood pressure and 
depression might vary in magnitude or severity, but individuals are classified as 
being normotensive/hypertensive or not depressed/depressed, and hence requiring 
treatment or not. Conversely, the dimensional tradition is exemplified by 
'psychometrics' in psychological and educational research, where a phenomenon 
under study differs only quantitatively at different severities. The science of 
psychometrics takes the writings of Stevens (1951) as received wisdom (Streiner & 
Norman, 1995). Stevens has provided a widely accepted definition of measurement 
as 'the allocation of numbers to things according to rules'and has introduced the 
notion of levels of measurement', which categorises variables into nominal, ordinal, 
interval, and ratio. The basic idea is that the more finely we can measure 
something, the better. 
Having examined the notion of outcomes and how these can be measured, with 
reference to the basic tenets of measurement theory, the following section will 
explore how measurement has been adapted in the pursuit of patient based 
outcomes. 
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Chapter 6 Patient based outcome measurement 
During the 20th century the developed world has seen a rise in life expectancy and 
a consequent increase in prominence of chronic diseases. Where previously 
mortality and morbidity rates were collected and were informative about the burden 
of illness and the quality of healthcare for the population at large - this is now less 
clear cut (Ebrahim, 1995). Particularly for chronic diseases, there has (necessarily) 
been a change in the way in which health and healthcare are measured and 
evaluated (Ware, 1995). Treatments and outcomes in these cases depend not just 
on quantity but on quality of life. 
In healthcare, there has been a shift from the reliance on population based 
measures of mortality and morbidity to what can be called 'patient based' measures 
of health and illness (McDaniel & Bach, 1994; McDowell & Newell, 1996). They are 
'patient based' in that they incorporate the patients' subjective experience of illness 
over more traditional biophysical measures that have previously dominated 
medicine in the evaluation of healthcare (Fitzpatrick, et al., 1984). Where more 
'patient based' measures are used to evaluate changes in health status and 
antecedent healthcare - then we have 'patient based measures of outcome' 
(Jenkinson, 1994). Some areas of medical speciality have readily incorporated or 
adopted patient based measures of outcome - for example oncology (Selby, 1993) 
and rheumatolgy (Liang & Katz, 1992). 
The focus of the current thesis is to examine the measurement of patient based 
outcomes. The term cannot easily be defined (McDaniel & Bach, 1994), but the 
common denominator of all instruments that can be termed 'patient based outcome 
measures' is that they are said to address some aspect of the patient's 'subjective' 
experience of health and the consequences of illness. Such instruments ask 
patients to report views, feelings, experiences that are necessarily perceived by the 
respondent (Mor & Guadagnoli, 1988). One of the key features of patient based 
outcomes measures is the recognition of the fact that the pa tien ts' perspective is 
worthy of measurement in its self (Fitzpatrick, et al., 1984). The patients' 
perspective will provide useful information that might not otherwise be obtained from 
'hard' (physical or laboratory based) parameters. This approach is based on 
theories of the 'subjective experience of illness', which assume that individuals 
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experience illness in ways that cannot be measured well through objective tests and 
that these feelings and perceptions influence health outcomes (Fitzpatrick, et al., 
1984). Respondents are asked about experiences such as satisfaction, difficulty, 
distress or symptom severity that are unavoidably 'subjective phenomena'. It is 
taken as given that such experiences cannot be objectively verified (Albrecht, 1994). 
A number of synonyms are used for patient based outcome; particularly quality of 
life, health status and health related quality of life. The terms quality of life and 
health status have crept into common usage and instruments designed to measure 
patient based outcome variously describe themselves as measures of health status, 
quality of fife or functional status. Few authors take the trouble to define these terms 
or explicitly describe what in fact they are measuring (Farquar, 1995; Gill & 
Feinstein, 1994). It is useful therefore to review the origins of these terms and their 
subsequent development and appropriation within medical vernacular. The 
theoretical underpinnings of quality of life and health status will be reviewed and the 
degree to which these terms might be considered synonymous will be considered. 
This discussion is not merely an academic one, but will outline debates of genuine 
relevance to how outcome is now measured and will inform a subsequent glossary 
of the confusing terminology that is used. 
The origins of 'quality of life' 
The first recorded uses of the term quality of life are discussed by various authors 
and reflect the origins of the term within the economic and social sciences. Albrecht 
(1994) cites Pigou's (1920) The Economics of Welfare where he discusses 
government support for the poor in terms of personal well-being and the national 
dividend. The Oxford English Dictionary first notes the use of quality of life in J. B. 
Priestly's work, Daylight on Saturday, 'The plans are already ... maturing that would 
give all our citizens more security, better opportunities and a nobler quality of life'. 
In the United States, J. K. Galbraith uses the term throughout his influential thesis 
The Affluent Society (Galbraith, 1958). 
The first recorded use of the term within the medical literature can be found in the 
American publication Annals of Internal Medicine, which published an editorial with 
the title 'Medicine and Quality of Life' (EI ki ngton, 1966), discussing the problems of 
transplantation medicine and how its benefits might be measured. 
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'Quality of life' has both an academic pedigree, in that various theoretical positions 
and traditions have shaped our understanding of the construct, and has come to be 
used in a non technical sense in everyday conversation. Patrick & Erickson (1993) 
provide a review of some early efforts to measure quality of life such as the US 
Eisenhower Commission on National Goals, which noted the a variety of social and 
environmental influences on quality of life and spurned research initiatives to 
operationalise, investigate and measure the concept of quality of life (Oliver, et al., 
1996). Patrick & Erickson (1993) also trace distinct theoretical bases that have 
contributed to our subsequent understanding of quality of life. These include the 
functionalist theories of sociology and anthropology, and theories of positive well- 
being and quality of life from psychology. Methods by which quality of life has come 
to be measured have also been influenced by utility theory form economics and 
decision sciences and by psychophysical theory from psychology. 
Those who choose to use measures of quality of life are far from making an 
atheoretical measurement. The choice of measurement instrument and the items 
that it contains are implicitly influenced by the theoretical standpoint of those who 
constructed the instrument. Differing instruments form differing theoretical 
standpoints may produce different answers when applied to the same phenomenon. 
For example, functionalist theories, such as those of espoused by Talcot Parsons 
involve the analysis of social and cultural phenomena in terms of the functions that 
they perform in a sociocultural system Parsons, in The Social System, defined 
illness as: 
'A state of disturbance in the normal functioning of the human individual including 
both the state of the organism as a biological system, and his personal and social 
adjustments'. (Parsons, 1951) 
This sociological basis has been the basis for many health and quality of life 
indicators, and has resulted in measures which focus on the individuals capacity to 
perform the major social roles - such as work, caring for others or ones own 
personal needs. This has in turn influenced the items that are included in measures 
of quality of life - such as ability or capacity to meet these social roles. 
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Similarly, The economic perspective on quality of life draws much of its theoretical 
foundation from the classical theories of utility espoused Jeremy Bentham 
(Bentham, 1789), whose utility principle holds that all individuals and society, as an 
aggregate of individuals, are directed towards a single end - to increase pleasure 
and to decrease pain, and that these preferences can be measured. Developments 
of these theories by, for example, Von Neumann and Morgenstern, who extended 
notions of uncertainty into preference judgements (von Neumann & Morgernstern, 
1944) have directly influenced the methods that are used to measure and value 
health states. For example the standard gamble, as a dimensional measure of 
quality of life draws directly from these theories of expected utility and decision 
making under uncertainty (Drummond, et al., 1997; Torrance, 1987). 
The ubiquitous nature of the term quality of life and the differing theoretical stand 
points which are assumed when it is discussed are reflected in the various differing 
definitions which are offered. For example, Calman (1984) has presented a widely 
used definition of quality of life as 'the gap between the patients expectations and 
achievements'. Thus, the smaller the gap, the higher the quality of life. Others use 
the term or'measure' the construct, but decline to define it (Farquar, 1995; Gill & 
Feinstein, 1994). The lack of definitional consensus is exemplified by Campbell 
(1976) who stated that 'quality of life is a vogue and ethereal entity, something that 
many people talk about, but which nobody cleady knows what to do about' 
(Campbell, 1976, cited in Bowling, 1995). 
In many cases, quality of life has been very broadly defined and operational i sed, 
through the recognition of the fact that there are many components of quality of life 
and influences which determine the quality of life for an individual. Health is just one 
(albeit important) component and determinant of subjective quality of life (Bowling, 
1995; Fitzpatrick, et al., 1992a; Patrick & Bergner, 1990). The intellectual influences 
of economics and welfare have recognised that quality of life is also dependent upon 
factors such as housing, financial security, employment and opportunity. Much 
subsequent disagreement, particularly when quality of life has been measured in 
relation to healthcare, has centred on the definition and relative importance of health 
and social influences on subjective quality of life, and whether these should be 
measured (Faden & Leplege, 1992; Greenfield & Nelson, 1992; Guyatt, eta/., 1991; 
Guyatt, et al., 1989). Critics of the use of 'quality of life', as it has come to be 
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operationalised and measured within much medical research, have commented that 
wider influences upon quality of life and health are ignored (Gill & Feinstein, 1994). 
Health Related Quality of Life 
In the face of these criticisms, the idea of health related quality of life (HRQoL) has 
emerged (Patrick & Erickson, 1993; Ware, 1985). HRQoL is a concept that attempts 
to encompass broader ideas of health than diseases or their absence, by 
incorporating both personal health status and social well being in assessing the 
health of individuals and populations (Guyatt, et a/., 1993a). One widely quoted 
definition of HRQoL is that offered by Patrick & Erickson (1993): 
'Health related quality of life is the value assigned to duration of life as modified by 
the impairments, functional states, perceptions, and social opportunities that are 
influenced by disease, injury, treatment or policy" 
The use of the term value should be noted in this definition. Any measure of HRQoL 
involves some explicit or implicit value judgement. Measures of HRQoL contain a 
value judgement on the part of those who develop them, in terms of what constitutes 
HRQoL and hence what should be measured. HRQoL measurement instruments, 
such as utility measures, explicitly set out to measure the valuation put on various 
health states (Torrance, 1987). 
Authors generally concur about the components of health which should be included 
in any measure of HRQoL, and these include psychological, social and physical 
health; duration of life; impairments; functional status; health perceptions and 
opportunities (Testa & Nackley, 1994). These are health related, in that they are 
influenced by disease, injury, treatment or health policy (Patrick & Bergner, 1990). 
Such items reflect states that are felt to be universally desirable (Faden & Leplege, 
1992). Other widely valued aspects of human existence that might be included in 
some measure of 'quality of life' are not generally domains of H RQoL. These 
include safe environment; adequate housing; guaranteed income and freedom. 
Such global concerns may adversely affect or be affected by disease, injury, 
treatment or policy, but are often unrelated to or distant from health or medical 
concern. Health Related Quality of Life generally distinguishes the social, familial 
and behavioural factors and processes that influence it, particularly when health is 
viewed as an outcome. It is from the outcome perspective that most health status 
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measures are developed and applied (Patrick & Bergner, 1990). Table 2 produces 
a comprehensive summary of some of the wide variety of components that have 
been included in operationalised measures of HRQoL. Not all instruments will 
measure each and every one of these dimensions, and the scope and 
comprehensiveness of the domains that are studied will in part depend upon the 
perspective and purpose of the measure of HRQoL. 
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Table 2: Concepts and domains of health related quality of life 
Adapted from Patrick and Erickson, 1993 
............... . ...... ... 
Concepts and domains Definitions/indicators 
... . .................................... .......... I ....... .................................................. ........................................ .......................... 
OPPORTUNITY 
Social or cultural handicap Disadvantage because of health 
Individual resilience Capacity for health; ability to withstand stress-, 
(reserve' 
HEALTH PERCEPTIONS 
Satisfaction with health Physical, psychological and social function 
General health perception Self rating of health; health concern/worry 
FUNCTIONAL STATUS 
Social Work and daily role 
Psychological Distress (anxiety, depression, loss of behavioural 
and emotional control) 
Cognitive Memory, alertness, reasoning 
Physical Activity restrictions, fitness 
MORBIDITY 
Signs Objective clinical findings directly observable 
Symptoms Subjective evidence indirectly observable 
Self reports Patient self reports of symptoms and conditions 
Physiologic Laboratory measures and pathology 
Diagnosis and severity 
DEATH & DURATION OF LIFE Survival, longevity, years of life lost. 
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Health status 
A construct which is related to and sometimes used interchangeably with quality of 
life and health related quality of life is that of 'health status' (Ware, 1987). The term 
was popularised and explicitly adopted by influential researchers such as John Ware 
- author of the SF-36 health status questionnaire (Ware & Sherbourne 1992) and 
Marilyn Bergner - author of the Sickness Impact Profile - SIP (Bergner, et al., 1981)). 
The preceding discussion highlights the sociological and economic origins of quality 
of life and HRQoL. However, health status begins from a theoretical position more 
grounded in health and healthcare. Exponents of the term health status begin with a 
consideration of what constitutes or defines 'health' and seek to operationalise this 
concept. Again the definition of health that most researchers have relied upon is 
that of the World Health Organisation (1948), which describes health as. 
'a state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity' 
Bergner (1985) states that in order to operationalise such a concept 'the factors that 
affect health must be distinguished for the factors that are health'. Accordingly, in 
developing measures of health status, she starts with the notion that 'health status 
ends at the skin'. Health status measures contain those elements that are an 
integral part of the person, but excludes those that exist and behave independently 
of the person (Ware, et al., 1981). Hence, wider economic and social influences on 
health - which might be included in some definition of 'quality of life' - are generally 
excluded form measures of HRQoL. 
Ina similar vein, Ware (1987) suggests that'.... the use of 'quality of life' 
nomenclature is likely to cause confusion because it is too encompassing. Jobs, 
housing, schools, and the neighbourhood are not attributes of a person's health, and 
they are well outside of the purviews of the health care system.... The goal of the 
health care system is to maximise the quality of life, namely health status' 
A further distinction between health status and HRQoL is that although health status 
measures are meant to be based upon definitions of health which include positive 
aspects of health (.... notjust the absence of illness), in effect they have generally 
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been based principally on negative aspects and definitions of health (Bergner, 1985., 
Bowling, 1995). This distinction raises problems. Proponents of ideas of positive 
health, believe that negative conceptions of health (i. e. the absence of disease) may 
be sufficient for measuring health status in ill patients (who constitute approximately 
20% of the population at one time (Stewart, et a/., 1989; Ware & Young, 1979)), but 
are of little value in defining the experience of the other 80-90% of the population. 
Proponents of health status have reflected on the lack of conceptual clarity or 
definition that surrounds the concept of quality of life (and inter-alia health related 
quality of life) (Bergner & Rothman, 1987) and the fact that those who purport to 
measure quality of life rarely define it (Gill & Feinstein, 1994). According to Ware 
(1995), 
'.. it has become fashionable to lump all measures that define health beyond 
traditional indicators of biologic functioning into a single category of quality of life 
measures. This practice offers a shorthand method for referring to a collection of 
concepts both more broad and more qualitative than traditional measures of clinical 
endpoints. However, quality of life as traditionally defined is a much broader 
concept than health. Quality of life encompasses standard of living, quality of 
housing and neighbourhood, job satisfaction, health, and other factors..... using 
quality of life nomenclature, without qualification is likely to cause some confusion. 
Debates about the distinction between health status and quality of life continue, but 
some authors have contested that the distinction is no longer relevant since the 
most commonly used measures of HRQoL and health status are in effect measuring 
the same dimensions (Ware, 1995). A useful summary of the core components of 
HRQoL and health status are provided in table 3, and when a health status 
measurement instrument measures all of these things it is in effect a measure of 
HRQoL. 
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Table 3. Components of Health Status and HRQoL 
Adapted from (Ware, 1987; Ware, 1995) 
Physical health 
Ability to perform physical activity and self care activities (e. g. eating, bathing & 
dressing), and the limitations caused by illness and pain. 
Mental health 
Intensity of symptoms of psychological distress and behavioural dysfunction 
consequent upon this. Includes not just psychological distress, but psychological 
well-being 
Social functioning 
Social contacts and other activities (e. g. visits with friends and relatives), and social 
ties or resources (e. g. close friends and relatives that can be relied upon for tangible 
and intangible support). 
Role functioning 
The performance (or ability to perform) usual role activities, including formal 
employment, school work, etc. 
General perceptions of health and well-being 
How people evaluate overall health and well-being. Representing an individual 
appraisal or overall evaluation of the above factors. 
Cognitive capacity and function 
Orientation, memory, comprehension, abstract reasoning and problem solving 
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In summary, the term Quality of Life is conceptually different from health status and 
HRQoL and when used should be defined or qualified, such that users of such 
scales are aware of exactly what is being measured (Gill & Feinstein, 1994). 
Mosteller attempts to explain the persistence of 'quality of life' (Mosteller, 1989) as 
being due to the intrinsic appeal of the term, which is 'such a winner of a title that 
none of us want to give it up'. A more useful approach than the argument over 
terminology might be the explicit statement of what is in fact being measured by an 
instrument. Thus, we can recognise that HRQoL and health status measures are 
the same, when we know what they include. Similarly, the oversimplification of 
HRQoL when it measures only one domain of health (such as depression or anxiety 
or physical functioning) does not cause problems when the scope of what is 
measured is made explicit (Pope & Tarlov, 1991). 
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Chapter 7 Taxonomies of measurement instruments 
One of the most influential and widely adopted taxonomic classification systems to 
have been proposed in recent years focuses upon a description of the area of 
application of a specific instrument. The broad distinction of measurement 
instruments into: (i) those that are generic and can be applied across all populations 
and disease groups and severities of disease, and (ii) those that are specific and 
focus upon problems associated with individual diseases, patient groups or areas of 
function. The distinction has developed as a way of classifying various patient 
based measures of outcome - particularly health status and quality of life measures 
(Bergner, 1985; Bergner, 1989; Guyatt, et al., 1989; Patrick& Bergner, 1990; Patrick 
& Deyo, 1989; Stewart, et a/., 1989). 
Generic HRQoL instruments are intended to provide a common metric with which to 
compare health, illness and outcome between different populations and conditions. 
Their purpose and requirements neatly summed up by Kane (1987), who described 
generic measures as- 
'the clinical equivalent of the Swiss Army knife - something small and easily taken 
into the fie/d with enough blades and attachments to fit any number of 
circumstances which may arisel. 
Thus, the ideal generic outcome measure will be an instrument that covers sufficient 
facets of life and health that are universally important to people - irrespective of their 
age, sex, disease or health-state. Similarly, they will be sufficiently brief and easy to 
complete such that patients will not be inconvenienced by their application. There 
are broadly two approaches to the measurement of generic HRQoL - profiles and 
utility measures. These are outlined below: 
Health profiles 
The measurement of health through the use of health profiles adopts an explicit 
'psychometric' approach. Psychometrics originally derived from the science of 
pscyhophysics - which attempted the measurement of human perceptions of 
different natural stimuli, such as heat and light (Nunnally, 1967). Psychometrics 
extended the methods of psychophysics into more subjective psychological 
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dimensions such as intelligence, attitudes and health perception (McDowell & 
Newell, 1996). 
Health profiles seek to measure important dimensions of health related quality of 
life. As noted above, these tend to be some combination of the following: physical 
functioning; social functioning; role functioning; mental well-being; and general 
health perceptions (Ware, 1995). Health profiles provide detailed information about 
multiple domains of HRQoL, which is useful for specifying the pattern of functioning 
and well being of the individuals being studied. Scores on each of these dimensions 
are either reported separately (a true health profile) or are occasionally combined to 
provide an overall summary score (a summary health index). Two widely used 
health profiles include the SF 36 (Ware & Sherbourne, 1992) and the Sickness 
Impact Profile (Bergner, 1985; Bergner, et al., 1976), which measure some 
combination of the above domains. 
Utility measures 
Despite the fact that health is multi-dimensional, there are practical reasons why it 
might be useful to obtain some overall summary score of 'health'that combines 
these dimensions. The main reason why this approach might be preferred to a 
health profile is that health profiles make it difficult to make decisions about health 
gain and comparisons between different interventions (Brazier, 1993). In 
psychometric terms, the scores generated by a health profile are not in units 
comparable either between its own dimensions, or with other consequences. For 
example, an intervention might produce health gain in one dimension (e. g. social 
functioning) and decrements in another (e. g. mental well-being), and it is difficult to 
know whether this represents an overall 'health gain'. Similarly, one intervention 
might produce benefit in one domain, whilst another intervention might improve a 
different domain. Individuals, patients or wider society might value a gain in one 
dimension as being more desirable than gain in another (Kaplan & Coons, 1992). 
When decision-makers come to allocate resources or set priorities, it is difficult to 
know which treatment is best, since there is no common metric between competing 
alternatives. The only basis upon which a treatment could be seen as better is if 
gain is demonstrated on all dimensions of a health profile. 
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Utility measures represent an attempt to produce a single summary index of health 
related quality of life, by collapsing these dimensions into a single score according to 
how they are valued (Torrance & Feeny, 1989) and are derived form economic and 
decision theory (von Neumann & Morgernstern, 1944). They reflect the preferences 
of patients for health states that result from intervention. The key elements of utility 
measures are that they incorporate preference measurements and relate health 
states to death (Torgerson & Rafterty, 1999). Thus they can be used in one specific 
type of economic evaluation that combines duration and quality of life - the cost 
utility analysis (Drummond, et a/., 1997; Torrance, 1987). Through the process of 
weighting HRQoL states and the duration of those states - quality adjusted life years 
(QALYs) are calculated (Williams, 1985). 
Disease and domain specific instruments 
The desire to produce a common metric which is applicable to all patients, 
conditions and populations is understandable, but in doing so, difficulties arise. The 
inclusion of only those aspects of health that are 'universal'will mean that important 
features of, say, a specific disease will not be measured, or their effects will be 
diluted. A clinically important change in health status might therefore not be 
recorded by the application of only a generic instrument. One solution might be to 
produce a generic instrument which is sufficiently comprehensive to measure all 
aspects of health for all diseases and populations - which would as a consequence 
be of enormous length and unacceptable (Golligher, 1987). Another approach has 
been to produce instruments that measure a facet of a specific disease - disease 
specific measures, or specific domains of functioning which are common to many 
diseases - domain specific measures (Bowling, 1997). These approaches will be 
considered below, with examples. 
Diseases specific measures 
Disease specific measures focus upon the symptoms or facets of health status, 
which are important for that specific disease. Their major advantage is their brevity 
(since they measure only what is necessary and avoid the use of redundant 
questions included in generic instruments) and their ability to detect small but 
clinically significant changes in health status and levels of disease severity. 
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Domain specific measures 
Important outcomes or domains are often excluded form generic instruments in the 
search for brevity. Whilst these outcomes are globally applicable to all patients, they 
are not of equal importance. Thus areas, such as cognitive functioning, or detailed 
assessment of mood, might not be included in generic instruments, but might be 
important in certain populations (such as the elderly) when assessing outcome or 
response to a certain intervention. 
Examples of commonly used domain specific measures include mood 
questionnaires (such as the Hospital Anxiety and Depression scale (Zigmond & 
Snaith, 1983); cognitive function and memory tests (such as the Mini Mental State 
Examination - Fostein, et aL, 1975); pain questionnaires (such as the McGill Pain 
Questionnaire - Melzack, 1975). Whilst such measures are very sensitive to 
changes in the underlying domain which they measure, they are often long and time 
consuming to complete. This becomes problematic when large 'batteries' of domain 
and disease specific questionnaires are employed to measure outcome. For this 
reason, generic questionnaires, with the only essential additional disease/domain 
specific measures is recommended (McDowell & Jenkinson, 1996; McDowell & 
Newell, 1996). 
The major disadvantage of disease and domain specific instruments is 
encompassed within their specificity. They do not allow comparisons in terms of 
health gain between conditions or populations to be made. Also in common with 
health profiles, they are constructed without reference to 'preferences'. Thus they 
might show 'improvement' whilst the patient themselves might feel worse off. As a 
consequence, they are of little use in resource allocation or priority setting (Cairns, 
1996). 
Strengths and weaknesses of generic and specific measures of health 
As described in the preceding section, there are inherent strengths and weaknesses 
to the various approaches to outcome measurement - these are summarised in 
table 4. General recommendations on the use of measurement instruments 
(particularly within clinical trials) involves the use of the minimum number of scales, 
which should include a generic profile and measurement of patient utility, together 
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with any necessary domain specific instrument (Bowling, 1995; McDowell & 
Jenkinson, 1996; McDowell & Newell, 1996; Wilkin, et a/., 1992). 
This taxonomy will be used throughout this thesis and measures will be described 
according to the following categories. Generic, disease specific, and domain 
specific. The latter two categories will to a certain extent overlap, and where this 
occurs this will be noted. 
Having introduced a vocabulary within which outcome measures and measure of 
patient based outcome can be discussed with some degree of clarity, this will be 
applied in subsequent sections of this thesis. 
Table 4: Strengths and weaknesses of generic and specific measures 
of health 
Measure Strengths Weaknesses 
Generic instruments 
Health profile Is a single instrument 
Has established reliability and validity 
Detects differential effects on different 
aspects of health status 
Allows comparisons between 
interventions or conditions 
Utility measurement Provides single number representing net 
impact on quality of life 
Allows cost utility analysis 
Specific instruments Are clinically sensible 
May be more responsive than generic 
instrument 
May not focus adequately on area of 
interest 
May not be responsive 
Difficult to know whether health state is 
improved (is more desirable) when gain 
in one dimension is accompanied with 
loss in another 
May involve difficulty in determining 
utility values 
Does not allow examination of effect on 
different aspects of quality of life 
May not be responsive 
Sometimes difficult for respondents to 
comprehend or agree to express 
preferences. 
Do not allow comparison between 
conditions 
May be limited in terms of populations 
and interventions 
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Chapter 8 Uses of patient based outcome measures. 
Patient based health outcome measures have been defined and their content 
examined in chapters 1-7. They have been put to several distinct uses in the realm 
of healthcare practice, research and policymaking. Several writers have described 
the various uses of measurement instruments in healthcare (Fitzpatrick, 1994; 
Fitzpatrick, et al., 1992a; Kane & Kane, 1981; Nelson & Berwick, 1989; Patrick & 
Bergner, 1990; Steinwachs, 1989; Ware, 1995). Similarly, some of these uses are 
more relevant to a discussion of patient based outcome measurement than others. 
These uses often reflect a US based focus of the research literature and also serve 
to illustrate the lack of clarity that is apparent when the term 'outcome' is used. The 
purpose of this section is to introduce a terminology that will be used throughout the 
rest of thesis in describing the uses of patient based outcome measures and to 
provide illustrative examples of these uses. 
Health Care Policy Evaluation 
The restructuring and reorganisation of healthcare systems - principally in the US, in 
response to escalating healthcare costs, has generated an impetus to measure the 
health consequences of these changes. As described previously in Chapter 2, 
healthcare systems have in the past been evaluated by crude measures of activity 
and utilisation, rather than patient based measures of health status (Kindig, 1977). 
The recognition that health care organisation and evaluation requires more complex 
and patient based measures has been one of the central tenets of the US'outcomes 
movement' (Ellwood, 1988). Reorganisation strategies such as cost containment, 
managed care, co-payment and the reimbursement of episodes of care according 
'Diagnostic Related Group' have raised fears that the care (and health) of certain 
groups of patients will suffer. For example, there is the concern that patients will be 
discharged from hospitals 'quicker and sicker'. 
Two important landmarks in the evaluation of health policy are the Health Insurance 
Experiment and the Medical Outcomes Study, which are described in some detail 
below. 
The Health Insurance Experiment (HIE) is the largest evaluation of health care 
policy to date, and has been discussed previously. Briefly, the healthcare effects of 
two cost containment strategies - cost sharing in a fee for service (FFS) system and 
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a prepayment method of insurance - were evaluated using standardised surveys of 
health and social function over a five year period (Patrick, et al., 1973). A total of 
4000 people were enrolled and followed up for three to five years, having been 
randomly allocated to differing health insurance programmes. Co-payment 
schemes resulted in one third less healthcare utilisation when compared to 'free at 
the point of entry' care. An expressed aim of those conducting the study was to 
determine the actual effect of this reduced healthcare utilisation on 'broader health' 
(Brook, et a/., 1983). Subjective health was explicitly measured in addition to harder 
outcomes, and a health questionnaire was developed for this purpose. The self- 
completed HIE health questionnaire consisted of 108 items, measuring five 
dimensions: physical functioning, mental health, social contacts, and health 
perception. According to the authors, the HIE 'cleady demonstrated the potential for 
scales constructed from self administered surveys as reliable, valid tools for 
assessing changes in health status for adults and children in the general population' 
(Ware & Sherbourne, 1992). Aside form the impact of this study on healthcare 
policy in increasing the use of cost sharing strategies, the enduring impact of the 
HIE has been to raise the profile of health status measurement. 
The subsequent Medical Outcomes Study (MOS) sought to further develop patient 
based measures, refining and making more practicable the instruments developed 
in the HIE, in order to investigate the effect of variations in system of care, clinician 
speciality, and clinicians' technical and interpersonal style on actual patient 
outcome. A total of 3000 patients with a number of medical conditions, including 
diabetes, hypertension, heart disease and depression were recruited and were 
followed up for two years. Aspects of service use and treatments were monitored 
and outcomes (both self reported and clinical'/laboratory measures) were examined. 
The study was able to correlate structures (e. g. method of payment), processes 
(e. g. aspects of practice style) with outcomes. The relevance of the Medical 
Outcomes study to mental healthcare evaluation in particular will be examined in 
detail in section 2 of this thesis. 
The self completed health status questionnaires developed in the MOS eventually 
evolved into the Short Form - 36, which has become one of the most widely used 
and heavily promoted patient based outcomes measures in the 1990s (Brazier, 
1993; Hays, et al., 1993; McHorney & Ware, 1995; McHorney, et al., 1993; Tarlov, 
et al., 1989; Ware & Sherbourne, 1992; Wright, 1994b). 
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Health care evaluation 
Clinical trials (particularly when randomised and double blind) provide the most valid 
form of evaluation of one treatment, intervention or technology against another 
(Guyatt, et aL, 1993b). Alternative treatment regimens and technologies can and 
should be compared in terms of their impact on patient functioning and well being, in 
addition to traditionally defined biologic endpoints (Guyatt, et a/., 1991). In the UK, 
the Department of Health (1992) suggests that the following should be incorporated 
into outcome measurement: survival rates, symptoms and complications, health 
status and quality of life, the experiences of carers and the costs and use of 
resources. Their report continued: 'many health technologies are intended to 
improve general health and the quality of life, so it is important to measure patients 
subjective experiences of illness and the care they receive'. 
In general, and with notable exceptions, patient based measures have not been 
used in healthcare evaluation (Aaranson, 1989; Sanders, et al., 1998). Broader 
measures of health status clearly have the potential to complement traditionally 
defined clinical endpoints in all conditions - but have generally not been measured, 
although this is not always the case. The two spheres of healthcare that seem to be 
particularly well advanced in this respect are rheurnatology and oncology. The 
example of outcome measurement in rheumatology and oncology serves to illustrate 
the need for and contribution of patient based measures. 
Rheurnatological conditions are chronic in their nature and important patient centred 
outcomes might include the ability to perform activities of daily living and resolution 
of pain. In the early 1980s, outcome was traditionally defined in terms of biophysical 
endpoints, such as blood titres of rheumatoid factor and range of joint movement 
expressed in degrees (Bombardier & Tugwell, 1982). Innovative treatments were 
introduced in the 1980s (such as aurofurantoin), which possessed both toxic side 
effects and a potential to modify disease activity. The evaluation of the relative 
contribution of adverse and beneficial effects at the patient level required the 
incorporation of broader measures of health status (Meenan, et a/., 1984). The 
introduction of patient based measures such as the Arthritis Impact Scale (AIMS) 
(Kazis, et aL, 1988) has broadened the way in which outcome is measured in many 
trials in rheurnatology trials. Similarly in Cancer therapies, where traditionally 
outcome is measured by five year survival rates, the dimension of health status has 
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been introduced to measure both quality and quantity of life, in order to evaluate 
therapy. A recent survey of RCTs in cancer showed that 29% of trials reported 
using some measure of health status or quality of life, compared to less than 2% of 
trials in other areas of healthcare (Sanders, et al., 1998). It is worthy of note that 
one of the earliest standardised measures of health status and, until recently, the 
most commonly used is the Karnofsky index. This scale was introduced to 
supplement mortality data in the evaluation of cancer treatment in patients in 1948. 
Making individual clinical decisions in routine medical practice 
In contrast to some of the more research-oriented uses outlined so far, health status 
instruments might also be used in routine clinical practice with aim of improving the 
quality of individual care. It has been argued that patient based outcome measures 
offer an important adjunct to clinicians in the care of their patients (Tarlov, et a/., 
1989). Here the purpose of patient based instruments might be (1) to aid the 
recognition of problems which might be otherwise unrecognised or (2) to monitor the 
progress of the individual patient and hence to monitor and guide treatment 
(Fitzpatrick, 1994). In the first of these uses, the identification of unrecognised 
problems, patient based instruments are in effect being used as screening or case 
recognition instruments. Traditional forms of screening, such as radiological 
investigations and biochemical tests, are generally evaluated using the parameters 
of sensitivity, specificity and predictive value. These parameters should be 
employed when investigating the performance of health status measures, although 
this is rarely the case (Fitzpatrick, 1994). 
Health professionals are often unaware of many of their patient's health and social 
problems (Sprangers & Aaranson, 1992) and there might be an expected benefit of 
health status measures in improving patient care. Generally, this expected benefit 
has not been seen in experimental evaluations of the health status measures when 
applied to routine practice. One study is that by Kazis, et al. (1990), who conducted 
a trial to examine the benefits gained by informing clinicians of their rheumatological 
patients' health status scores. Patients who completed health status questionnaires 
and had the results of these scales fed back to their clinicians had no better 
outcome than patients who did not have results fed back to their clinicians. The lack 
of evidence supporting the application of health status questionnaires in effecting 
improved care and clinical outcome is reviewed by Fitzpatrick (1994). 
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It has been noted that patients welcome the opportunity to impart information which 
is generally outside of the scope of the traditional clinical interview - but which they 
feel to be important (Nelson & Berwick, 1989). In this use, patient based 
instruments might be seen as an adjunct to traditional clinical encounters, which 
facilitate better communication. This is an explicit (but not sole) purpose of a 
number of health status and quality of life instruments, such as the Nottingham 
Health Profile (Hunt, et al., 1985a) and the Lancashire Quality of Life Profile (Oliver, 
et a/., 1996). For some instruments, such as the Dartmouth COOP, this is the 
primary function and most important influence on design (Nelson, et al,, 1990) - i. e. 
it is brief, easy to understand and complete and asks questions which patients will 
find relevant. The 'ease of use' of an instrument will ultimately influence the degree 
to which an instrument is acceptable to patients and clinicians. For this reason, 
short forms have been developed which are easy to incorporate into routine practice 
(Nelson, et al., 1990). 
Economic evaluation and resource allocation 
The measurement of both monetary cost and outcome (positive and negative) is the 
defining feature of an economic evaluation. Cost and outcome can be combined to 
produce measures of hypothetical benefit, which can be obtained for a given 
expenditure, such as incremental cost effectiveness ratios, and quality adjusted life 
years (QALYs) (Williams & Kind, 1992). 
One of the most controversial applications of health status and quality of life 
measures has been their use in allocating limited resources among competing 
healthcare programmes (Spiegelhalter, et al., 1992). The instrument most used in 
this context is a specific type of measure - the Quality Adjusted Life Year (QALY). 
The nature, underlying assumptions and properties of utility measures, such as the 
QALY, have been introduced in a previous section. Briefly, QALY measures 
combine quantity and quality of life into a single measure (Williams, 1985), in order 
to assess benefit brought about by a funded programme. For each programme, this 
benefit (in terms of QALYs) can be divided by its economic cost and the resulting 
ratio (cost/QALY) used to allocate resources. QALYs can be used chose between 
alternative programmes for treating the same patient's or more controversially, to 
choose among programmes targeted at different groups. 
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The underlying philosophy behind the use of QALYs and cost/QALY estimates is 
that rationing of resources is inevitable and that it is best to be explicit and 
accountable (Smith, 1991). 
Clinical audit 
Audit consists of reviewing and monitoring current practice and evaluation 
(comparison of performance) against predefined standards and the use of this 
information to improve standards (Higginson, 1994; Standing Committee on 
Postgraduate Medical Education, 1989). Audit has tended to use measures of 
process in preference to measures of outcome as the 'standards'that are measured 
(Crombie & Davies, 1997). However, the systematic measurement of outcome has 
been proposed as a 'standard' in audit (Frater & Costain, 1992). Long & Dixon 
(1996) identify two scenarios whereby outcome can be usefully measured in the 
audit process. Firstly, by using adverse events or outcomes as sentinel events that 
prompt an investigation into the process of care to judge what (if anything) went 
wrong? An example of this might be confidential inquiries into perioperative deaths 
and critical incident monitoring in anaesthesia. Secondly, by setting a standard in 
terms of outcome and monitoring whether this outcome is achieved in routine 
practice. 
Monitoring the health and assessing the needs of population ('healthcare 
needs assessment'). 
Those responsible for purchasing and providing health care are increasingly 
expected to base their decisions about the allocation of health care resources on 
evidence (Kelly, et al., 1996). The 'needs' of a population is one component of 
rational allocation of resources. It has been argued that patient based measures 
provide a feasible and valid measure of health status, which supplement traditions 
epidemiological indices of mortality and morbidity (Hunt, et al., 1985b). Some 
authors discuss this use as an example of 'outcomes measurement' (Delamonthe, 
1994; Frater, 1992; Geigle & Jones, 1990), although a single snapshot of the health 
status and needs of a population does not fulfil the definition offered earlier - i. e. a 
measure of change in health. 
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Chapter 9 Introduction to the rest of the thesis 
The preceding discussion has highlighted a number of core themes which emerge in 
considering the historical development of outcomes measurement in healthcare and 
the movement towards the use of more 'patient based' measurement instruments. 
The broad purpose of the current thesis is to produce a critical overview of patient 
based outcome measurement in psychiatric research and practice. Some of the 
major themes that have emerged from the preceding chapter are outlined below, 
together with a discussion of how and why these themes will be explored within the 
realm of psychiatry. 
Section 2 Outcomes measurement in psychiatric research 
Given the variety of perspectives and tools that can be adopted in the measurement 
of outcome, then it will be of interest to know how outcome has come to be 
measured in psychiatric research. A series of surveys, with illustrative examples will 
empirically demonstrate the tools and methods that are used in psychiatric research 
- with particular emphasis on patient based measures. 
The output of this section of the thesis will be an overview of the current use of 
outcomes measures in psychiatric research. 
Section 3 Outcomes measurement in clinical practice 
The urge to incorporate outcome measurement into the routine day to day care of 
patients is built upon the supposition that the information collected within such 
measures reflects the patients' perspective and that such information is useful in 
actual decision-making. However, we know little about what measures are actually 
used in routine practice and in healthcare decision making in the UK. Empirical 
research will therefore demonstrate what (if any) outcome measures are used in 
actual psychiatric patient care and decision making in the current NHS. This 
empirical research is intended to complement the review of the use of patient based 
outcome measures in actual psychiatric research. It will, for example, be of interest 
to know to what extent measures used in psychiatric research are actually used in 
routine care. 
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The collection of patient based outcome data in the context of actual routine care is 
in itself a fruitless exercise unless it improves the quality or actual outcome of care. 
The empirical research base from wider healthcare is at best contradictory in 
providing any support for the routine collection of outcomes in this respect 
(Fitzpatrick, 1994; Fitzpatrick, et al., 1992a). It will therefore be of interest to know 
what research evidence exists to support the routine collection and use of outcomes 
in psychiatric care. The research evidence to support routine outcomes 
measurement (particularly patient based outcomes measurement) will be examined 
using a systematic review methodology. 
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Section 2- Outcomes measurement in psychiatric research 
Section 2.1 Introduction 
Section 2.2 Outcomes measurement in clinical trials in psychiatry 
Section 2.3 Outcomes research in psychiatry 
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Section 2.1 Overall Introduction to outcomes measurement in 
psychiatric research 
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Chapter 10 Measurement in psychiatfy 
Measurement in psychiatry has had to incorporate the operational isation and 
recording of subjective experience - i. e. the measurement of patient's reports of 
internal psychic phenomena in the form of psychiatric symptoms, aspects of mood, 
anxiety, delusions and hallucinations. These are phenomena that cannot be 
externally observed or verified. There is no (as yet identified) diagnostic 
pathophysiological basis for'functional' psychiatric disorders (such as schizophrenia 
and depression), and most classificatory systems (such as DSM and ICD) diagnose 
illness according to the presence or absence of mental symptoms that are 
'subjective' in their nature in that they are perceived by the patient (Cooper, et al., 
1972). These diagnostic systems, for the greatest part, involve the use of trained 
observers asking standardised questions of patients to record (in a reproducible 
manner) the presence or absence of internal mental symptoms. Similarly, there has 
been significant work in the production of 'standardised' measurement instruments 
with which to diagnose psychiatric disorder in a reliable manner and/or to quantify 
the degree of severity of a 'disorder'. These standardised instruments have made 
possible subsequent epidemiological studies of population incidence and prevalence 
of major mental disorders (e. g. Reiger & Kaelber, 1995; Sartorius, et al., 1986) and 
investigations of the course of illness (e. g. Shepherd, et al., 1989). Thus 
standardised instruments, which have been shown to be both valid and reliable in 
diagnosing and measuring the severity of psychiatric disorders are available to 
researchers and clinicians - and are seen as valid tools in the conduct, presentation 
and communication of psychiatric research. 
Max Hamilton, the author of one of the most influential standardised instruments in 
psychiatry, the Hamilton Depression Rating Scale (Hamilton, 1967), writing in 1972 
reflected the optimism and embrace of standardised measures in psychiatric 
research, when he stated: 
'A rating scale is, in a sense, an end product of the development of psychiatry. 
When the phenomena to be studied have been completely defined in nature and 
range, then it is possible to construct a scale to evaluate them'. (Hamilton, 1972) 
Standardised symptom based measures therefore form the backbone of psychiatric 
research, and there seems to have been an industry in their construction. However, 
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psychiatry has not restricted its self to the measurement of psychopathology. 
Thornley & Adams (1998) in a survey of over 2000 randomised trials conducted in 
schizophrenia found 640 scales to be in use, of which only one third were explicit 
measures of psychopathological symptoms. The main reason for this proliferation 
and dominance of standardised outcomes instruments are likely to be the fact 
psychiatry generally involves the care of persons with chronic and often socially 
disabling disorders such as schizophrenia, for which standard and easily recordable 
endpoints such as mortality have limited meaning. 
A commonly used classification system for outcomes measures in general (and 
patient based outcomes measures in particular) divides instruments into generic, 
disease specific and domain specific measures (Bowling, 1997) -see section 1. 
Difficulties arise when applying this taxonomy directly in the sphere of psychiatry. 
Firstly, many authors consider instruments that measure the frequency and intensity 
of psychiatric symptoms (especially those encountered in mood disorders) to be 
patient based measures of outcome e. g. (Bowling, 1997; Sanders, et a/., 1998), 
since this is a core component of the dimensions and domains considered to be 
integral to health related quality of life (Ware, 1987; Ware, 1995). However, this 
analysis is difficult to support in psychiatry. Other specialities (such as 
rheumatology and oncology) rightly contrast biophysical measures of outcome with 
patient based measures of outcome. For example, in rheumatology, the erythrocyte 
sedimentation rate or the number of joints that are affected may have little bearing 
on the way in which the individual with arthritis lives their day-to-day life. In order to 
assess this, patient based measures are adopted. However, in functional 
psychiatric disorders, there are no biophysical correlates of disease. Instead, 
instruments are used which measure the frequency and intensity of subjective 
psychiatric symptoms, with little examination of how these relate to the impact of the 
disorder on the individual. The nature and basis of common psychopathological 
ratings scales are considered in more depth below, but for the purposes of the 
present thesis, these will not be considered as patient based measures of outcome 
(either generic or domain specific). Secondly, some commonly used measures in 
psychiatry fall somewhere between measures of psychopathology and measures of 
functioning - these include some important global measures of outcome. The 
nature and basis of these measures is also considered below. 
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In summary, throughout this and subsequent sections, a distinction will be drawn 
between standardised instruments which count the frequency and intensity of 
symptoms associated with the diagnosis and severity of a disorder (symptom based 
psychopathology measures), and instruments which judge the impact of psychiatric 
disorders on the individual and how they live their day to day life (patient based 
measures). 
The following section outlines some of the major methods and instruments that are 
available for use in evaluative psychiatric research, and which will be explored in 
more detail in subsequent sections. 
Standardised measures of psychiatric symptoms 
Examples of such symptom-based instruments are the Brief Psychiatric Rating 
Scale (used in schizophrenia) and the Hamilton Depression Rating Scale (used in 
depression). The content of these two measures is outlined in Table 5. These are 
usually (but not always) clinician or interviewer administered and rated instruments. 
Table 5: Content of two common symptom-based measures 
Hamilton Depression rating Scale (HDRS) (Hamilton, 1967) 
The HDRS is a clinician-completed scale, with 17 items that cover the following symptoms associated with 
depression: 
" Depressed mood 
" Self depreciation and guilt feelings 
" Suicidal impulses 
Insomnia 
" Somatic symptoms 
" Retardation/agitation 
" Anxiety 
" Sexual interest 
" Ability to work and engage in interests 
Brief Psychiatric Rating Scale (Overall & Gorham, 1962) 
The BPRS measures the following symptoms associated with schizophrenia, together with depressive symptoms 
" Somatic concerns (including delusions) 
" Anxiety 
" Emotional withdrawal 
" Conceptual disorganisation 
" Self depreciation and guilt 
" Movement disorders 
" Depressed mood 
" Hostility/suspiciousness 
" Hallucinations 
" Motor retardation 
" Unusual thought content 
" Blunted or inappropriate affect 
" Disorientation or confusion 
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Global measures of outcome 
Global measures of outcome have a long history in psychiatry, which begins with the 
Health Sickness Rating Scale by (Luborsky, 1962) in 1962, which represented an 
attempt to rate health/sickness on a 100 point scale. Subsequent modifications 
include the Global Assessment Scale in 1976 (Enndicot, et al., 1976), and the 
Global Assessment of Functioning scale, which forms axis V of the fourth edition of 
the Diagnostic and Statistical Manual - DSM-IV (American Psychiatric Association, 
1994). Most measures have attempted to include some overall assessment of both 
functioning and psychiatric symptom intensity, usually made by clinicians. 
Such scales therefore lie somewhere between symptom based measures, and 
those measures which tap domains included in instruments which have hitherto 
been referred to as patient based measures (see below). Spitzer, et al., (1996) in a 
review of the content and psychometric properties of the GAF, refers to it as an 
overall measure of 'psychosocial health/sickness'. Global measures, such as the 
GAF are intended to be applied to all patients with psychiatric disorders, irrespective 
of diagnosis. The structure of the GAF is outlined in Table 6. 
Table 6: An example of a global outcome measure 
The Global Assessment of Functioning Scale (Spitzer, et aL, 1996) 
Clinicians are urged to rate global function between 0 (worst) and 90 (best), considering 'psychological, social and 
occupational functioning on a hypothetical continuum of mental health-illness. ' 
Raters are provided with a series of anchor points to guide their rating: 
Code 81-90 
'absent or minimal symptoms (e. g. mild anxiety before an exam), good functioning in all areas, interested and 
involved in a wide range of activities, socially effective, generally satisfied with life'. 
Code 41-50 
'Serious symptoms (e. g. suicidal ideation, severe obsessional rituals) OR any serious impairment in social, 
occupational or school functioning' 
Code 1 -10 
Persistent danger of severely hurting self or others (e. g. recurrent violence) OR persistent inability to maintain 
minimal personal hygiene OR serious suicidal act with clear expectation of death. 
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Social and role functioning 
Mental disorders are generally strongly associated with social dysfunction, 
particularly schizophrenia and the major affective disorders (Wiersma, 1996). Since 
the 1960s, there has been a proliferation instruments to measure social and role 
functioning (Katching, 1983; Weissman, 1975). Wiersma (1996) identifies the major 
domains that are included in popular measures of social and role function: 
" Occupational role (work, eductaion, household, reguair activities) 
" Household role (participating and contributing to the household and its economic 
independence) 
" Marital role (emotional/sexual relationship with partner) 
" Parental role (relationship with children, caring) 
" Family or kinship role (relationship with parents and siblings) 
" Social role (relationships with community, with friends and acquaintances) 
" Leisure activities and or general interests 
" Self care (grooming and appearance) 
Commonly used standardised instruments include the Social Adjustment Scale 
(Weissman & Bothwell, 1976); Katz Adjustment Scale (Katz & Lyerly, 1963); Social 
Functioning Scale SFS (Remmington & Tyrer, 1979); Index of activities of Daily 
Living (Katz, et al., 1963). 
Quality of life and health related quality of life 
There are a number of quality of life, health related quality of life instruments that 
have been developed specifically for the use amongst persons with mental 
disorders. The common feature of these instruments is that they measure more 
than just psychopathological symptoms or single domains of health related quality of 
life (Ware, 1995), such as social functioning. According to Lehman (2001), common 
features of quality of life measures designed for use in people with mental disorders 
is the fact they 'cover patientsperspectives on what they have, how they are doing 
and how they fee/ about their life circumstances'. Specifically, they include sense of 
wellbeing; functional status; access to resources and opportunities. An example 
includes Lehman's own Quality of life Interview - QOLI (Lehman, 1983b), which is 
described in table 7. 
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Table 7: Lehman's Quality of life Index 
The QOLI is a self-report. interviewer-administered measure, which consists of 153 items, and takes 40 minutes to 
complete. The QOLI measures global life satisfaction as well as objective QOL (what they do) and subjective QOL 
(how they feel about these experiences) in eight life domains: 
Living situation; 




Work and school; 
Legal and safety issues and health. 
It was designed for persons with severe and persistent mental illness, particularly in community settings, but it has 
been adapted for those in long term institutional care.. An example of a typical question is given below: 
Q. In the past year, how often did you get together with a member of your family? 
Answer Once a day, once a week, once a month, at least once during the year, not at all. 
How do you feel about: 
A. Your family in general? 
B. How often you have contact with your family? 
C. The way you and your family act toward each other? 
Answer Tertible; unhappy; mostly dissatisfied; mixed; mostly satisfied' pleased; delighted 
(Lehman, 1983b) 
Having briefly outlined some of the instruments that are available to researchers in 
psychiatry, the following section will now examine how these instruments have been 
used to measure outcome in two major forms of evaluative research: Clinical trials 
(section 2.2) and outcomes research (section 2.3). 
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Section 2.2 Outcomes measurement in clinical trials in psychiatry 
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Chapter 11 Introduction to the survey of clinical trials 
The previous section outlined some of the methods and standardised measures that 
are available with which to measure outcome in psychiatric research. The purpose 
of this section is to seek to examine, using the taxonomy introduced in the previous 
section, the way in which outcome is measured in clinical trials conducted in 
psychiatry. 
Clinical trials are considered to be the most robust form of evidence in deciding what 
works in healthcare in general (Sackett, et a/., 1991), and also in mental health 
(WHO, 1991). In particular, randomised controlled clinical trials (RCTs) have been 
judged to be the best method available, largely due to their ability to eliminate 
confounding by ensuring that treatment is allocated according to the play of chance 
through randomisation (Guyatt, et a/., 1993b; Pocock, 1983). The prominence of 
clinical trials has been recognised within the recent evidence based movement, 
where they form the highest level of clinical evidence, and where the application of 
this evidence in clinical decision making and policy formulation is encouraged 
(Sackett, et al., 1991). Similarly, efforts to produce systematic reviews of clinical 
trials have been seen as a priority, with initiatives such as the establishment of the 
international Cochrane Collaboration (Chalmers & Altman, 1995). 
A central component of the design of any trial is the choice of outcome measure that 
is used in deciding the success or otherwise of a healthcare intervention. Therefore 
in applying the results of a trial in clinical practice or in formulating healthcare policy, 
a core consideration is not just the choice of experimental method used by 
researchers, but also the choice of outcome measure. For example, Sackett, et al. 
(1991) suggest that in judging the applicability of a clinical trial, a fundamental 
judgement must be made about whether all clinically relevant outcomes were 
recorded, including quality of life. 
The previous section outlined the diversity of methods that are available to 
researchers when measuring outcome. There is a danger that outcome may be 
solely assessed by a limited method, such as by counting the frequency or 
attempting to measure the severity of psychopathological symptoms associated with 
common psychiatric disorders, without reference to how these symptoms impact on 
the individual and how they live their lives. A survey was therefore undertaken in 
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order to establish the methods that are used in measuring outcome in high quality 
epidemiological research - randomised clinical trials. 
Aims of the survey: 
1. To examine the methods that are used in measuring outcome in randomised 
controlled trials in psychiatry. 
2. To examine which, if any, patient based measures are used to measure 
outcome in randomised controlled trials in psychiatry. 
3. To examine how the measurement of outcome has changed over time in 
randomised controlled trials in psychiatry. 
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Chapter 12 Methods of the survey of outcomes measurement in 
psychiatric trials 
An empirical survey of controlled trials was conducted, using high quality systematic 
reviews of randomised trials as a sampling frame for this survey - the Cochrane 
Database of Systematic Reviews (The Cochrane Database of Systematic Reviews, 
2000). A number of topic areas were examined in more detail, in order to provide 
illustrative examples of patterns that were apparent in the measurement of outcome 
in clinical trials. Throughout the following section, a contrast will be drawn between 
two divergent methods of measuring outcome: (1) the use of symptom based clinical 
measures that count or measure the frequency or severity of symptoms of 
psychiatric disorders, and (2) patient based measures which examine the impact of 
psychiatric disorders on the individual and their quality of life. 
Survey method 
Target population 
The target population for the purposes of this survey was defined as: 
Randomised trials of interventions for common functional psychiatric disorders. 
Trials relating to the following were therefore excluded: 
0 Drugs and alcohol problems; 
0 Child and adolescent populations; 
* Cognitive impairment. 
Sampling frame 
The sample frame for the purposes of the survey was randomised controlled trials 
included in systematic reviews conducted within the Cochrane Collaboration. Two 
specific Cochrane groups conduct systematic reviews of interventions in mental 
health- the Cochrane Schizophrenia Group (CSG) and the Cochrane Depression, 
Anxiety, and Neurosis Group (CCDAN). Together, these two groups conduct 
reviews that cover the major diagnostic groups suffering from functional psychiatric 
disorders. 
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Cochrane reviews were chosen as a sample frame for the following reasons of 
practicality, ease of data collection and convenience: 
0 Cochrane reviews have each judged the methodological quality of their 
component trials, particularly with respect to randomisation, therefore ensuring 
only randomised trials be included in the survey. 
0 In the course of completing a review, researchers are required to record the 
outcomes measures that are reported in the individual component trials. 
0 Hard copies of each of the component trials are held in the relevant editorial 
bases of the respective review groups, allowing further information to be sought, 
and ambiguous outcomes to be checked. 
All reviews published in the Cochrane Library, up to and including issue 2 2001, 
were sampled. In total, twenty complete reviews conducted under the auspices of 
the CCDAN, and 59 complete reviews conducted under the auspices of CSG were 
available for the survey. All potentially relevant CCDAN reviews were included, and 
a random sample of half of the CSG reviews was taken. 
Data collection 
For each component trial, the following were sought. 
1. Year of publication 
2. Mental health problem: the specific disorder of population under examination was 
recorded, and these were classified into (i) depression, anxiety and related 
disorders, and/ or (ii) schizophrenia or other severe mental illness. 
3. Intervention: the specific intervention under examination was recorded, and these 
were classified into (i) drug treatments or physical interventions (ii) psychosocial 
interventions, or (iii) health policy interventions. 
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4. Standardised outcomes measures used 
All standardised instruments used to measure outcome within each trial were 
recorded. Standardised outcomes instruments were defined as those using an 
interview schedule or questionnaire format, which was administered in a defined and 
reproducible manner. Unpublished rating scales, particularly those produced for the 
purposes of the study, without reference to published literature on the psychometric 
properties of that instrument were considered as non-standardised measures of 
outcome, and were not included in this survey. 
Each standardised outcome was then subsequently classified into one of the 
following categories: 
A. Psychopathological rating scale: defined as a scale or instrument that 
predominantly measured symptoms association with a common functional 
psychiatric disorder. 
B. Global outcome measure: a measure which gave an overall appraisal of 
disease severity, with reference to the global severity of the disorder or its impact on 
overall functioning, rather than by counting the number or frequency of individual 
symptoms associated with as disorder. Examples of this form of outcome measure 
include the Global Assessment of functioning (GAF) (American Psychiatric 
Association, 1994) and Global Assessment Scale (GAS) (Enndicot, et al., 1976). 
C. Generic patient based outcome measure: a measure which examines several 
domains of health status or health related quality of life, and which is designed to be 
applied across different population, irrespective of illness or diagnosis. Examples 
include the Short Form 36 - SF36 (Ware, et al., 1993) or Sickness Impact Profile - 
SIP (Bergner, et al., 1976). 
D. Disease specific patient based outcome measure: a measure which examines 
several domains of health status or health related quality of life, and which is 
designed to be applied to specific patient groups or a specific disease category. 
E. Domain specific patient based outcome measure: a measure that examines 
a specific domain associated with health status or health related quality of life. For 
the purposes of this survey, the domains identified by Ware (1995) considered to be 
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the core components of health related quality of life, and include: physical health; 
social functioning; role functioning; general perceptions of well-being; cognitive 
capacity. In addition, satisfaction with treatment or healthcare services was included 
as a domain that is sometimes considered to be a facet of patient based outcome, 
particularly in mental health (Ruggeri, 2001) - see table 4 for operational definitions 
of these domains. 
F. Other outcomes: in addition to the above, the presence of the following, as 
outcomes in individual component trials was recorded: relapse; mortality; service 
use. 
Data were extracted from the summary reports of outcomes used in individual trials, 
as reported in Cochrane Systematic reviews. The content of individual outcomes 
measure was judged from one of several reference textbooks (Bech, et al., 1993; 
Bowling, 1995; Bowling, 1997; McDowell & Newell, 1996; Sederer & Dickey, 1996; 
Thompson, 1989), prior to categorisation, as outlined above. Where this could not 
be established, clarification regarding content was sought by reference to the 
original paper. 
Data were entered into a custom designed Microsoft Access relational database 
(Microsoft Corporation, 1998) 
Quality assurance 
Since the survey relies on the extraction of data from reviews conducted by others, 
a random sample of 5% of the original trials were obtained and cross checked in 
order to establish the reliability with which the presence of standardised outcomes 
measures had been established within Cochrane systematic reviews. Systematic 
reviews found to have poor reporting of standardised outcomes instruments were 
then subject to verification by reference to original component studies. Poor 
reporting was operationally defined as missing more than one standardised 
outcomes measure. 
Data analyses 
Descriptive statistics regarding the frequency and type of outcomes were calculated 
using Microsoft Excel spreadsheets (Microsoft Corporation, 1997a). Specific 
comparisons were made in order to examine whether outcome was measured in 
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different ways according to different diagnostic categories or according to different 
treatments being evaluated. Trends over time with respect to method of outcome 
measurement were undertaken by weighted regression techniques, using the 
StatsDirect commercial statistical package (Buchan, 2000). 
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Chapter 13 Results of the survey of outcomes measurement in 
psychiatric trials 
Included studies 
In total 490 individual trials were identified. The topic area of individual reviews and 
their component trials is given in Table 8. A total of 233 studies of interventions for 
schizophrenia and related disorders and 257 studies of interventions for depression, 
anxiety and related disorders were included. Year of publication ranged from 1956 
to 2000. The annual publication of studies rose over time (see figure 1). 
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General overview of method of outcome measurement 
The majority of studies examined outcome using a standardised symptom based 
outcome measure. Global measures were also used commonly to measure 
outcome. Patient based outcome (generic, disease specific or domain specific) was 
not measured in the vast majority of studies. Table 9 summarises the methods 
adopted in measuring outcome amongst trials, with a breakdown according to 
patient or diagnostic group, and by type of intervention. The specific patterns of 
outcome measurement are explored in more detail below. 
Psychopathological rating scales 
Symptom based psychopathological rating scales were the most commonly used 
standardised outcome measure for all disorders and interventions. They were used 
more commonly for drug-based interventions, compared to psychosocial 
interventions in both schizophrenia (79.9% vs 49.2%, difference = 30.5%, 95% Cl 
17.2 - 43.5%), and depression, anxiety and related disorders (90% vs 70.3%, 
difference = 19.7%, 95% CI 0.06% - 36.2%). For schizophrenia and related 
disorders, the most commonly used measures were: the Positive and Negative 
Syndrome Scale (Kay, 1991), and the Brief Psychiatric Rating Scale (Overall & 
Gorham, 1962). For depression and related disorders, the most commonly used 
measures were: the Hamilton Depression rating scale (Hamilton, 1967) 
Global measures 
Global measures were used in less than half of all trials. They were more commonly 
used in drug trials, than in psychosocial interventions, for both schizophrenia (54% 
versus 21.7%, difference = 32.3%, 95% Cl 18.9% - 43.2%), and depression, anxiety 
and related disorders (35.0% versus 10.0%, difference = 25.0%, 95% Cl 9.2% - 
33.9%). The most commonly used measures were the Global Assessment of 
Function (American Psychiatric Association, 1994), and the Global Assessment 
Scale (Enndicot, et al., 1976). 
Generic patient based outcomes measures 
In contrast to symptom based and global measures, there was little evidence of the 
use of generic patient based outcome measures, with approximately 1% of trials 
using these measures. Those that were used were the Short form 36 (Ware, et al., 
1993) - n=5, the Dartmouth COOP (Nelson, et a/., 1990) - n=1. These were used in 
both drug based and psychosocial interventions conducted in the mid to late 1990's. 
Disease specific measures. 
In contrast to generic measures, there was evidence that a substantial minority of 
trials of interventions for schizophrenia and related disorders used a disease specific 
measure. Psychosocial interventions were evaluated more commonly than drug- 
based interventions using disease specific measures (15.9% versus 2.5%, 
difference = 13.4%, 95% Cl 5.8 - 24.0%). The survey found no examples of 
disease specific patient based measures being used to evaluate interventions for 
depression, anxiety or related disorders. The measures used were the Heinrichs 
Quality of Life Scale - QLS (Heinrichs, et al., 1984); the Lehman Quality of Life 
Interview (Lehman, 1983a); the Oregon Quality of Life Questionnaire - OQLQ 
(Bigelow, et a/., 1982). 
Domain specific patient based outcomes measures 
A substantial minority of trials in schizophrenia used a domain specific measure of 
patient based outcome, with 40% of psychosocial interventions using such a 
measure. The most commonly evaluated domain was that of social functioning 
(n=30), followed by cognitive functioning (n=10); role functioning (n=8) and 
perceptions of wellbeing. 
Social functioning was largely measured using four major scales: the Social 
Adjustment Scale (Weissman & Bothwell, 1976); Katz Adjustment Scale (Katz & 
Lyerly, 1963); Social Functioning Scale SFS (Remmington & Tyrer, 1979); REHAB 
scale (Baker & Hall, 1988). 
Domain specific measures were much less commonly used in trials for depression, 
anxiety and related disorders. Details of domains measured and instruments used 
are given in table 10. 
Trend over time in the measurement of outcome 
In order to examine changes over time in the measurement of outcome, all patient 
based measures (generic, disease specific, and domain specific) were conflated, 
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and the presence or absence of such a measure was recorded for each trial (figure 
2). 
Figure 2: Proportion of trials using a patient based outcome measure, 








Five-year periods indicated, together with 95% confidence intervals 
Trends over time in terms of the measurement of patient based outcome were 
examined by pooling five year periods from 1955 onwards, and conducting a 
regression of year (Yr) against proportion of studies using a patient based measure - 
weighted by the absolute number of trials in any five year period. The regression 
analysis showed no increase in the use of these measures overtime (r" = 0.002, two 
sided p=0.9). 
A feature of the plot of use of patient based measures over time is the observation 
that studies prior to 1970 used patient based measures, whereas those conducted 
between 1980 and 1990 did so less frequently. Coincident with this observation is 
the finding that randomised trials conducted during the 1980s were dominated by 
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drug trials (Figure 3) comparing new anti-depressants with older tricyclic drugs. In 
these trials, patient based outcome was very rarely measured, and the sole criterion 
for success was a statistically significant change on a symptom-based measure 
such as the Hamilton Depression Rating Scale (Hamilton, 1967). The use of 
symptom-based measures in drug trials is discussed below. 
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Three case examples of methods used in measuring outcome in a specific 
area of psychiatric treatment and healthcare delivery: 
In order to illustrate some overall patterns in the measurement of outcome in 
psychiatric trials, three case examples are chosen: the evaluation of new drugs 
for schizophrenia and depression, and the use of specific models of community 
care for those with severe mental disorders 
New drugs for schizophrenia and depression 
The 1980s and 1990s have seen an intense period of research activity, largely 
by the pharmaceutical industry, with the emergence of new classes of first, anti- 
depressants (Serotonin Specific Re-uptake Inhibitors), and then anti- 
schizophrenia drugs (atypical anti-psychotics). 
Almost one hundred trials have been located and included in a recent 
systematic review of trials comparing new and older anti-depressant drugs 
(Geddes, et aL, 2001). Amongst these trials, the primary endpoint of interest to 
researchers is consistently the suppression of depressive symptoms, measured 
using a handful of rating scales, applied serially over a six-week period. No 
trials included in this review measure broader health related quality of life, 
although ten trials do measure global outcome, using the CGI. 
A similar pattern of outcomes measurement is seen amongst trials conducted to 
examine the comparative effectiveness of new atypical anti-psychiatric drugs in 
the care of those with schizophrenia. Several Cochrane reviews have been 
conducted into individual drug entities (Bagnall, eta/., 2001 a; Duggan, eta/., 
2001; Gilbody, et al., 2001 a; Kennedy, et al., 2001; Lewis, et al., 2001 a; Lewis, 
et al., 2001 b; Srisurapanont, et al., 2001; Tuunainen & Gilbody, 2001), and 
these have recently been collated in a review of the value of atypical drugs to 
the UK National Health Service, commissioned by the Health technology 
Assessment Programme (Bagnall, et al., 2001 b). All trials use symptom-rating 
scales as their primary outcome of interest, with successful treatment being 
operationally defined as a 50% shift from baseline score on one of two rating 
scales (the BPRS and the PANSS) over a six-week period. Approximately half 
also measure global functioning. However, 27% of trials also measure social 
functioning on one of the available clinician rated scales. Only two published 
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trials of new anti-psychotics, which have thus far been included in systematic 
reviews, measure broader quality of life. One published trial incorporates the 
Short Form 36, whilst three use a mental health specific quality of life measure. 
The dominance of short-term measurement of psychiatric symptoms as a 
primary outcomes measure is explored in more detail in the discussion. 
Case management and assertive community treatment for severe mental 
disorders 
Two important reviews included in the present survey examine the use of 
different models of community care for those with severe mental illness, 
including schizophrenia and related disorders (Marshall, et al., 2001; Marshall & 
Lockwood, 2001). Trials included in these two reviews measured psychiatric 
symptoms much less frequently than in drug trials, but instead measured a 
much more broad range of patent based outcomes. Symptom based scales 
were used in only one third of trials, whereas quality of life measures (e. g. 
Lehman's Quality of Life Scale (Lehman, 1983b) and or domain specific 
measures (especially social function, role function, self esteem, and satisfaction) 
were measured in over half of included studies. 
A large majority of studies also measured simple aspects of service use, such 
as hospital admission and length of stay, in addition to using standardised 
measures of outcome. The clear focus in a number of these trials was not just 
psychiatric symptoms amongst persons with often-chronic disorders, but rather 
the impact of their illness and attendant symptoms on how they lived their day- 
to-day life, and their need for services. 
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Chapter 14 Discussion of the survey of outcomes measurement in 
psychiatric trials 
Survey methods 
The survey used a ready available source of systematic reviews of randomised 
trials as its sampling frame. The generalisabilty and representativeness of these 
data deserves further consideration. The survey was not a random survey of 
randomised trials in mental health, but rather a survey of trials that have been 
included in systematic reviews. 
The advantages of this approach include the fact that data had been already 
extracted in a standardised way by those preparing systematic reviews under 
the auspices of Cochrane guidelines (Mulrow & Oxman, 1999). This allowed a 
much larger number of trials to be sampled in a much shorter period of time, and 
at less cost than would have been possible if primary studies had been used in 
the first instance. The quality of the data was monitored within the survey and 
was found to be acceptable. 
The danger from using data from systematic reviews is the fact that studies 
included in reviews may not be representative of studies that are conducted in 
general. However, it might be argued that the studies included in systematic 
reviews represent the trials which individuals find the most important in the 
context of their day to day work and decision making processes, since topics are 
likely to have been selected for the process of systematic review for these 
reasons rather than for intellectual curiosity alone. One particular limitation that 
needs to be borne in mind with, for example, Cochrane reviews in the sphere of 
schizophrenia, is that particular effort has been made to review each of the new 
drug entities and that particular funding has helped this process received via the 
NHS Health Technology Assessment Programme (www. hta. nhsweb. nhs. uk/). 
The result of this reviewing activity might be that the trials included in the survey 
might include a disproportionate number of trials conducted into new drugs and 
that these might not be representative of schizophrenia trials as a whole. The 
summary statistics presented showing the proportion of studies measuring 
outcome in one specific way need to be viewed with this potential bias in mind. 
However, the survey has revealed important trends that have been examined in 
more detail in the case examples. Of note is also the fact that some of the 
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results found in this survey are in line with trends revealed in an earlier survey 
by (Thornley & Adams, 1998), which limited its scope to schizophrenia trials. 
Main findings 
The main findings of the study are that the dominant method of outcomes 
measurement in randomised trials in psychiatry remains symptom based 
psychopathology scales. The increasing popularity of generic patient based 
measures, such as the Short Form 36 - available since the early 1990s, is not 
reflected in psychiatry. Similarly, the existing quality of life measures developed 
specifically for those with mental illness have largely not been included as 
measures of outcome in clinical trials. The findings of this survey therefore 
mirror the findings of other surveys of patient based outcomes measurement in 
other specialities. Sanders, et al. (1998) in a survey of trials included in the 
Cochrane Controlled Trails Register (The Cochrane Controlled Trials Register, 
2000) found that less than 5% of trials overall (in any speciality) use patient 
based measures. The main exception to this being cancer and cardiovascular 
disease trials, where 29% and 26% of trials respectively used a patient based 
measure. Psychiatry seems therefore no worse then the majority of specialities 
in its use of patient based measures in evaluative research. 
However, there remain a substantial minority of trials where symptom based 
measurement is supplemented by the measurement of domains that can be 
considered facets of patient based outcome. Specifically these include social 
and role functioning. The survey shows that these instruments are commonly 
used in trials of psychosocial interventions for those with mental illnesses, such 
as schizophrenia. These instruments have been in existence for many years, 
and have therefore been available to research as outcomes instruments in 
evaluative research. The present survey shows that patient based outcomes 
measurement is therefore not a new phenomenon in psychiatry, and that 
domains of patient based outcome, such as social functioning, have been 
incorporated into trial designs since the 1960s. 
Wiersma (1996) outlines two reasons why social functioning has traditionally 
been of interest and has come to be measured as an outcome in its own right. 
Firstly, the trend towards community oriented care models required careful 
evaluation, with respect to its consequences. In order to judge the 
consequences of community versus hospital treatment, a separate series of 
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measures is justified for those with chronic and enduring mental disorders 
whose social functioning has traditionally been poor. Secondly, there is 
evidence that disease progression, symptomatology and social dysfunction may 
vary relatively independently. Social disablement of a patient may be 
characterised much more by using measures of social disabilities than by 
measures of psychiatric symptoms. Further, interventions targeted at social 
disability may be successful in helping gain or maintain independence, whilst 
having little impact on psychotic symptoms. 
The dominance of symptom-based measures in the majority of the trials 
surveyed in this review deserves further discussion. Commentators on the 
measurement of outcome in other specialities such as rheumatology and 
oncology (e. g. Albrecht 1994) have drawn attention to the fact that the 
development and use of 'patient based measures' represent a reaction to the 
over dependence on biophysical measures of outcome, which say little about 
the impact of disease or illness on the individual. This analysis may not directly 
relevant to psychiatry, since there have not been biophysical correlates of 
disease, which can be appropriated as (limited) measures of outcome. 
However, the over reliance upon instruments which record the number or 
severity of the individual 'symptoms' associated with a specific psychiatric 
disorders might be seen as analogous. The use of 'symptom based' 
measurement scales as an outcome, without reference to how these symptoms 
affect the individual in their day to day life provides a similar scenario to that 
seen in wider healthcare. The present survey therefore lends empirical support 
to observations that have been made previously, for example in the sphere of 
schizophrenia research, Collins, et al. (1991) has stated that: 
'A recurrent criticism of measurement in schizophrenia research is that symptom 
suppression is overemphasised as the sole criterion measure of treatment 
effectiveness, to the neglect of other endpoints, such as the quality of life and 
subjective experience of the patient' 
This observation is especially true in the case of drug trials in psychiatry. The 
success or otherwise of new drugs is almost entirely measured using symptom 
based measures, without reference to the value of these new and relatively 
expensive new technologies in terms of wider quality of life. One example of 
this comes from a widely disseminated and cited trial of the value of one new 
anti-schizophrenia drugs - olanzapine, manufactured by Eli Lilley. This 
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industry-sponsored trial is one of the largest drug trials ever conducted in 
psychiatry, with almost 2000 participants (Tollefson, et a/., 1997). The 
outcomes used in this trial included four symptom based measures and a series 
of standardised assessments of side effects, each of which were applied every 
two weeks. In total, two million questions were asked of its nearly 2000 
participants, but failed to ask whether patients felt they were substantially better 
ýProfessor Clive Adams, personal communication). The main cause of this 
over-dominance of symptom based measures is likely to be the fact that these 
trials are essentially designed to meet the demands of drug licensing authorities, 
such as the US Food and Drug Administration, and the UK Medicines Control 
Agency. These bodes require evidence of the value of a new drug entity 
(efficacy), and are happy that this is demonstrated by the use of symptom based 
measures. They make no demands that effectiveness or the ability to make 
substantial changes to patients'wider health related quality of life should be 
demonstrated before granting product licence (FDA, 1997). There is therefore 
no economic incentive to conduct trials which measure patient based outcome. 
Suggestions for further research 
The present survey has demonstrated that there is a dominance of symptom 
based instruments in the measurement of outcome in clinical trials. This is 
despite the existence of disease specific and generic patient based measures. 
This prompts two main topics for further research. 
First, fundamental research is needed into the suitability of patient based 
measures for inclusion in clinical trials in mental health. Fitzpatrick, eta/. (1998) 
have produced a general series of recommendations based upon a systematic 
review of the methodological literature surrounding patient based outcomes, 
which can be applied in all areas of health. They recommend that before 
inclusion in a trial, judgements should be made according to eight criteria: 
appropriateness, reliability, validity, responsiveness, precision, interpretability, 
acceptability and feasibility. There is little point in including an instrument in a 
trial if it is valid and reliable, but shows no response to change in underlying 
dimensions of quality of life that are important to the patient. Similarly, many 
patient based measures are over-long or unacceptable to patients, and their 
addition to an already lengthy battery of questionnaires might prove too onerous 
to trial participants. For example, Lehman's QOLI, designed for persons with 
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severe mental disorders takes 45 minutes to complete (Lehman, 1983b). 
Generic patient based outcomes measures, such as the Nottingham health 
Profile or the Short Form 36, may be difficult to apply to patients with mental 
health problems if they concentrate on physical functioning by asking about an 
individual's ability to climb stairs, whilst ignoring those aspects of social and role 
functioning that are important in chronic and severe mental illness. They may 
therefore be insensitive to underlying change in health status, and may include 
large numbers of questions that are irrelevant to the individual, also making 
them unacceptable to respondents. 
Clearly, the desirable attributes outlined by Fitzpatrick, et a/. (1998) may be 
present for many measures and the fact that they are not included in trials 
represents an omission. A systematic summary of these attributes for available 
instruments, when used in populations with mental health problems is needed 
as a matter of urgency. Such a summary would be an invaluable resource for 
researchers and those who must interpret the meaning of research which uses 
patient based outcomes. 
Second, despite the theoretical appeal of patient based instruments, in that they 
extend the measurement of outcome beyond symptom suppression, it remains 
to be demonstrated if the results of trials are substantially different when they 
are used. If the results of trials are in fact substantially different according to 
how outcome is measured, then there needs to be an examination of what 
should be the primary endpoint of trials, and which results should be used in 
decision making processes, which incorporate trial based evidence. 
It had been anticipated that the current survey would provide sufficient examples 
of trials that measure both patient based and symptom based outcomes, in 
order that this question be examined empirically. Unfortunately this proved not 
to be the case. An ongoing piece of research by the present author seeks to 
examine this question further (see appendix 1 for a protocol of this study) 
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Section 2.3 Outcomes Research in Psychiatry 
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Chapter 15 Background to the survey of outcomes research in 
psychiatry 
Randomised controlled trials have generally been accepted as the 'gold 
standard' design when deciding what interventions work in psychiatry (WHO, 
1991). Most randomised studies in psychiatry have investigated the effect of 
drug or psychotherapy interventions in tightly controlled and largely artificial 
experimental conditions (Hotopf, et a/., 1997; Thornley & Adams, 1998), while 
patients, clinicians and other decision-makers need to know how treatments 
work in the real world and whether they are cost effective under routine 
conditions (Wells, 1999). Important questions relating to the organisation and 
delivery mental health services are also rarely addressed in randomised trials 
(Gilbody & Whitty, 2001). 
The need for research relating to effectiveness (rather than efficacy) has 
prompted a number of responses: One has been the call to conduct randomised 
trials in real-world settings, using pragmatic designs (Hotopf, et al., 1999). 
Another has been to synthesise various data sources using decision analysis 
(Lilford & Royston, 1998). A response which has been highly influential in the 
United States in the past decade involves the analysis of large databases of 
patient data collected in routine care settings - known as outcomes research 
(Anonymous, 1989; Ellwood, 1988; Wennberg, 1991). 
The origins of outcomes research. 
Outcomes research forms a cornerstone of the outcomes movement discussed 
in sectionl, and outlined by Paul Elwood in his 1988 Shattuck lecture (Ellwood, 
1988). In this lecture, he called for the routine collection of outcomes measures 
by clinicians, in order to create a 'technology of patient experience'. He 
proposed that these data should be assimilated in large databases that would 
form a resource for clinical and health services research. Such data could 
eventually be used inter-alia to compare existing treatments and to evaluate 
new technologies, thereby avoiding both the expense of clinical trials and the 
loss of generalisability that resulted from the selective recruitment to 
conventional efficacy trials. 
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A core component of outcomes research, according to Elwood, was the type of 
outcomes that would be collected and analysed. Accorrding to Elwood: 
'The centre piece and unifying ingredient of outcomes research is the tracking 
and measurement of functioning and well being or quality of life'. i. e. the 
collection of patient based outcomes. 
The Agency for Health Care Policy and Research - AHCPR (now the Agency 
for Healthcare Research and Quality - AHRQ) was established under public law 
in 1989 in order to conduct 'outcomes research' into common medical 
conditions, with the establishment of Patient Outcome Research Teams - 
PORTs (Wennberg, et a/., 1993). The research programme was allocated $6 
million in its first year, rising to $63 in 1991, with the purpose of using routine 
outcomes data to determine 'outcomes, effectiveness and appropriateness of 
treatments' (Anderson, 1994). It was decreed by Congress, via the General 
Accounting Office, that new primary research conducted by the PORTs was not 
to be the traditional randomised controlled trial, rather it was to be observational 
in design, utilising the vast amounts of data routinely collected on US patients 
(General Accounting Office, 1992). This health research policy produced a new 
breed of health researchers; known as database analysts (Anonymous, 1989; 
Anonymous, 1992), with the motto 'Happiness is a humongous database' 
(Smith, 1997). 
Outcomes research differs from traditional observational or quasi-experimental 
research in a number of ways, particularly with respect to the outcomes that are 
used, and the setting in which these outcomes are collected. In outcomes 
research, competing interventions that are already used in routine care settings 
are compared by analysis of routine data collected by clinicians or by other 
agencies (such as insurance companies), whereas q uasi-experi mental studies 
implement interventions in one setting or amongst one group of patients, and 
compare outcomes with patients who have not been subject to the intervention 
(Gilbody & Whitty, 2001). Quasi-experimental studies are therefore more like 
randomised trials, and are considered to be clearly different in their approach 
and ethos to outcomes research (Aday, et al., 1998). The outcomes that are 
studied in outcomes research are generally those that are already collected as 
part of routine care, although there is no reason why these cannot be in added 
to in the light of the specific question being asked. 
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Outcomes research in psychiatry 
The previous survey of clinical trials has demonstrated the infrequency with 
which patient based outcomes are used. A clear aspiration of Elwood's was that 
outcomes research would address the limited methods by which outcomes are 
measured in traditional evaluative research. It would be expected that 
outcomes research in psychiatry might use a more patient based approach than 
has been demonstrated within this thesis. 
Enthusiasm for outcomes research has, in the US, led to the establishment by 
the American Psychiatric Association of Practice Research Networks - PRNs 
(Zarin, et al., 1997; Zarin, et a/., 1996). This initiative involves the recruitment of 
1 000s of practising psychiatrists, who will routinely measure a broad range of 
outcomes for their patients, in order to: provide benchmarking for practice, judge 
the extent and consequences of variations in practice; and to examine the 
effectiveness in real world settings of all manner of healthcare interventions - as 
an alternative to the randomised trial. There are advocates of outcomes 
research in non-US mental health services research, particularly in 
psychotherapy (Barkham, et al., 1998; Guthrie, 2000; Marginson, et al., 2000; 
Mellor-Clarke, et a/., 1999). Similarly, the pharmaceutical industry is keen to 
extend the method in the evaluation of new and relatively expensive drug 
therapies; for example the Schizophrenia Health Outcomes Study - SOHO, 
funded by Ell Lilly, aims to recruit European collaborators to collect outcomes 
from patients with schizophrenia in receipt of typical and atypical drugs. Others 
have urged caution (Sheldon, 1994), and the principle concerns that have been 
expressed about outcomes research include: (1) their observational (rather than 
experimental) design; (2) the poor quality of the data which are used; (3) the 
inability to adjust sufficiently for case mix and confounding; (4) the absence of 
clinically meaningful outcomes in routinely collected data (lezzoni, 1997). 
As in the survey of randomised trials reported in preceding sections, a key 
component in interpreting and using the results of research is the type of 
outcomes that are collected and presented. The purpose of the present 
research is to produce the first systematic survey of the use of outcomes 
research in psychiatry, since this has not hitherto been described. 
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Aims 
1. To examine the specific types of outcomes that have been collected and 
used within outcomes research, in examining the effectiveness of 
interventions in psychiatry. 
2. To examine the specific uses to which routinely collected data have been 
put in examining the effectiveness of interventions in psychiatry. 
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Chapter 16 Methods of the survey of outcomes research in 
psychiatry 
Sources of outcomes research 
No specific database of outcomes research was available for the conduct of this 
research, and the source of potentially relevant studies was therefore the large 
amounts of literature that were identified in the searches detailed in appendix 1. 
Survey method 
Target population 
All examples of outcomes research which fulfilled the following inclusion and 
exclusion criteria. 
Inclusion criteria 
Reports were included if they fulfilled each of the following criteria: 
1. The research was conducted in a care setting that was part of usual care 
in a healthcare system. 
2. The outcomes data used were those collected routinely for all patients - 
either for administrative purposes, or as a means of monitoring outcomes 
within the service being evaluated. 
Exclusion criteria 
Studies were excluded if they fulfilled any of the following criteria: 
1. Research that only examined the costs and processes of illness and 
healthcare from routinely collected data, with no linkage to the outcomes 
of care. For example, primary care prescription databases have been 
used to conduct research into newer psychotropic drugs (eg Donoghue, 
et al., 1996), but since they are not linked to patient level data and 
outcomes, they cannot be considered outcomes research. 
2. Quasi-experimental or non-randomised evaluations of new technologies, 
where an intervention is implemented and outcomes measurement 
systems established only in the course of its evaluation (Cook & 
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Campell, 1979). For example, the PRiSM Psychosis study (Thornicroft, 
et a/., 1998) is an example of aq uasi-experi mental evaluation of a model 
of community care for those with severe mental illness, where districts 
were non-randomly allocated to implement an experimental service, and 
outcomes were measured under experimental and control conditions as 
part of the study. 
3. Studies that only examined the relation between patient characteristics 
and outcome, with no direct comparison between competing treatments 
or health policy strategies (e. g. Rosenheck, et a/., 1997). 
4. Reports of routine outcomes measurement in practice, with no direct 
report of comparative service or treatment evaluations based on the 
data. 
Sampling frame 
Studies were drawn from all published studies that were included in the 
following databases, up to and including the following dates: 
MEDLINE; EMBASE; Cinahl; British Nursing Index; Cochrane Controlled trials 
register - to June 2000. See appendix 2 for details of the search strategy used. 
Sampling method 
Studies formed a complete sample of all those identified using the search terms 
outlined in appendix 2. 
Data extraction 
Data were extracted on the following: 
Population. 
Clinical or organisational question being asked 
Setting 
Sample size and length of follow up 
Outcomes studied, and source of outcomes studied. 




It was anticipated that relatively few examples of outcomes research would be 
identified. The principle form of data synthesis was a descriptive overview of 
major trends in terms of the following: 
0 Outcomes studied, and source of outcomes studied. 
With due consideration of: 
" Clinical or organisational question being asked 
" Setting 
" Sample size and length of follow up 
" Adjustment for case mix and confounding 
" Results 
Salient examples were used to illustrate trends, particularly in terms of outcomes 
measurement. 
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Chapter 17 Results of the survey of outcomes research in 
psychiatry 
Despite the widespread advocacy of outcomes research in healthcare, relatively 
few published examples relating to mental health were found. Several of these 
studies were published in the past three years, highlighting an increase in the 
use of the design. The scope, design and analysis of the studies we identified is 
summarised in table 11. In the following section important characteristics these 
nine studies are reviewed. 
Research questions addressed 
Outcomes research has been used in broadly two areas of mental health 
research: 
(1) The evaluation of mental health policy, including aspects of service 
delivery, organisation and finance 
The earliest and perhaps most important example of outcomes research in 
mental health is the Medical Outcomes Study (MOS) conducted by the RAND 
corporation in the United States in the late 1980s (Tarlov, et al., 1989; Wells, et 
al., 1989; Wells, et al., 1996). The design and objectives of this study were 
shaped by US health care policy debates: on the role of financing and 
reimbursement strategies in private care (fee for service versus pre-payment), 
and on the place of speciality (secondary) care. 
The authors justified the use of observational methods in two ways. First, the 
authors claimed that the cheaper design and reduced burden on participants 
could maximise the number and range of collaborators and patients, particularly 
from non-research settings. Second, the authors claimed that the specific 
research questions precluded the use of randomisation, since the very act of 
randomisation would alter the functioning of existing health care delivery 
systems (Wells, et al., 1996). 
Three other studies researched health policy and organisation questions, such 
as the consequences of the withdrawal of mental health benefits from insurance 
plans (Rosenheck, et al., 1999a); the effectiveness services directed at 
homeless persons (Lam & Rosenheck, 1999); the difference in outcome 
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between private and publicly funded health providers (Leslie & Rosenheck, 
2000). 
(2) The evaluation of new technologies. 
Four studies (Croghan, et a/., 1999; Hong, et aL, 1998; Hylan, et al., 1999; Melfi, 
et al., 1998), utilised an outcomes research design to demonstrate the worth of 
new antidepressants and anti-psychotics in routine care settings. One further 
study (Rosenheck, et a/., 2000) examined the value of an innovative 
psychosocial intervention for those with war-related Post Traumatic Stress 
Disorder. 
Source and choice of cases and outcomes 
Outcomes studies can be broadly be divided into: 
(1) Those which collect data prospectively on a service-wide level, where the 
choice of outcomes is decided a priori and is influenced by the research 
question or population under examination, and (2) those which utilise existing 
outcomes data, collected for other purposes. 
The MOS is the best-known example of prospective outcomes research. The 
authors set out to measure patient-centred outcomes, in addition to clinician- 
rated depressive symptoms within existing healthcare services. The enduring 
legacy of the MOS is the fact that patient-centred measures of health status 
were developed for the study, and eventually evolved into the Short Form 36 
(Stewert & Ware, 1992) - now the most commonly used generic measure of 
health related quality of life. 
A further study (Rosenheck, et al., 2000), measured multiple outcomes, 
including disease-specific measures relating to the underlying condition (Post 
Traumatic Stress Disorder), measures of social function, health-related quality of 
life, and service use. This study used a large and already existing dataset 
describing all of the 600,000 patients in receipt of mental healthcare under the 
US Veterans Administration (National Committee on Quality Assurance, 1995), 
supplemented with routinely collected disease-specific patient outcomes 
measures collected for all patients in receipt of care for PTSD (Rosenheck, 
1996). 
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All the other studies that were identified utilised existing outcomes already 
entered on large administrative databases, studying a much more limited range 
of outcomes. For example, studies examining the value of new anti- 
depressants in routine care settings use a commercially available medical 
insurance database (eg MarketScanTM) of linked pharmacy and medical claims 
data on 750,000 individuals (Croghan, et al., 1999; Hylan, et a/., 1999; Melfi, et 
aL, 1998). Cases of depression were identified retrospectively, either from a 
reimbursement claim for anti-depressant medication or by the presence of one 
of six ICID codes indicative of depression. This approach is problematic, since 
antidepressants are commonly prescribed for a number of conditions other than 
depression (Streator & Moss, 1997). Similarly, depression is consistently under- 
identified by clinicians (Jencks, 1985), and mislabelled or underreported, in part 
as a consequence of the stigma of mental illness (Rost, et al., 1994). 
Administrative databases such as MarketScan Tm also hold no direct information 
relating to disease severity, such as scores on symptom rating scales. Disease 
progression, relapse or remission cannot be directly measured and database 
studies are forced to use alternatives. For example, (Hylan, et al., 1999) used 
continuous six-month claims for refills of prescriptions as a proxy measure of 
acceptable pharmacotherapy and therefore good outcome, ignoring the fact that 
patients discontinue medications for a whole host of reasons other than 
treatment failure. 
Sample size and length of follow up 
Sample size was generally much greater than that achieved in the traditional 
randomised trial, with a median sample size of n= 2678 (range 1034 to 20,814). 
Those studies that recruited subjects prospectively in the context of a study, 
such as the MOS (Wells, et al., 1989), achieved smaller sample sizes (n= 1772) 
than those which selected subjects retrospectively from large existing datasets 
(Croghan, et a/., 1999; Rosenheck, et al., 1999a) - median n=4052. Periods of 
follow up were of median six months (range 4 to 48 months). 
Adjustment for confounding and case mix 
All studies made some attempt to describe and adjust for confounding factors, 
typically using some form of regression analysis, or propensity scoring (Rubin, 
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1997). Authors rarely reported each of the potentially confounding factors that 
were entered into their analysis - often restricting reports to those that were 
positive and related to outcome. However, it was clear that the ability of studies 
to adjust for confounding was determined by the collection or availability of 
suitable measures. Two studies serve to illustrate the contrast between limited 
and more complete adjustment for confounding. 
The authors of the MOS prospectively measured a broad range of case-mix 
variables, including disease severity and co-morbidity, in addition to traditional 
demographic characteristics, such as age, sex and socio-economic status. This 
is especially important in the MOS since the type of healthcare provider is 
inexorably linked to disease severity, making unadjusted comparisons of 
outcome un-interpretable. 
One of the more unexpected results of the MOS demonstrates the limitation of 
an observational approach and the need to measure and adjust for case-mix 
and confounding. In unadjusted samples, the receipt of any treatment (anti- 
depressant medication or counselling) was associated with a much worse 2- 
year outcome than the receipt of no treatment. In analyses that adjusted for 
baseline health differences, treated and untreated patients had a comparable 2- 
year outcome. In a subgroup analysis, designed to minimise unmeasured 
biases by restricting the analysis to those with the most severe depression, 
treatment was in fact associated with a significantly better 2-year outcome 
(Wells, 1999; Wells, et al., 1996). 
In contrast, outcomes studies based on administrative data are much more 
limited in their ability to measure and adjust for confounding. For example, in 
retrospective database studies of new anti-depressants (eg Hylan, et aL, 1999; 
Melfi, et aL, 1998) disease severity could not be measured since these data 
were not directly included in administrative data, and could only be crudely 
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Chapter 18 Discussion of the survey of outcomes research in 
psychiatry 
Survey methods 
The survey uses only published examples of outcomes research, and only those 
examples that are included in widely available databases. It is likely that a 
proportion of outcomes research is either unpublished or if published, is not included 
in the databases sampled. Outcomes research is a method that may be used to 
produce relatively quick and cheap evaluations, often for the purposes of healthcare 
providers or pharmaceutical companies (Anonymous, 1989; Anonymous, 1992), and 
this research may not be published. Similarly, if published, it may be in the form of 
reports and monographs. These forms of publication are not included in databases 
such as MEDLINE, and are often termed 'grey literature' (NHS Centre for Reviews 
and Dissemination, 2000). 
Failure to include unpublished or difficult to find literature in surveys and systematic 
reviews introduces a potential bias, in that published literature or that which is in 
common databases may be unrepresentative of the research as a whole. The 
problem of publication bias is discussed in more detail in chapter 24. The results of 
this survey should be considered in the context of this potential bias. 
Main findings 
Despite the enthusiasm with which outcomes research was adopted and funded in 
the US, by the 1990s, its value was being called into question. The US Office of 
Technology Assessment offered a stinging appraisal: 
'Contrary to the expectations expressed in the legislation establishing the AHCPR.... 
administrative databases have generally not proved useful in answering questions 
about the comparative effectiveness of alternative medical treatments' (Office of 
Health Technology Assessment - US Congress, 1994) 
Clearly, the superficially appealing opportunity to generate large-scale studies from 
readily available and existing data sources should be approached with caution. The 
present survey highlights both the strengths and the limitations of outcomes 
research as a method for evaluating mental health services. 
Strengths of outcomes research 
The criticism is often made that randomised trials are undermined by the fact that 
the participants form a highly selected and homogenous group, and their healthcare 
and follow up is different from that received by the majority of patients (Anonymous, 
1994). The consequence is that it is not always possible to apply the results in 
clinical practice - that is, trials lack external validity (Naylor, 1995). 
One potential advantage of outcomes research is that observational data are 
routinely collected for all patients and the results can therefore be applied more 
generally. Further, data are generated in routine healthcare services, rather than in 
artificially constructed trials. Lastly, outcomes research might be able to deliver 
answers to some questions relatively quickly and cheaply and with greater statistical 
power and without the need to seek ethical approval and individual patient consent, 
compared to the time consuming, and costly, randomised trial. 
The present review suggests that outcomes research in psychiatry has indeed 
realised these advantages - incorporating large numbers of subjects from real life 
clinical populations and following them up for clinically meaningful periods of time. 
Weaknesses of outcomes research 
Elwood's original vision of outcomes research required that a rich and clinically 
meaningful set of outcomes would be collected for all patients during their routine 
care (Ellwood, 1988). However the feasibility and cost of such data collection has 
meant that the building blocks of much outcomes research (with notable exceptions) 
have been data that are collected as part of the administrative process (lezzoni, 
1997). These administrative data (produced by federal health providers, state 
governments and private insurers) contain the minimum amount of information 
required to fulfil an administrative function, particularly billing. They generally 
include little more than routine demographic data, ICD-9 diagnostic codes, details of 
interventions received during a hospital episode, length of stay and mortality during 
a hospital episode. The fundamental problem with research using these data is that 
the outcomes that are available are generally not those that we would like to study. 
ill 
Research becomes driven by the availability of data rather than by the need to 
answer specific questions, as acknowledged by one outcomes researcher. 
"/ utilise data that are available. / do not start with 'what is the problem and what is 
the outcome? ' / saygiven these data, what can / do with them? ... (Blumberg, 1991). 
The other major problem with outcomes research, as with all observational 
research, is the problem of confounding and selection bias (Cook & Campell, 1979; 
lezzoni, 1997). The treatment that a patient receives will often be determined by a 
number of factors that are related to outcome, such as disease severity. Thus 
patients will differ in many ways other than the treatment they receive, and it is 
therefore difficult to attribute any differences in outcome to the treatment itself 
(Green & Byar, 1984). 
The present survey suggests that, in psychiatry, large-scale studies using 
'humongous databases' are largely achieved at the expense of clinically meaningful 
outcomes and limited opportunities to adjust for confounding. Only two studies 
stand out as having collected a broad range of clinically important outcomes and 
case mix variables, reflecting not just disease severity, but the facets of service use 
and health-related quality of life - the MOS (Wells, et a/., 1989), and Rosenheck's 
study of PTSD (Rosenheck, et a/., 1999b). 
Can outcomes research ever be useful in the UK? 
Professor Nick Black has recently called for the establishment of large-scale high 
quality clinical databases across all disciplines in the UK (Black, 1999). The most 
ambitious example of this work in the UK has been in intensive care (Rowan, 1994). 
According to Black, such databases need not be seen as an alternative to the 
randomised trial, but rather a complement. The attractions for researchers include 
the possibility of generating large samples from multiple participating centres, and 
including clinically important subgroups of patients, who might be traditionally 
excluded from trials. Outcomes research can also be used to promote rather than 
replace randomised trials in a number of ways: First, by raising the level of 
uncertainty among clinicians as to the effectiveness of established interventions, 
they might increase clinicians' likelihood of participating in a randomised trial. 
Second, by providing a permanent infrastructure for mounting multi-centre trials. 
Finally, the adoption of such databases means that research is no longer the 
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preserve of a minority of clinicians working in specialist centres; thus enhancing the 
generalisability of the results. 
Suggestions for further research 
In the UK, there are research initiatives underway. For example, The Centre for 
Outcomes Research and Effectiveness (CORE) has been established under the 
auspices of the British Psychological Society (Clifford, 1998) in order to generate 
'practice based evidence' of effectiveness framed within routine services 
(Marginson, et aL, 2000). At this juncture, it would be timely to learn from the 
examples of outcomes research in the US, and to recognise the limitations and 
potential of the approach. 
Rosenheck, et al. (1 999b), who provide one of the more rigorous examples of 
outcomes research, outlines several ingredients of a successful clinical outomces 
database, capable of producing rigorous and informative research. Outcomes 
databases should: (1) include large numbers of subjects; (2) use standardised 
instruments that are appropriate for the clinical condition being treated; (3) measure 
outcomes in multiple relevant domains; (4) include extensive data in addition to 
outcomes measures, in order to support matching; (5) collect data at standardised 
intervals after a sentinel event such as entry to hospital, or discharge from the 
hospital; (6) take aggressive steps to achieve the highest possible follow up rates. 
Data should also be collected prospectively if they are to meet these aims 
Such databases are going to require substantial time, effort and expense to 
establish, making outcomes research far from the quick and cheap research option 
that is envisaged. For example, the whole MOS cost US$12 million, and the 
depression component cost about US$4 million (Wells, et a/., 1996). They are also 
going to require resolution of the practical and ethical problems of using clinical data 
for research purposes - as highlighted in recent debates about the data protection 
act; the European Human rights act and Health and Social Care Bill (Al-Shahi & 
Warlow, 2000; Anderson, 2001; Kmietowicz, 2001; Medical Research Council, 
2000) 
The pharmaceutical industry is especially keen to use outcomes research to 
examine the effectiveness of its products. The current survey highlights that, so far, 
outcomes studies conducted by the pharmaceutical industry have been of generally 
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poor quality and do not adhere to the sensible recommendations outlined by 
Rosenheck, et a/. (1 999b). The use of this method has clear advantages for the 
pharmaceutical industry - particularly in terms of cost. In conducting such research, 
the industry can claim that expensive (pragmatic) randomised trials are no longer 
needed in order to examine clinical and cost effectiveness in routine care settings, 
nor will they have to provide and dispense the drugs for the many thousands of 
patients who are included in these studies. Informed consent and ethical approval 
may no longer be required, since treatment is as received as part of usual care and 
outcomes are those that are collected anyway. Large-scale outcomes studies that 
are currently underway - such as the SOHO study - will need to demonstrate that 
they are methodologically robust and that their results are believable. The current 
survey provides a framework within which the quality of such studies can be judged. 
Mental health researchers must give clear thought as to how outcomes databases 
should be constructed; how resources might be put in place and to what extent 
informed consent is required for research conducted using these data. A necessary, 
but not sufficient condition in the implementation of outcomes research as a distinct 
method is the collection of a wide variety of outcomes, including patient based 
outcomes, by psychiatrists in the context of their routine care. The following section 
considers in detail the practicalities, advantages and potential barriers to this 
approach. 
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Section 3 Outcomes measurement in clinical practice 
Section 3.1 How do psychiatrists measure outcome? 
Section 3.2 Does outcome measurement make a difference? 
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Section 3.1 Measuring outcome in psychiatric practice -a survey of UK 
consultant psychiatrists 
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Chapter 19 Background to the survey 
Outcome measurement forms a central component of recent mental health policy 
formulations. For example, in the UK, there have been a number of initiatives in 
recent years aimed at the introduction of outcomes measurement tools into routine 
mental health practice, as part of a government health strategy to 'improve 
significantly the health and social function of mentally ill people' (Department of 
Health, 1991). 
It was shown in section 1 that outcomes measures broadly serve four purposes: (1) 
the evaluation of the clinical and cost effectiveness of interventions in experimental 
situations, such as trials; (2) the monitoring of population health; (3) clinical audit, 
and; (4) as an aid to clinical decision making in routine practice and patient care 
(Faden & Leplege, 1992; Fitzpatrick, 1994; Fitzpatrick, et al., 1992a; Ware, 1995). 
Despite the availability of various standardised tools with which to measure 
symptom severity of common psychiatric disorders, and wider quality of life and 
health status, little is known about the actual use of standardised outcomes 
measures by clinicians (Slade, et al., 1999). One previous survey of 73 consultant 
psychiatrists from 1989 established which of a pre-specified range of symptom 
based clinical measures were in use at that time. This survey suffered from a 
number of methodological problems, including: small sample size; being restricted 
to one health region, and failing to examine in detail the actual specific uses of these 
measure in clinical practice. This survey is also now out of date. 
Little is therefore known about the extent to which instruments developed in 
response to The Health of the Nation Document (Department of Health, 1991), and 
the National Health and Community Care Act (House of Commons, 1990) have 
been adopted in practice. This is especially important for measures such as the 
Health of the Nation Outcome Scale (HoNOS), which were intended to measure 
outcome, need and inform the provision of healthcare at a population level. For 
these data to be useful in this respect they must be collected by clinicians routinely, 
for each and every patient, and for clinicians to do this, such measures must be 
useful in the care of individual patients. 
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In order to establish the use of outcomes measures by UK psychiatrists, a survey of 
the current use of outcomes measures in psychiatric practice in the UK was 
undertaken. 
Aims of the survey 
1. To examine the use of outcomes by practising psychiatrists in the day-to-day 
care of their individual patients. 
2. To examine the use of outcomes measures by practising psychiatrists for the 
purposes of clinical audit. 
3. To examine the collection of outcomes measures by hospitals and Trusts, 
and their use in planning and organising the care of patients. 
4. To establish barriers and advantages to the use of outcomes measures by 
practising psychiatrists. 
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Chapter 20 Methods of the survey 
A questionnaire survey of consultant psychiatrists practising in the UK was 
conducted. Since there are approximately 4000 general adult psychiatrists 
practising in the UK (Department of Health, 2000), then a survey of all clinicians was 
neither practical within the time and resources available, nor an efficient use of 
resources. A sampling procedure was therefore employed to extract the required 
information in a rigorous and methodologically efficient manner. The methods 
employed in the conduct of the survey are outlined below, and follow best practice 
guidelines outlined in key texts by Moser & Kalton (1971) and Fowler (1993). 
The four key stages in the conduct of the survey are as follows and are discussed in 
detail below: 
1. Respondent identification and sampling procedure 
2. Questionnaire design and administration. 
3. Survey methods 
4. Survey analysis 
Respondent identification and sampling procedure 
Target population. 
The target population for the purposes of the survey was defined as practising 
consultant psychiatrists responsible for the care of working age adult patients in the 
National Health Service of England Wales, Scotland and Northern Ireland. 
Sample frame 
The sample frame was drawn from consultant psychiatrists listed in the Medical 
Directory CD-ROM (Financial Times Healthcare, 2000). This is a commercially 
available resource, updated and published annually, containing the details of all 
medical practioners listed in the medical register held by the General Medical 
Council. In compiling and updating the Medical Directory, all practioners with an 
entry in the medical register are contacted by post on an annual basis, and invited to 
provide up to date information, including: their background details (medical school 
and year of qualification); postgraduate qualifications and membership of Royal 
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Colleges and societies; area(s) of clinical speciality; current appointments and 
places of work. In addition, this includes an up to date correspondence address 
provided by the individual, most usually the place of work. 
An initial plan to use a database of addresses supplied by the Royal College of 
Psychiatrists was abandoned, since this database was unable to provide details of 
clinical speciality, clinical grade and a hospital based correspondence address. 
Additionally, it was prohibitively expensive to purchase this resource. The medical 
directory CD ROM was therefore used in preference, since this contained personal 
contact addresses, which are likely to be up to date. Previous surveys of consultant 
psychiatrists have also shown that the Medical Directory is an efficient and 
reasonably up to date resource for the purposes of conducting postal surveys. 
Previous surveys of consultant psychiatrists identified from this resource have been 
shown to achieve response rates of 72% (Adams, et al., 1999) and 80% (Bristow, 
1999). 
Sampling procedure 
Practising psychiatrists are classified within the Medical Directory under the 
following specialities: 
" 'Psychiatry - general adult' 
" 'Psychiatry - old age' 
" 'Psychiatry - child and adolescent' 
" 'Psychiatry - leaming disabilities' 
" 'Psychiatry - forensic' 
" 'Psych otherapy' 
When compiling the Medical Directory, these specialities are presented to 
respondents when completing their individual entry as 'forced choice', non-exclusive 
categories to indicate their own field of interest. In addition, a free text box is 
provided which allows stated areas of clinical interest and areas of subspecialty to 
be added. Of the available categories above, the category 'Psychiatry - general 
adult' was felt to be the most relevant to the stated target population of the survey. 
A computerised search for entries under 'Psychiatry - general adult', excluding all 
those 'retired', resulted in 3992 individuals. A random sample of 500 adult 
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psychiatrists was drawn from this pool, using a computer generated random number 
table (STATA corporation, 1999). 
Confirmation that subjects fulfilled the specified inclusion criteria was also sought, by 
examining whether their stated main speciality corresponded with their'free text' 
description of their areas of interest and sub-speciality, and that they included a 
NHS hospital as their place of work. Those that did not fulfil these criteria were 
replaced by further random sampling of the Medical Directory database. 
All 500 contact addresses were manually entered into a computerised database 
(Microsoft Corporation, 1998). 
Questionnaire construction. 
A self-completed/self-report questionnaire was produced. The content of the 
questionnaire was informed by a comprehensive and systematic literature survey, 
which had (1) identified the main clinical uses of routine outcome measures and (2) 
had identified the outcomes measures which are most commonly reported in 
published psychiatric research (See previous chapters). 
Information sought in the questionnaire 
The questionnaire sought to identify the following- 
1. For commonly encountered psychiatric disorders, which standardised 
outcomes measures were used by adult psychiatrists for the purpose of. 
A. Identifying and assessing the severity of clinical disorders 
B. Identifying patients' needs and deficits in social functioning, and quality of 
life. 
C. Monitoring patient progress. 
D. Clinical audit. 
Common clinical psychiatric disorders were subdivided into the following four 
broad categories: 
Depress ion/a nxiety and related disorders 
Schizophrenia & other psychoses, 
Drugs and alcohol problems; 
Dementia and related organic disorders. 
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2. Outcomes measures routinely collected by hospitals/Trusts. (Including 
administrative outcomes such as length of stay, re-admission rates and 
standardised measures such as HoNOS scores). 
3. Clinicians' reports of outcomes measures being used in the allocation of 
resources and the planning of psychiatric services. 
4. Clinicians personal views on the use of outcomes measures in psychiatric 
practice 
Questionnaire design and administration 
The design and response format followed best practice guidelines outlined in key 
texts by Fowler (1993) and Dilman (1991), and summarised in a recent systematic 
review by McColl, et al. (2001). Brown, et al. (1989) provide a useful framework 
within which to consider the conduct of a survey in order to maximise response rate. 
A task analysis model of respondent decision making in completing and returning a 
questionnaire breaks the task down to: 
(1) Interest in the task; (2) Evaluation of the task; (3) Initiation and monitoring of the 
task, and; (4) Completion of the task. 
Each of these stages can be facilitated within the design of the survey, by attention 
to a number of factors. For example, interest in the task is maximised when a 
personal letter is used, which addresses the questionnaire to the specific 
respondent, and uses a visually well-designed questionnaire. The use of a 
personalised covering letter is also useful in this respect, and the content of this 
letter can maximise interest in a task by highlighting the timeliness and relevance of 
the question being asked, and identifying the sponsor of the research and outlining 
the credentials of the investigator. Tangible rewards can also be offered for 
participation, in order to maximise interest. Table 12 summarises a task analysis of 
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The questionnaire design and administration adhered to these principles, and 
the specific methods used are elaborated below. The questionnaire was 
designed using a commercially available desktop publishing computer package 
(Microsoft Corporation, 1997b) - see appendix 3 for final version. 
Pre pilot survey 
A two stage pre-pilot survey was conducted in order to identify any problems 
with individual question items, and to test the return rate of the questionnaire. A 
specified return rate of 60% of questionnaires and a completion rate of 90% for 
all items was set in advance as an acceptable result, suggesting a 
representative sample (McColl, et a/., 2001). 
In order to establish any initial design flaws and to identify any ambiguous terms 
or items, a cognitive interviewing technique was used, as described by Fienberg, 
et a/. (1985). Briefly, this technique involves the administration of a postal 
questionnaire in the presence of a researcher, with the purpose of identifying 
design flaws and ambiguous items, which might not have been apparent in the 
initial design. Using this technique, five respondents were individually asked to 
complete the questionnaire following the instructions given on the forms. They 
were also asked to raise any problems that they encountered in completing the 
questionnaire with the interviewer. These were noted and modifications to the 
wording and layout were effected in response to these comments. 
The key modifications made at this stage were. 
The exclusion of a 'does not apply' response category, 
0 Change in the sequence of questions and the allocation of numbers for 
each item. 
e The provision of a definition and example of an 'outcome measure'. 
0 The provision of a free text box to give examples of some uses of 
outcomes measures. 
The modified survey was then mailed to 50 individual consultants, together with 
a covering letter (appendix 4). The accompanying letter followed established 
guidelines in maximising response rate (Dilman, 1991; Harvey, 1987), in that it. 
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" Briefly set out the purpose of the survey, 
" Highlighted the funding source of the research, 
" Appealed to respondent's altruism in asking for a reply, 
" Identified the key researcher (SG) as someone who was likely to be 
aware of the issues being surveyed, 
" Provided a nominal inducement to participate (entry to a draw to win a 
copy of the Oxford Textbook of Psychiatry - an up to date textbook, 
recently published and likely to be coveted by respondents) 
" Provided contact details of the researcher (SG) to answer any questions 
" Provided a pre-paid envelope for return of the questionnaire. 
This approach, together with a single reminder letter at ten days (appendix 4), 
resulted in a response rate of 56% within three weeks of mailing. A second 
reminder and further copy of the questionnaire increased this response rate to 
66% (appendix 5). All items provided sufficient useable data in over 98% of 
cases. However, 9% of respondents were no longer engaged in routine clinical 
NHS practice and had either retired or were only involved in private practice. 
Retrospective analysis of the Medical Directory indicated that they had been 
incorrectly identified by the Medical Directory as not being retired, and in active 
NHS clinical practice. However, by studying year of qualification, the majority of 
these clinicians were in fact likely to be over 55 years of age, a common 
retirement age of psychiatrists in the UK (assuming medical qualification at the 
age of 23 years). The original database of 500 psychiatrists was therefore 
modified, by eliminating all clinicians likely to be over the age of 55 by virtue of 
having qualified before 1968. Further psychiatrists fulfilling the inclusion criteria 
were selected at random to bring the total up to 500 adult psychiatrists. No 
further modifications were therefore made at this stage, and a further pilot 
survey was not deemed necessary 
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Survey 
The survey proper was conducted by mailing the questionnaire, covering letter 
and a pre-paid reply envelope to each of the remaining 500 respondents on the 
contact database. Reminders and second copies of the questionnaire were sent 
in accordance with the following time-scale: 
Figure 5: Time scale of the survey 
Time in weeks 
01234 
First mail shot First reminder Second mail shot 
All data were entered into a specifically designed Microsoft Access relational 
database (Microsoft Corporation, 1998), and respondents were sequentially 
eliminated from the mail address database. Reminders and second mail shots 
were sent only to non-respondents. 
Analysis 
Data were sorted and analysed using Microsoft Access relational database 
(Microsoft Corporation, 1998). Responses to each individual item and 
confidence intervals for proportions were calculated using StatsDirect statistical 
package (Buchan, 2000). 
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Chapter 21 Results of the survey 
Questionnaire responses 
In total, 369 (74%) of the 500 questionnaires were returned in a six-week period. 
Figure 6 demonstrates the time scale over which responses were received. The 
response rate in the first 10 days was only 42%, and the effect of the first 
reminder and the mailing of the second questionnaire were key in increasing the 
response rate to 71 %. 
Figure 6: Cumulative responses to postal questionnaire over time 
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Of the 369 returned questionnaires, 29 were either not been completed (n=8), or 
were competed by consultants who fell outside of our inclusion criteria (n=21). 
Reasons for being returned without completion were (total n=8). 
0 No longer in post/not known at this address (n=4), 
Deceased (n=2), 
Reason not stated (n= 2). 
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Reasons for non-fulfilment of exclusion criteria were (n=21): 
0 No longer in NHS practice (n=7); 
Retired (n= 9); 
Child/learning disability/old age psychiatrists (n=5) 
Twenty nine of the 369 retuned questionnaires were therefore excluded from the 
final analysis (final eligible response rate = 340/500 - 68%). When ineligible 
responses were excluded from the denominator, the final response rate was 
72% (340/471). 
Details of respondents. 
The vast majority of respondents gave their main stated speciality as 'general 
adult psychiatry' (82%). The breakdown of respondents by speciality is given in 
table 13. Most respondents reported working in a non-teaching hospital/non 
teaching community mental health trust (225/340 - 65%), whilst others reported 
working in a teaching hospital/community trust (117/340 - 35%). Survey 
respondents reported having been a consultant psychiatrist for a mean 12.4 
years (range 2 to 25), and were each responsible for an average of 14 in- 
patients (range 0 to 42); 17 day-hospital patients (range 0 to 36), and 29 
outpatients (range 0 to 44) in any one week. 
Table 13: Specialities of respondents 
Speciality Main speciality Sub specially/special interest Total 
General adult psychiatry 264 14 278/340 
82% 
Community psychiatry 40 36 76/340 
22% 
Rehabilitation psychiatry 16 24 40/340 
12% 
Liaison psychiatry 8 20 28/340 
7% 
Drugs and alcohol 10 14 24/340 
7% 
Academic psychiatry 8 10 28/340 
7% 
Forensic psychiatry 12 10 22/340 
6% 
Psychotherapy 6 6 12/340 
4% 
Some respondents indicated more than one speciality, so figures add up to >1 00% 
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1. Reported uses of standardised outcomes measures by clinicians in 
the day-to-day care of patients. 
A. Case identification and assessing the severity of specific 
psychiatric problems 
Respondents were asked about the use of outcomes measures in identifying 
cases and assessing the severity of the following problems: depression/anxiety; 
schizophrenia/psychosis; cognitive impairment; drugs/alcohol problems. 
Depression/anxiety and cognitive impairment were the disorders where 
outcomes measures were most commonly used for this purpose, with 44.6% 
(95%Cl 39.3-50.2%) and 55.3% (95%Cl 49.8-60.7%) respectively reporting 
using these measures, either routinely or occasionally. For disorders such as 
schizophrenia, and drug and alcohol problems, outcomes measures were 
reportedly never used for this purpose amongst the majority of consultants (for 
schizophrenia 72.9%, 95%Cl 67.9-77.6%, and drugs/alcohol 83.3%, 95%Cl 
79.1-87.3%, report never using a standardised measure for this purpose). The 
most commonly used measures for the detection of depressive and anxiety 
disorders were the Beck Depression Inventory - BDI (61/340); the Hospital 
Anxiety and Depression scale - HAD (53/340); and the Hamilton Depression 
Rating Scale - HDRS (46/340). The most commonly used measure in detecting 
cognitive impairment was the Mini Mental State Examination - MMSE (Fostein, 
et a/., 1975) (134/340). Although infrequently used, the most commonly 
reported measures used in the detection of psychotic illnesses were the Positive 
and Negative Symptom Scale - PANSS (Kay, 1991) (25/340), the Health of the 
Nation Outcome Scale - HoNOS (Wing, 1994) (25/340), and the Brief 
Psychiatric Rating Scale - BPRS (Overall & Gorham, 1962) (17/340). For drugs 
and alcohol problems, the most commonly reported measure was the CAGE 
questionnaire (Mayfield, et a/., 1974) (10/340). 
Exact response rates are given in table 14 and figure 7. The most commonly 
used instruments are given in tables 20-23. 
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Table 14: Case identification and assessing the severity of specific 
psychiatric problems 
Never Occasionally Routinely 
(95% Cl) (95% Cl) (95% Cl) 
Depression/anxiety 188/340 116/340 36/340 
55.3% 34.1% 10.5% 
(49.8-60.1%) (29.0-39.4%) (7.5%-14.4%) 
Sch izo ph re ni a/psych osis 248/340 70/340 22/340 
72.9% 20.6% 6.5% 
(67.9-77.6%) (16.4-25.3%) (4.1-9.6%) 
Cognitive impairment 152/340 138/340 50/340 
44.7% 40.6% 14.7% 
(39.3-50.2%) (35.3-46.0%) (11.1-18.9%) 
Drugs/alcohol 284/340 36/340 20/340 
83.3% 10.6% 5.9% 
(79.1-87.3%) (7.5-14.3%) (3.6%-8.9%) 
B. Identifying deficits in social functioning, quality of life or the 
assessment of patients needs. 
Respondents were asked about the use of outcomes measures in detecting 
deficits in social functioning, quality of life or the assessment of patients needs. 
Very few clinicians reported using standardised instruments at all for this 
purpose, amongst any patient groups. The following percentages of clinicians 
reported never using a questionnaire amongst the following clinical groups: 
Depression/anxiety 80.6% 95%Cl 75.9-84.7%); schizophrenia/psychosis 75.6% 
(95%Cl 70.4-79.8%); cognitive impairment 83.5% (95%Cl 79.2-87.3%); 
drugs/alcohol 88.8% (95%Cl 84.9-91.9%). For the small minority who did report 
using a standardised questionnaire, only a small percentage specified which 
measure they chose to use. For depression, the most commonly reported 
measures were the HoNOS (Wing, 1994) (20/340) the Social Adjustment Scale 
(Weissman & Bothwell, 1976) (9/340); and the Social Functioning Schedule 
(Remmington & Tyrer, 1979) (5/340). For schizophrenia/psychosis, the most 
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commonly reported measures were the PANSS (20/340); the BPRS (13/340), 
and the HoNOS (Wing, 1994) (16/340). For cognitive impairment and drugs and 
alcohol problems, the most commonly reported measure was the HoNOS 
(13/340 and 12/340 respectively). 
Exact response rates are given in table 15 and figure 8. The most commonly 
used instruments are given in tables 20-23. 
Table 15: Identifying deficits in social functioning, quality of life or 
the assessment of patients needs. 
Question: Do you use standardised outcomes measures to check for deficits in 
social functioning, quality of life, or to assess patient needs? 
Never Occasionally Routinely 
(95% Cl) (95% Cl) (95% Cl) 
Depression/anxiety 274/340 44/340 22/340 
80.6% 12.9% 6.5% 
(75.9-84.7%) (9.6-17.0%) (4.1-9.6%) 
Schizophrenia/psychosis 256/340 46/340 38/340 
75.6% 13.5% 11.2% 
(70.4-79.8%) (10.1-17.6%) (8.0-15.0%) 
Cognitive impairment 284/340 36/340 20/340 
83.5% 10.6% 5.9% 
(79.2-87.3%) (7.5-14.4%) (3.6-8.9%) 
Drugs/alcohol 302/340 20/340 18/340 
88.8% 5.9% 5.3% 
(84.9-91.9%) (3.6-8.9%) (3.2-8.2%) 
Measuring clinical change over time and therapeutic response 
Standardised measures were most commonly used in order to measure change 
over time amongst those with depression and anxiety problems, with 41.7% 
(95%Cl 36.5-47.2%) of clinicians reporting using a measure at all, although only 
11% (95%CI 8.0-15.0%) reported using a measure on a routine basis. A larger 
proportion of clinicians reported never using a standardised questionnaire for 
cognitive impairment (66.5%, 95%Cl 61.2-71.5%), schizophrenia (73.5%, 95%Cl 
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68.5-78.1 %) and drugs and alcohol (91.2%, 95%Cl 87.6-94.0%). The most 
commonly reported questionnaires, in the case of depression/anxiety were the 
BDI (Beck & Ward, 1961) (49/340); HAD (Zigmond & Snaith, 1983) (41/340); 
HDRS (Hamilton, 1967) (23/340); and the HoNOS (18/340). The most 
commonly used measure in the case of schizophrenia/psychosis were the 
PANSS (Kay, 1991) (20/340); the BPRS (Overall & Gorham, 1962) (13/340), 
and the HoNOS (Wing, 1994) (16/340). The most commonly used 
questionnaires in the case of cognitive impairment was the MMSE (Fostein, et 
aL, 1975) 60/340, and the HoNOS (Wing, 1994) (13/340). Of the few clinicians 
who reported using a standardised questionnaire to measure change over time 
amongst those with alcohol problems, the most commonly stated measure was 
the HoNOS (Wing, 1994) (10/340). 
Exact response rates are given in table 16 and figure 9. The most commonly 
used instruments are given in tables 20-23. 
Table 16: Measuring clinical change over time and therapeutic 
response 
Question: Do you use outcomes measures to measure change overtime or 
therapeutic response? 
Never Occasionally Routinely 
(95% Cl) (95% Cl) (95% Cl) 
Depression/anxiety 198/340 104/340 38/340 
58.2% 30.5% 11.2% 
(52.8-63.5%) (25.7-35.8%) (8.0-15.0%) 
Schizophrenia/psychosis 250/340 68/340 22/340 
73.5% 20.0% 6.5% 
(68.5-78.1%) (15.9-24.7%) (4.1-9.6%) 
Cognitive impairment 226/340 84/340 30/340 
66.5% 24.7% 8.8% 
(61.2-71.5%) (20.2-29.6%) (6.0-12.4%) 
Drugs/alcohol 310/340 14/340 16/340 
91.2% 4.1% 4.7% 
(87.6-94.0%) (2.3-6.8%) (2.7-7.5%) 
132 
D. Standardised questionnaires used for audit. 
Overall, standardised questionnaires were used much less for clinical audit, than 
for the other purposes outlined above. The most commonly reported condition 
for which they were used was depression/anxiety, where 19.4% (95%Cl 15.3- 
24.0) of clinicians reported their use either occasionally or routinely in the course 
of clinical audit. The most commonly reported measures for this condition were 
the BDI (Beck & Ward, 1961) (18/340), the HoNOS (Wing, 1994) (18/340); the 
HDRS (Hamilton, 1967) (13/340), and the HAD (Zigmond & Snaith, 1983) 
(12/340). For those with schizophrenia/psychosis, 21.2% (95%Cl 16.9%-25.9%) 
of clinicians reported using a standardised measure occasionally or routinely, 
and the most commonly reported measures were the HoNOS (Wing, 1994) 
(24/340); the PANSS (Kay, 1991) (6/340), and the BPRS (Overall & Gorham, 
1962) (8/340). Standardised measures were very rarely used for those with 
cognitive impairment or drugs or alcohol problems. 
Table 17: Stanclardised questionnaires used for audit. 
Question: Do you use standardised outcomes measures as tools for clinical 
audit? 
Never Occasionally Routinely 
(95% Cl) (95% Cl) (95% Cl) 
Depression/anxiety 260/340 52/340 14/340 
76.5% 15.3% 4.1% 
(71.6-80.9%) (11.6-19.6%) (2.2-6.8%) 
Schizophrenia/psychosis 268/340 40/340 32/340 
78.8% 11.8% 9.4% 
(74.1-83.0%) (8.5-15.7%) (6.5-1.3%) 
Cognitive impairment 294/340 36/340 10/340 
86.5% 10.6% 2.9% 
(82.4-89.9%) (7.5-14.4%) (1.4-5.3%) 
Drugs/alcohol 310/340 12/340 18/340 
91.2% 3.5% 5.3% 
(87.6-94.0%) (1.8-6.1%) 95%Cl 3.2-8.3% 
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In addition to standardised questionnaires, an enquiry was made into the use of 
the following routinely collected data in the process of audit: Length of stay; Use 
of the Mental Health Act; Mortality; Suicide; Readmission rates. 
The most commonly used measure was length of stay, with 60.6% (95%Cl 95% 
CI 55.2-65.8%) of clinicians reporting experience of the use of this measure for 
audit purposes. Other routine data were reported to be used by over half of the 
clinicians. 
Table 18: administrative data used for clinical audit 




95% Cl 26.8-37.0% 
Suicide 200/340 
58.8% 
95% Cl 53.3-64.1% 
Length of Stay 206/340 
60.6% 
95% Cl 55.2-65.8% 
Readmission 194/340 
57.1% 
95% Cl 51.6-62.3% 
Use of the Mental Health Act 186/340 
54.7% 
95% C 149.2-60.1 % 
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2. Outcomes measures collected under the instruction of the 
Trust/hospital 
Very few clinicians reported being required to collect outcomes measures by 
their trust. Only 13.5% reported being required to collect outcomes data 
themselves for all of their patients (irrespective of diagnosis). Of those that 
specified which measure they were required to collect, the HoNOS was the most 
common (25/340), with some also reporting the requirement to collect the Global 
Assessment of Functioning (5/340). Exact response rates are given in table 19. 
Table 19: Outcomes required by the Trust 
Question: Are you asked to routinely collect standardised outcomes measures 
by your hospital/Trust for the following patients/problems? 
Proportion of respondents reporting routine collection 
All patients 46/340 
13.5% 
95% Cl 10.0-17.6% 
Depression/anxiety 14/340 
4.1% 
95% Cl 2.3-6.8% 
Schizophrenia 18/340 
5.3% 
95% Cl 3.2-8.2% 
Drugs and alcohol 10/340 
2.9% 
95% Cl 1.4-5.3% 
Cognitive impairment 6/340 
1.7% 
95% Cl 0.6-3.8% 
Clinicians were specifically questioned about being asked or required to collect 
the Health of the Nation Outcome Scale (Wing, 1994), or specific Needs 
Assessment Tools by their hospital trust. With respect to the HoNOS, 26% 
(95% Cl 21.3-30.1 %) reported being asked to collect these data on their 
patients, whilst only 8.2% (95% Cl 5.5-11.7%) reported being asked to use 
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specific needs assessment tools (such as the Camberwell Assessment of Need 
and the MRC Needs for Care). 
Data collected routinely by hospitals/trusts 
Clinicians were asked about data that they knew to be routinely collected by 
hospitals and trusts. In contrast to standardised questionnaires such as the 
HoNOS, trusts commonly collected the following data: 
" Use of the Mental Health Act (88.2%, 95% Cl 84.3-91.5%), 
" Length of stay (86.5%, 95% Cl 82.7-89.9%); 
" Suicides (82.4%, 95% CI 77.9-86.3%); 
" Deaths (75.3%, 95% Cl 70.3-79.8%); 
" Readmission rates (70.6%, 95% Cl 65.4-75.4%). 
These data were also commonly fed back to individual clinicians, with 72.6% 
reporting that this happened in their individual trust or hospital. 
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Table 20: The use of questionnaires for depression & anxiety 
Proportion of consultants using Measures/instruments used 
instruments occasionally or 
routinely 
Screening for 152/340 - 44.6% BDI - 61/152; HAD - 53/152; HDRS 
depression/anxiety - 46/152; HoNOS - 11 /152; MADRS 
- 10/152; Other (GAF; GHQ; Zung-, 
GDS; SCAN) - 1/152 
Screening for deficits in 66/340 - 19.3% HoNOS - 20/66; SASS - 9/66; SFQ - 
social functioning/QoL/needs 5/66 
GAF - 4/66; CAN - 3/66; QL 
checklist - 2/66; MRC needs for Care 
-1/66 
Measuring therapeutic 143/340 - 42.1% BDI - 49/143; HAD - 41/143; HDRS 
response - 23/143; HoNOS - 18/143; MADRS 
- 10/143; GAF/CGI - 9/143; 
Speilberger - 4/143; BAI - 3/143; 
Zung - 2/143 
GDS - 1/143 
Clinical audit 80/340-24% BDI - 18/80; HoNOS - 18/80; HDRS - 
13/80; HAD - 12/80; MADRS - 3/80; 
Speilberger - 2/80; Zung - 1/80 
Table 21: The use of questionnaires for schizophrenia/psychosis 
Proportion of consultants using Measures/instruments used 
instruments occasionally or 
routinely 
Screening for and diagnosing 93/340 - 27.4% PANSS - 25/93; HoNOS - 
schizophrenia/psychosis 20/90; BPRS -17/90; KGV - 
9/90; PSE/SCAN 6/90; GAF - 
5/90; CAN - 2/90 
Screening for: deficits in social 84/340 - 21.5% PANSS - 20/84; BPRS - 13/84; 
function ing/Q o Uneeds HoNOS - 16/84; KGV - 6/84; 
SFS - 3/84; Lancashire - 2/84; 
CGI - 1/84 
Measuring therapeutic response 91/340 - 26.7% HoNOS - 33/91; BPRS - 13/91 
PANSS - 12/91; GAF/CGI - 
9/91; Lancashire - 3/91; SFS - 
1/91; CAN - 1/91; SAD/SANS - 
2/91 
Clinical audit 73/340 - 21.5% HoNOS - 24f73; PANSS - 6173; 
BPRS - 8/73; Lancashire - 4/73; 
CAN - 2f73 
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Table 22: The use of questionnaires for cognitive impairment 
Proportion of consultants using Measures/instruments 
instruments occasionally or used 
routinely 
Screening for and diagnosing cognitive 188/340 - 55.3% MMSE - 134/188; WAIS - 
impairment 9/188, CAMCOG - 3/188 
Screening for deficits in social 56/340 - 16.5% HoNOS - 13/56; QL 
functioning/QoUneeds checklist - 3/56; CAN - 
2/56 
Measuring therapeutic response in 91/340 - 26.7% MMSE - 60/188; HoNOS - 
cognitive impairment 13/188; WAIS - 6/188; 
ADASCOG - 1/188; 
CAMDEX - 1? 188 
Clinical audit of cognitive impairment 47/340 - 13.8% MMSE - 13/47; HoNOS - 
9/47; WAIS - 2/47 
Table 23: The use of questionnaires for Drugs and Alcohol 
problems 
Proportion of consultants using Measures/instruments 
instruments occasionally or used 
routinely 
Screening for and diagnosing drugs and 56/340 - 16.5% CAGE - 10/56; SADQ - 
alcohol problems 3/56; HoNOS - 4/56; SCID - 
2/56; Maudsley Addictive 
Profile - 2/56 
Screening for: deficits in social 37/340 - 10.9% HoNOS - 12/37; SAS - 
functioning/QoL/needs 2/37; MRC - 1/37; GAF - 
1/37 
Measuring therapeutic response in 29/340 - 8.5% HoNOS - 10/29; Maudsley 
drugs and alcohol problems Addictive Profile - 2/29 
Clinical audit of drugs and alcohol 30/340 - 8.8% HoNOS - 8/30; ARPQ - 
problems 2/30; Maudsley Addictive 
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3. The use of outcomes data in planning services and allocating specific 
funds. 
Only a minority of clinicians (107/340 - 31.5%) reported knowledge that outcomes 
measures had ever been used in planning services or in allocating specific 
resources within their hospital or trust. Of the 107 respondents reporting the use of 
outcomes measures in planning services, 53 gave specific examples. Analysis of 
the content of the comments given shows that broadly four specific uses of 
outcomes measures are defined, which are outlined below, together with specific 
examples: 
Demonstrating the effectiveness of new treatments and models of service 
delivery (n=23). 
Examples included the monitoring of the use and effectiveness of atypical anti- 
psychotic medication (n=17), and the use of specific community based treatment 
models of care - such as assertive outreach (n=7). Specific examples are given 
below 
Specific examples: 
'Effectiveness of crisis response team and assertive outreach, admissions and re- 
admissions before and after' 
'HoNOS scores have provided evidence for the benefit of clozapine, and this has 
helped get Health Authority funding prescribe it. ' 
'Demonstration of the effectiveness of CM. Finances appropriately directed. ' 
One respondent described the use of outcome data to compare performance 
between different hospital trusts, and to justify funding: 
'We use what are largely positive outcomes in comparison to neighbouring trusts to 
show we are using resources properiy and to petition for more (consultants, CPNs, 
ICU beds, increased drug budgets etc. ). ' 
Defining specific local problems within the clinical catchment area, and 
responding to these appropriately (n=16). 
Specific examples were given of the use of outcomes measures in identifying 
specific problems in a locality and using this to develop services. Examples 
included: the use of waiting times for those with alcohol problems to justify a new 
post; the use of depression and suicide measures amongst hospital populations in 
the development of liaison services; the use of out of area referral rates to justify 
home treatment services. 
Specific examples: 
'Waiting list times led to development of a post to assess people with alcohol 
problems referred to alcohol treatment unit. ' 
'Depression and suicide scores amongst general hospital patients used to develop 
ialson psyc /a ry. 
'High rate of out of area admissions led to the development of home treatment 
services. Audit of clinical caseloads allowed for prioritisation of severely mentally ill. ' 
Rational planning and organisation of services (n=11). 
Most frequent examples were the definition of clinical catchment areas (n=4), and 
the provision of appropriate staffing levels and caseload sizes (n=3). Two 
respondents described the use of needs assessment tools in order to target 
resources more specifically at those with severe mental illness. Another described 
the use of measures in the closure of long stay beds and the re-provision of 
services. 
Specific examples: 
'Audit of clinical caseloads allowed for prioritisation of severely mentally ill. ' 
'Attempts have been made to reform catchment areas using some of the above 
measures (specified within the questionnaire). ' 
'HoNOS being used in the development of our 16 years-19 year's (adolescence) 
community and in patient service. ' 
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Negative comments 
In addition to the above, three respondents used this space to explicitly state their 
negative views of the use of outcomes data in planning services. These statements 
centred on the unreliability of the data. 
Specific examples: 
'They make them up as they go along from useless data collection, which is 
unreliable in the first place. ' 
'The data have been of low quality and unreliable. Collection systems have been 
poor and it is only now that appropriate systems are being installed. ' 
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4. Clinicians' personal views relating to the use and experience of 
outcomes measurement 
Respondents were asked in a non-directive manner to give their views on the use of 
outcomes measures in clinical practice. Approximately one third (120/340) used this 
space to give comments, which centred on the following themes: 
0 The nature of measurement and outcome in psychiatry (n=40) 
0 The psychometric properties of the instruments available (n=28) 
0 The skills, time and resources used in measuring outcome on a routine basis 
(n=63) 
0 The utility of measures in clinical practice (n=22) 
0 The response of organisations to routinely collected outcome measures 
(n=3) 
0 Specific comments relating to the Health of the National Outcome Scale - 
HoNOS (n=26) 
0 The role of routine outcome measurement within the wider multi-disciplinary 
team (n= 15) 
Each of these themes will now be considered in turn 
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The nature of measurement and outcome in psychiatry (n=40) 
40 respondents expressed a negative view of standardised outcomes measures, 
questioning the ability of outcomes measures to capture the subtlety of multi-faceted 
outcome and to describe the individual patient. 
Specific examples: 
'Outcome measure such as those described above are rather simplistic. Most of 
clientele have severe enduring illness and require a much more sophisticated 
outcome measure. ' 
'Often find little advantage over proper clinical assessment. Can become a paper 
exercise unless specific purpose. We use specific individual care plans with 
objectives. ' 
'Deep reservations about the value of any scale which divides a continuous 
fluctuating process into arbitrary categories which are themselves the subject of 
entirely personal evaluation. ' 
'/ am appalled at the direction psychiatry has taken, patients are not so much 
examined and listened to and responded to as human beings. They are categorised 
by symptoms and evaluated according to their'scores'. It is a semi-robotic process. ' 
'A bit time consuming. Not clinically relevant. ' 
'Have been interested in their use, but never been convinced of their 
usefulnesslreliability. They also seem time consuming, add a pseudo-scientific 
gloss. I 
'Very limited clinical application. Diagnoses are ambiguous' 
'Rehabilitation psychiatry is more about maintaining stability and quality of life than 
on change and getting results. So these measures are less relevant. 1 
'Never used in routine care. No time, questionable value in the real worid. ' 
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'/ monitor my patients carefully - using a sort of Gestalt of their well-being or by 
identifying their needs. Pursuing and trying to address them. ' 
The psychometric properties of the instruments available (n=28) 
Respondents explicitly questioned the basic psychometric properties of validity, 
reliability and sensitivity to change for available measures (n=28). 
Specific examples: 
'Outcome scales are time consuming, of questionable validity, very subjective and 
variable depending on rater' 
'Used exclusively on their own, they are very imprecise and faidy unhelpful when 
assessing risk and outcomes. ' 
'Have been interested in their use, but never been convinced of their 
usefulnessAreliability. They also seem time consuming, add a pseudo-scientific 
gloss. ' 
'Doubt validity of many outcome scales. ' 
'Most questionnaire measures were found not sensitive enough to be of use. 
HoNOS may be an exception. ' 
'The validity and appropriateness of outcome measures concems me. ' 
The skills, time and resources used in measuring outcome on a routine basis 
(n=63) 
Respondents stated that outcome measurement requires training in order that it is 
done in a valid and reproducible manner (n=25), and that a robust infrastructure, 
particularly in terms of administration and information technology resources, is 
needed to support the process (n=20). Respondents generally felt that these were 
lacking, representing a barrier to their use. 
Specific examples: 
'Would like to use them, but need more time, ' 
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'Difficult to use in CMHT, no time. 
'Use of measures requires a robust infrastructure and the time required; skilled staff; 
/T support. Such an infrastructure has not been made available, nor will it ever 
become available in my working lifetime; sadly! ' 
'Our service is pressurised so that we have little time at present to use outcome 
measures' 
'A bit time consuming. Not clinically relevant. 1 
'My concern is: 1) the time involved- haven't 2) / don't know how to use it. ' 
'If doctors in psychiatry have to use them routinely our workload has to be reduced 
by 50%. 1 
'My own strong view is that 'bolt on'forms, risk assessment, CPA will never work, 
and add to tisk because the notes become impossibly bulky and are a) not used b) 
not read. ' 
'The use of outcomes measures represents an opportunity cost, and my precious 
tj . me wl . // be distracted from more useful and productive activities. ' 
'/ had used the HoNOS for inpatients but it took so long that / dropped it. ' 
'To be meaningful they would have to be part of well thought through collaborative 
effort-accepted and taken on board sufficiently well resourced and fed back. These 
conditions do not apply here. ' 
'would love to use outcome measures, but my adult service has been on the beech 
at Dunkirk for years..... Unless there are more adult Psychiatrists !, 
The utility of measures in clinical practice (n=22) 
Respondents stated that they did not find the results of standardised outcomes 
measures particularly useful in clinical practice (n=21). One respondent stated that 
they were more 'research tools ', rather than instruments that are useful in clinical 
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practice, and that they 'are more indirect measures than my overall knowledge of 
the patient'. Another stated that the 'use of scales detl-acts from therapeutic 
relationship. ' 
Specific examples: 
'Do not find scores and scales useful in treating and monitoring psychiatric patients. ' 
'Generally unhelpful in clinical practise, of some use in planning service. ' 
'Rating scales are useful in research to provide objective measure of change but 
they do not fulfil a useful role in clinical practice. They are more indirect measures 
than my overall knowledge of the patient. ' 
'In practice these are rarely used. For formal audit never, For assessment if severity 
or progress sometimes. ' 
'My own strong view is that 'bolt on'forms, risk assessment, CPA will never work, 
and add to risk because the notes become impossibly bulky and are a) not used b) 
not read. ' 
Use of scales detracts from therapeutic relationship. 
'Seldom makes use of outcome measures, normally relies on clinical judgement. ' 
'Never used in routine care. No time, questionable value in the real worid. ' 
'Very useful in routine practice. No noticeable impact in service planning or resource 
allocation. ' 
The response of organisations to routinely collected outcome measures (n=3) 
Three respondents expressed concern that there is no support within trusts for the 
collection of outcomes measures, or that if there were, then these would not be used 
in planning services. 
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Specific examples: 
'I'm interested, but never get any feedback or assistance, so enthusiasm has 
waned. ' 
'Use of measures requires a robust infrastructure and the time required; skilled staff; 
/T support. Such an infrastructure has not been made available, nor will it ever 
become available in my working lifetime; sadly! ' 
'Managers pay little attention to such unhelpful details, such as clinical data, but 
blithely follow political dictat. ' 
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Specific comments relating to the Health of the National Outcome Scale 
(HoNOS) (n=26) 
26 responses specifically related to the HoNOS, whereas no other measure was 
mentioned specifically by name. Comments were largely critical (n=21), and related 
to: time to complete (n=16); inadequate psychometric properties (n=8); the lack of 
additional information that it adds to the routine clinical assessment (n=5); the lack 
of enthusiasm amongst staff (n=7). Positive comments (n=7) included the fact that it 
could be completed by non-ciinicians (n=4), and that it acted as a useful aide 
memoire in clinical decision making (n=3). One person stated that 'the HoNOS, 
although scientifically flawed, is useful for bringing together a// members of the multi- 
disciplinary team'. 
Specific examples: 
'Attended HoNOS training day at RCPsych, consider-able difficulties in implementing 
into general usage in this Trust. Training offered to all clinical staff but little 
enthusiasm to use HoNOS in practice. ' 
'We have used HoNOS with CPA patients in quite a lengthy pilot study but / have 
not found it particularfy helpful. It does not add anything to a clinical assessment, 
tends to distort the CPA (care programme approach) process. ' 
'We tried using HoNOS as a routine measure but it wasn't found to be useful for 
anything. / have often thought that we should use a severity rating scale on each 
patient admitted (eg. HDRS for depressives, PANSS for schizophrenia) and re-rate 
prior to discharge. We haven't managed it yet. ' 
'HoNOS: useful as an aide memoire to patient and their current state-good process 
measure but very poor as measuring outcomes overtime, also aggregate score 
meaningless doesn't allow companson of services. Despite this is best available. ' 
'Insufficl . ent understanding of which scale is best for which condition/situation. The 
HoNOS is gaining ground, especially as it doesn't require a doctor to complete it, 
that frees up important time. ' 
I had used the HoNOS for inpatients but it took so long that / dropped it. 
HoNOS is a useless tool, conceived by a government lackey! ' 
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'We were involved in the piloting of HoNOS. It was a disappointing experience. 
Hours of work were put into collecting data. The Research Unit promised that we 
would get useful data back and would be able to compare our performance with 
other trusts. What we got back was very disappointing and of very little clinical 
relevance. Nothing of great relevance was revealed. All the staff involved felt that 
the routine collection of data which cannot be readily used is of little benefit. ' 
'HoNOS although scientifically flawed is useful for bringing together all members of 
the Multi Disciplinary team. ' 
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The role of routine outcome measurement within the wider multi-disciplinary 
team (n=15) 
15 respondents commented that other members of the multi-disciplinary team, 
particularly nursing staff, often carry out outcomes measurement. Similarly, others 
thought that the use of outcome measures fostered greater interdisciplinary 
communication. 
Specific examples: 
'For many condi . tions / rely on rating scales carried out by trained nursing staff, 
social workers and psychologists. ' 
'Discuss in the MDT leads to better assessments and analysis of outcomes, as 
Psychiatry is still a very inexact science. Rating scales only improve things 
marginally - shared experience in the MDT setting presents better evaluation, 
though of course rating scales etc may be helpful in giving a fuller picture. ' 
'Nursing staff do routine assessments, depressionlanxiety and risk assessment in 
/PCU. I 
'Nurses collect HoNOS. ' 
'HoNOS although scientifically flawed is useful for bringing together a// members of 
the MD team. ' 
'To be meaningful they would have to be part of well thought through collaborative 
effort-accepted and taken on board sufficiently well resourced and fed-back. These 
conditions do not apply here. ' 
'Largely an activity by the nursing stafl' 
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Chapter 22 Discussion of the main results of the survey 
Survey methods 
The method employed in this study was that of a postal survey, which represents a 
relatively cheap and efficient way of accessing the thoughts and experiences of a 
large number of individuals (Fowler, 1993). Postal questionnaires are, for example, 
cheaper and less time consuming to conduct than face to face or telephone 
interviews (Oppenheim, 1992). However, postal surveys, as with all forms of 
research, are prone to a number of potential biases that require further discussion. 
Surveys with low response rates are especially prone to biases, since the danger is 
ever apparent that those who complete surveys differ in systematic ways from those 
who fail to respond. For example in postal attitude surveys of the general 
population, response is consistently found to positively correlate with socio- 
economic status, and to negatively correlate with age, since respondents are shown 
to younger and better educated than non-respondents (Goyder, 1987). For this 
reason, recommendations are made that response rates should be in excess of 65- 
70% (Borg & Gall, 1983; Fowler, 1993; McColl, et al., 2001), in order to dilute this 
and other potential biases, which can ultimately never be avoided. It is not known to 
what extent this general observation of respondent bias might be directly applicable 
to surveys of consultant psychiatrists. However, the observation that those over 55 
were found to respond less in the pilot survey may in part been explained by the fact 
that older clinicians may have been less inclined to respond, in addition to having 
retired from practice. The consideration must be borne in mind that the results of 
the present survey may have been biased towards the responses of younger or in 
some way selected consultants. However the choice to exclude clinicians over the 
age of 55 can be defended on practical grounds, given the very poor response rate 
and plausible explanation for their non-response - i. e. that they had retired. 
In addition to the systematic biases that exist between those who respond to 
surveys and those who do not, there are a number of practical reasons why people 
fail to respond to surveys. These include: moving on from the listed address; being 
away from the listed address over the duration of the survey; and refusal to 
participate. Active steps were taken to minimise the effect of the first two biases, by 
using an up to date data resource which has previously yielded high response rates, 
and ensuring that reminders spread out over several weeks, together with further 
155 
copies of the questionnaire instrument were sent. Further active steps that were 
planned in the event of a low response rate were to make contact by phone to non- 
respondents, in order to confirm that a correct correspondence address was in fact 
obtained, and to encourage completion of the questionnaire. The fact that a 
response rate was achieved which is comparable to other surveys using this 
resource (Adams, et al., 1999; Bristow, 1999), at the upper range of respondent 
rates of clinician surveys in general (Asch, et al., 1997), and in the region of the 65- 
70% recommended response rate, lends credibility to the findings of the survey. 
Factors that are known to affect response rates in general were attended to in the 
design of the questionnaire and survey methodology. Of particular relevance is the 
fact that surveys that are perceived as 'boring' or where the topic of research is seen 
as unimportant to the respondent are known to have lower response rates 
(Herberlein & Baumgartner, 1978). The fact that a relatively high response rate was 
obtained may in some way reflect the fact that clinicians perceived this to be an 
important topic, about which they felt it important to record their actions and their 
experiences. This, however, also raises the possibility that those responses that 
were obtained were not typical of practising clinicians. It can be postulated that 
those with strong positive or negative views regarding the use of outcomes 
measures chose to respond. Some of the responses to open ended questions were 
in fact quite strongly negative or positive, suggesting that respondents were more 
likely to use this space if they had something other than a neutral stance on the 
topic. 
One major limitation of all forms of respondent survey is the fact that what is 
recorded is a self-report of real events and practices, rather than a direct and 
independent observation of what actually happens. Additional research would be 
needed which directly observed clinician behaviour in order to corroborate the 
findings of this survey. 
Of potential concern within the survey is the ability of clinicians to understand what 
is meant by'outcome' and an outcome measure. The process of cognitive 
interviewing identified this at the pre-pilot survey design stage. In particular, the use 
of the term outcome without an operational definition left some clinicians unclear 
about what was being asked. The addition of an operational definition was intended 
to rectify this. However, it was clear from some responses that a small minority of 
clinicians confused outcomes with process measures (e. g. waiting list times), 
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particularly when asked to give free text examples. This ambiguity of terminology is 
not unique to psychiatrists, and ambiguity exists in the research literature (see 
chapter 5). The results of the survey must be considered alongside the general 
difficulty that exists in assuming that the questions and terminology were 
understood. The use of cognitive interviewing at the design stage follows best 
practice guidelines in ensuring this bias was kept to a minimum. 
The use of forced choice questionnaires is particularly good for eliciting factual 
information, but is less good for enquiring into the nature of topics about which little 
is previously known (Mays & Pope, 1996). For this reason, a mixture of forced 
choice factual questions and open-ended questions were employed, with the latter 
being used to elicit respondents' experience of outcomes measurement. That many 
chose not to elaborate on this topic does not devalue the responses that were 
obtained. However, these data are limited in many respects. Most importantly, 
hitherto unexplored issues were raised within these 'free text' responses, which 
would justify further research or investigation - for example some of the barriers that 
were identified to the routine use of outcomes measures. Respondents generally 
tend to be less expansive in writing than in speaking. Therefore, there is clearly a 
role for further interview based research, where respondents might be encouraged 
to elaborate on some of the topics raised, allowing more spontaneous and richer 
information to be obtained and recorded verbatim. The research needed to explore 
some of the issues identified within this quantitative survey is of a qualitative nature. 
Techniques such as 'in depth interviews' would usefully allow some of the important 
issues and hypotheses to be explored in greater detail (Denzin & Lincoln, 1994). 
Main findings 
Use of outcomes measures by adult psychiatrists in the day-to-day care of 
their patients 
The main finding is that the majority of clinicians do not use outcomes measures at 
all in their day-to-day practice. The only exception to this is in screening for 
cognitive impairment; although only a minority of clinicians do this routinely and this 
condition represents only a small component of the case mix in general adult 
psychiatry. What is particularly surprising is the infrequency with which patient 
needs and psychosocial problems are measured in any standardised way, despite 
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political pressures and explicit government policy (Glover, et a/., 1997; Secretary of 
State for Health, 1999) to adopt measures such as the HoNOS and needs 
assessment tools. This may reflect a failure simply to use standardised measures, 
or perhaps a wider indifference towards and failure to address psychosocial 
outcomes and needs. 
HoNOS does seem to have found a place in measuring outcome in UK mental 
health services, albeit a small one. It is only used by a small minority of clinicians, 
but seems to be the main tool that is used in measuring psychosocial outcome for 
those schizophrenia and other psychoses. 
Outcomes measures routinely collected by hospitals/trusts 
When data are collected by trusts, they are administrative outcomes - such as 
length of stay and readmission rates. These are generally the measures that are 
the easiest to collect, but which potentially bear little relation to the clinical or 
psychosocial outcome of the individual patient or clinical population. Interestingly, it 
is these data that are routinely fed back to clinicians, and are used in clinical audit, 
rather than standardised patient based measures. This is perhaps not surprising, 
since it is administrative outcomes that will form the basis upon which success of 
individual trusts or clinicians is to be judged in the performance management 
framework of the 'New NHS' (Secretary of State for Health, 1999). The desirability 
of these 'performance indicators' as the main measurement of success or failure is 
debatable (Davies & Crombie, 1997; Davies & Lampel, 1998). Of particular concern 
that these figures are the easiest to manipulate or'improve', without conferring any 
overall health gain on the population or service under consideration (Smith, 1996b). 
Organisations (both medical and non-medical) are known to concentrate on the 
manipulation and improvement of single outcomes indicators, at the expense of all 
others, when they are elevated to the status of 'performance indicators'. This 
distortion of the behaviour of organisations has been termed 'gaming' (Davies & 
Lampel, 1998; Smith, 1996a). There is a very real danger that the elevation of easy 
to collect data, rather than clinically meaningful data, to the position of a 
performance indicator will adversely affect the outcome of patients, or will at best, 
confer little advantage. 
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Use of outcomes measures in the allocation of resources and the planning of 
psychiatric services. 
Relatively few examples were found of measures of patient based outcome or need 
being used in planning services. Several of the examples that were offered by 
consultants related to the use of outcomes measures to demonstrate the worth of 
new and expensive technologies in psychiatry, such as new drugs for the treatment 
for schizophrenia. The use of outcomes measures collected in the context of routine 
practice, rather than experimental research settings, raises a number of issues. 
First, the collection of routine data in order to assess the effectiveness of 
interventions has several drawbacks. These include the fact that effectiveness 
needs to be evaluated using robust methodological research, ideally using 
comparison or control groups, and with due consideration of confounding and 
extraneous variables that could offer plausible explanations for a demonstrated 
effect or lack of effect (Sackett, et al., 1991). Examples of published versions of the 
use of routine outcomes measures to demonstrate the clinical and cost 
effectiveness of new drugs for schizophrenia in routine care settings suggest that 
flawed methods are used. For example, the clinical and cost effectiveness of new 
drugs such as clozapine (an example cited by one of the respondents) has been 
judged in local settings using underpowered, and uncontrolled before and after 
studies (eg Aitchison & Kerwin, 1997), with little consideration of basic 
epidemiological principles when judging the results of such studies (eg Adams, 
1997). Better-resourced attempts have also been made to use routinely collected 
data in order to judge the effectiveness of new technologies in general (Sheldon, 
1994), and in psychiatry in particular (see earlier chapters). These have largely 
been unsuccessful, and have failed to make a convincing case for the use of this 
method being used appropriately in practice. 
Second, the successful application of routinely administered outcomes measures to 
evaluate the effectiveness of interventions or policy initiatives presupposes that the 
instruments are fit for this purpose. Instruments must be valid, reliable, and most 
importantly sensitive to change (Guyatt, et al., 1993a; Streiner & Norman, 1995). 
Unfortunately most respondents failed to mention the specific instrument that was 
used for the purposes that were outlined. The suitability of the instruments used 
cannot be therefore commented on in most cases. However, several respondents 
mentioned that the HoNOS was used to measure the effectiveness of interventions, 
including the effectiveness of new atypical drugs. The basic psychometric 
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properties of the HoNOS have been questioned (Stein, 1999), and this instrument 
has specifically failed to show sensitivity to change in the underlying condition 
(Bebbington, et al., 1999), making it of limited use as a measure of outcome and 
responsiveness in individual patients. It is possible that these limitations are not well 
appreciated by clinicians when using instruments to infer clinical change and 
assume that the effectiveness of an intervention has been demonstrated in a local 
setting. Conversely, it was also apparent from a number of respondents that some 
clinicians are all too aware of the limited psychometric properties of the available 
instruments. The HoNOS was specifically named by respondents when voicing 
negative comments about the potential for outcomes measures to be used in routine 
practice. 
Clinicians personal views on the use of outcomes measures in psychiatric 
practice 
The largely negative views regarding the use of outcomes measures in psychiatric 
practice are important in several respects. These views give an insight into the 
reasons behind the general reluctance to use outcomes measures that has been 
demonstrated in the survey. 
The concern regarding the basic psychometric properties of available measures and 
the time taken to complete them represent real barriers to their use. Slade, et al. 
(1999) have speculated that outcomes measures will never be used on a routine 
basis unless instruments are available that are psychometrically robust, brief, quick 
and easy to administer. The research presented here provides empirical evidence 
to support this assertion. 
The greatest number of respondents articulated the widely held view that outcomes 
measurement is an activity that consumes resources - particularly time. It is clear 
that clinicians either do not view this as a productive use of resources, or believe 
that sufficient resources have not been provided in order to make routine outcomes 
measurement a reality. 
Routine outcomes measurement represents a 'technology' (Ellwood, 1988), and as 
such, its implementation should be justified on the grounds of demonstrated clinical 
and cost effectiveness. The evidential basis for the clinical and cost effectiveness of 
routine outcomes assessment for those with mental disorders is discussed in 
greater depth in the following chapter. However, respondents themselves directly 
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questioned whether this was in fact a clinically and cost effective approach. Even 
those writers that have lent support to the idea that routine outcomes measurement 
(e. g. Marks, 1998; Slade, et a/., 1999) have claimed that this will only be achieved if 
sufficient resources are provided to make this a reality. Importantly, one aspect of 
these resources might be adequate information technology to record, store and 
allow easy retrieval and feedback of outcomes to clinicians. Several respondents 
directly commented that outcomes measurement had been imposed as a top down 
initiative, with no other resources provided to support this. Specifically, it was clear 
that in many cases outcomes measurement was expected to be undertaken in 
addition to clinicians existing workload, and that information technology was not 
adequately provided or resourced. This generated a certain amount of resistance 
amongst clinicians to the implementation of this strategy. Clinicians also expressed 
the concern that outcomes measurement within trusts was a largely bureaucratic 
exercise, with little feedback of centrally collated outcomes, and little perception that 
they had been actually used in changing or organising services for the better. 
The general reluctance amongst clinicians to measure outcome in a standardised 
way may also be explained by the reservations that were expressed about the ability 
of such measures to adequately capture the subtlety and complexity of the individual 
patients' health and well-being. This is an issue that goes beyond the traditional 
psychometric concerns of validity and reliability, and extends into the realms of the 
very nature of measurement and a belief that complex experiences can not be easily 
operationally defined and condensed to a series scores on a scale. Of significance 
was the expressed view that outcomes measures add little to the normal processes 
of patient assessment, such as history taking and mu Iti-d iscipli nary assessment. 
The use of terms such as 'dehumanising' represents an extreme expression of this 
belief. Clearly, if clinicians believe that standardised outcomes measurement adds 
nothing to their traditional way of working, then they are unlikely to use them, or if 
they do use them with some reluctance, then they are unlikely to incorporate their 
results into clinical decision making. 
The following chapter will address the question as to whether there is in fact any 
demonstrable benefit in terms of improving the care of the patient in more depth. 
However, on the basis of the findings of the present survey, that a significant barrier 
to the use of standardised outcomes measures in routine practice is the fact that 
clinicians do not perceive their use to be of any direct benefit to themselves or the 
care of the individual patient. 
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Specific comment is justified for the responses offered regarding the HoNOS. This 
measure has above all come to symbolise the shift towards outcomes measurement 
within British psychiatric practice, since it was conceived in response to early policy 
documents that held the measurement of outcome as central to quality improvement 
(Department of Health, 1991). It was also developed by psychiatrists' own 
professional organisation - the Royal College of Psychiatrists (Wing, 1994). It forms 
a central component of the most recent major policy document in mental health 
(Department of Health, 1998), which stipulates that a minimum data set (Glover, et 
al., 1997) be collected for all those with severe mental illness in the course of care 
planning. 
The HoNOS does seem to have found a definite place in the measurement of 
outcome in UK psychiatric practice, since it is the main method by which outcome is 
measured for mental disorders such as schizophrenia, albeit by only a small minority 
of clinicians. Aspirations that it would initially be collected on a service wide basis, 
so that it could be used in both individual patient care, and in assessing the needs 
and adequacy of service provision at a population level (Curtis & Beevor, 1995), 
have clearly not been realised. The general barriers to the routine use of outcomes 
measures, outlined above, apply to this measure. More specifically however, this 
was the only measure mentioned by name, when respondents were asked to give 
their personal views regarding the use of outcome measurement in routine practice. 
Clinicians who offered their views felt it to be psychometrically unsound, 
cumbersome and over long, thus not fulfilling the criterion of usability set down by 
Slade, et al. (1999). Paradoxically, the instrument was said by a small minority of 
respondents to be a useful adjunct to history taking, and a useful focus of discussion 
within multi-disciplinary team meetings. The enduring benefit of this measure might 
therefore be as an adjunct to improve the process by which care is given - by 
improving professional communication, rather than as a measure of outcome, where 
it is widely held to be a flawed instrument. The future role of the HoNOS was 
recently summarised by Stein (1999), who said: 
'Eventually, the HoNOS will find its place within the research armamentarium, but 
whether it will improve the health of this nation, or any other nation, remains open to 
question Y 
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Sharma, et a/. (1999) provide a useful insight into the real value of this instrument 
when adopted on a service wide basis as a routine outcomes instrument. Sharma, 
et al. (1999) routinely administered the HoNOS questionnaire to 204 consecutive 
patients in an inner city psychiatric service, and showed that scores changed in the 
anticipated direction over time. However, the most interesting observation of the 
authors is the statement that: 
'HoNOS ratings were rarely used in the care meetings in our team ...... We found 
that [patient] review meetings were the place for rating HoNOS, rather than for using 
the HoNOS ratings to formulate a care plan. Even if the HoNOS ratings were made 
available in review meetings, their value in care planning would have been limited. ' 
Upon completion of the project, the instrument fell from use. In providing some 
explanation for this, Sharma et al commented that: 
'The use of any standardised schedule in routine clinical practice will require 
adequate administrative support, as well as the motivation of health professionals. 
National Health Service trusts should take account of both of these factors, before 
introducing this or any other instrument into routine work. ' 
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Section 3.2 Does routine outcome measurement improve outcome in 
mental illness? A systematic review 
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Chapter 23 Background to the review 
Routine outcome measurement 
The previous section (3.1) highlighted the fact that outcomes measures are rarely 
used on a routine basis in the care of those with psychiatric illnesses. Several 
barriers to the use of these measures were identified, and the question of whether 
this was a clinically and cost effective intervention was raised. The purpose of this 
section of the thesis is to examine the evidence base to support the policy of the 
routine use of outcomes measures in improving the quality of care for those with 
psychiatric illness. As a preliminary, the theoretical basis of the potential for 
routinely administered measures to improve the care of those with psychiatric 
disorders will be examined. 
The benefits of routine outcome measurement 
When used as aids to decision making in routine care, outcome measures are 
thought to be useful in improving patient care in a number of ways. First, by 
identifying problems which might not otherwise be recognised by clinicians or those 
responsible for care. For example, clinicians are often unaware of patients' social 
and psychological problems (Sprangers & Aaranson, 1992), and the identification of 
these problems might trigger an appropriate response and improve the overall 
quality of patient care. Second, outcome measures might be used to monitor the 
course of patients' progress over time, to make decisions about treatment and to 
assess subsequent therapeutic impact. Third, surveys have suggested that 
clinicians find these data useful in formulating a more comprehensive assessment of 
the patient (Kazis, et al., 1990; Young & Chamberlain, 1987). Lastly, patients often 
welcome the opportunity of giving clinicians information regarding their health status, 
particularly when they perceive this information is not otherwise comprehensively 
assessed, thus aiding effective patient-doctor communication (Nelson, et al., 1990). 
There are broadly two areas in which routine outcome assessment might be applied 
in the improvement of the quality of care for those with psychiatric disorders, and 
which will be examined in this review. The first is in the recognition and 
management of psychiatric disorders, such as anxiety and depression, in non- 
psychiatric settings (such as primary care and the general hospital). The second is 
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in the management of already recognised psychiatric disorders in specialist care 
se ings. 
Disorders such as anxiety and depression are especially prevalent in both primary 
care and general hospital settings. Evidence for this comes from a number of 
sources and the most robust evidence involves the use of research interviews - 
designed to allow diagnoses in a reproducible and standardised manner against 
accepted diagnostic criteria. For example, the work of Goldberg and colleagues 
(Goldberg, et al., 1970; Goldberg & Huxley, 1980) has shown that attenders at 
general practices show a prevalence of depression and anxiety several times 
greater than that in the general population, and that this often goes unrecognised. 
Similarly, Feldman, et a/. (1987) have studied the prevalence of psychiatric 
disorders in general hospital inpatients and found it to be 15-20% (2-3 times the 
general population incidence). Only half of those 'cases'were detected by 
clinicians. Research by others has shown higher than expected rates of psychiatric 
disorder in general hospital outpatient attenders (van Hemert, et al., 1993). 
Less robust evidence comes from the use of psychiatric screening ('case finding'), 
questionnaires administered in these settings, which consistently show an elevated 
prevalence of psychiatric disorder - compared to that observed with standardised 
interviews (Meakin, 1992). Examples of such questionnaires include the General 
Health Questionnaire (Goldberg, 1972), and the Beck Depression Inventory (Beck & 
Ward, 1961) and the Hospital Anxiety and Depression scale (Zigmond & Snaith, 
1983). According to the author of one of these instruments, high scores on these 
screening questionnaires should, therefore, lead to closer investigation to confirm or 
eliminate the presence of minor psychiatric illness - which might warrant further 
intervention (Goldberg, 1986). However, the use of such measures in non- 
psychiatric settings to identify problems and to monitor progress would be consistent 
with their use as an outcome measure. 
Similarly, recently introduced measures of health status and health related quality of 
life, such as the short form 36 (SF36) contain items and sub-scales which measure 
'psychological well-being' (Ware & Sherbourne, 1992). In the case of the SF36, the 
mental health sub-scale was validated by its correlation with already established 
measures of depression and in its ability to discriminate between those with and 
without clinically diagnosed depression (McHorney & Ware, 1995; McHorney, et al., 
1993). Psychological well being is in fact a core component of many 'health status 
166 
measures' (Bowling, 1997; Ware, 1995) and is clearly related to the domains which 
are measured by instruments such as the GHQ, HAD and BDI. Measures of health 
status and health related quality of life have been advocated as being suitable for 
routine use in clinical care settings (Greenfield & Nelson, 1992). Where such 
measures are used to explicitly identify minor psychological problems (such as 
depression and anxiety symptoms) and to monitor changes over time, then this is 
consistent with their use as a routinely administered outcome measure - and the 
suitability of their use in this context will be considered within this review. 
Routine outcome measurement has also been advocated as an adjunct to patient 
care within psychiatric services (Marks, 1998), where measures of psychiatric 
symptoms might be applied in order to measure therapeutic response and to inform 
management decisions. Similarly, associated health status and health related 
quality of life amongst those with commonly encountered psychiatric disorders such 
as depression and schizophrenia has been shown to be poor, and at least as bad as 
that seen in chronic medical conditions such as rheumatoid arthritis and ischaernic 
heart disease (Orley, et a/., 1998; Wells, et al., 1989). In the case of schizophrenia, 
impairments in quality of life and health status are often unrelated to the number or 
severity of symptoms, such as delusions and hallucinatory experiences (Anthony & 
Rogers, 1995; Becker, et al., 1993). This is especially important, since it is the level 
of symptoms that forms the major focus of clinical consultations and practice, and is 
the major criterion by which the success (or otherwise) of treatment is judged in both 
practice and research (Revicki & Murray, 1994). Consequently, clinicians' 
perceptions of these problems are often poor; clinicians underestimate the health 
status or health related quality of life of patients when patient and clinician ratings 
are compared (Becker, et a/,, 1993; Lehman, 1983a; Lehman, 1983b; Sainfort, et 
al., 1996). The use of more comprehensive outcome measures, which capture both 
symptoms and wider health related quality of life, might therefore, be useful in 
identifying needs, monitoring clinical response and making clinical decisions in those 
with severe mental illness. Further, it might be supposed that the use of patient 
based measures in addition to symptom-based measures might provide a more 
comprehensive assessment of patient outcome, since they potentially move the 
clinical consultation beyond the isolated consideration of the severity of clinical 
symptoms such as delusions and hallucinations. 
In consideration of these possible benefits, in the UK, there have been a number of 
initiatives in recent years aimed at the introduction of outcomes measurement tools 
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into routine mental health practice, as part of a government health strategy to 
'improve significantly the health and social function of mentally ill people I 
(Department of Health, 1991). For example, the Health of the Nation Outcome 
Scale (HoNOS) has been developed with a number of uses in mind, including the 
assessment of local service requirements and psychiatric morbidity at a population 
level (Stein, 1999). However, a key aim of the developers of the HoNOS is that it 
should be useful to clinicians in actual individual care planning, since without this 
feature it would not be widely used and so the data would not be collected which 
would ultimately inform decisions at a population level (Wing, 1994). In a related 
vein, there has also been substantial research activity into the development of 
instruments aimed at assessing the needs of those with severe mental illness. Such 
needs assessment tools are intended to define health and social needs at both a 
population level and, ideally, at an individual level (Thornicroft, et al., 1992), such 
that healthcare provision might be more rational, responsive and 'appropriate' 
(Stevens & Gillam, 1998; Wright, et al., 1998). Examples of individual patient needs 
assessment tools for use in severe mental illness include the Camberwell 
Assessment of Need (CAN) (Phelan, et aL, 1995); IVIRC Needs for Care 
Assessment (Brewin & Wing, 1993). 
Possible disadvantages of routine outcome measurement 
The routine measurement of outcome has not been without its critics (Crombie & 
Davies, 1997; Davies & Crombie, 1997), and concerns have been raised that 
( outcomes measures' are un-interpretable, unwieldy and a bureaucratic hindrance to 
successful patient care. 
One way in which the success or usefulness of these measures in everyday routine 
care might be judged is by evaluation of the degree to which their adoption improves 
the outcome and quality of care. Research in other specialities has generally not 
been positive in this respect. For example one important study by Kazis, et al. 
(1990) examines the benefits of informing clinicians of their patients' health status 
scores. Patients included in this study all had a diagnosis of rheumatoid arthritis 
and were attending routine outpatient follow up. The health related quality of life 
instrument examined was the patient completed disease specific Arthritis Impact 
Measurement Scale (AIMS) (Meenan, 1982) or modified Health Assessment 
Questionnaire (MHAQ) (Pincus, et al., 1983). Patients in the experimental group 
completed health status instruments that were then sent to clinicians on a quarterly 
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basis over a year. An 'attention placebo group'completed instruments quarterly, but 
these data were not fed back to their physician. A 'control group' only completed 
instruments at the beginning and end of the study. There were no detectable 
differences between groups at the end of the year in terms of outcomes such as 
patient satisfaction or changes in health related quality of life (as measured by the 
AIMS and MHAQ). Nor were there any differences in terms process variables, such 
as changes in medication or referrals to other agencies. 
There are various reasons to be cautious about the likelihood that the routine use of 
outcome measures would improve outcome and quality of care, which might explain 
the inability to establish any benefit in the above experimental example. Firstly, 
many clinicians find the information conveyed by outcome measures and health 
status measures irrelevant to clinical decisions, time consuming, difficult to interpret 
and too cumbersome to be integrated into routine practice (Deyo & Carter, 1992, 
Deyo & Patrick, 1989; Greenfield & Nelson, 1992). Additionally, the measures may 
not be sufficiently psychometrically robust to inform individual patient care. The 
most important facet of validity is sensitivity to change, if they are to be informative 
as outcome measures (Guyatt, et al., 1993a). If they are not sensitive to change, 
then their results will not be interpretable and important changes will not be detected 
or acted upon (Fitzpatrick, et al., 1992b). Reliability is often demonstrated at a 
'group' level (using correlational statistical analysis), but high indices of 'group level' 
reliability can obscure large 'between-individual' and 'within individual' variation 
scores which make instruments uninformative at an individual patient level (Dunn, 
1996; Streiner & Norman, 1995). 
The measurement of outcome in the context of individual patient care is not without 
cost. Instruments must be developed, administered (often by clinicians), coded, 
stored and retrieved - all of which have resource implications. Similarly, there is a 
danger that outcome measurement triggers resource intensive interventions which 
are of no proven benefit to patients, and which might actually harm them. Perhaps, 
more subtly, there is also a danger that the uptake of outcome measurement in this 
context represents a marketing ploy, in which measurement is used to demonstrate 
an institution's 'customer orientation', but which does not inform the provision of care 
(Fitzpatrick, 1994). 
In summary, the case for the benefit of routine outcomes measurement is far from 
clear. 
169 
Aims of the review 
To review systematically the best available evidence of the value of routine outcome 
and needs assessment in the day to day care of those with common mental 
disorders such as anxiety, depression and schizophrenia and related disorders. 
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Chapter 24 Systematic reviews and their application in mental health 
The method chosen to answer the specific question of whether there is any 
evidence to support the clinical and cost effectiveness of routine outcomes 
measurement for common mental disorders is that of systematic review. The 
following section briefly outlines the rationale behind systematic reviews, and the 
stages involved in the conduct of a review. Particular reference is given to the 
application of a systematic review methodology to questions pertaining to the 
delivery, organisation and quality of health services, and the application of 
systematic reviews in the sphere of mental health services research. 
The origins of systematic reviews. 
In the field of mental health, as in all healthcare, evidence of the effectiveness of 
interventions is often contradictory, partly because of differences between the 
studies in terms of methodological rigour, patient populations and interventions 
(Gilbody & Petticrew, 1999). In order to make sense of this disparate and often 
contradictory literature, practitioners, policy makers and consumers of healthcare 
have relied on traditional 'review' articles, which are generally prepared by 'content 
experts' in a field. Unfortunately, such reviews have been shown to be prone to a 
number of biases and their conclusions can be just as contradictory as the primary 
research (Mulrow, 1987). For example, content experts may come to a particular 
field with their own prejudices and there is a risk that the primary research will be 
plundered selectively in order to confirm the authors opinion (a "confirmatory bias"). 
The reader is left unclear as to how the primary studies have been selected for 
inclusion or how a particular conclusion has been reached. In the face of growing 
dissatisfaction with the lack of transparency of methods and lack of trust in the 
conclusions of traditional review articles, the systematic review article has emerged. 
The need for and rationale behind systematic reviews is neatly summarised by 
Mulrow (1987): 
'Through critical exploration, evaluation and synthesis the systematic review 
separates the insignificant, unsound and redundant, from the salient and critical 
studies that are worthy of reflection' 
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Systematic reviews adopt an explicit method in order to limit bias in the search, and 
selection of studies for review. This takes the form of extensive (including 
electronic) literature searches, followed by selection of the highest quality studies for 
review - ideally these should be random ised-control led trials (RCTs), where these 
are available or feasible. This evidence is (where appropriate) synthesised in order 
to produce a clear message or conclusion regarding effectiveness. It may be 
summarised narratively, or in some cases it is possible to summarise the results of 
the primary studies quantitatively, in the form of a meta-analysis (NHS Centre for 
Reviews and Dissemination, 2000). 
The use of such methods in mental health has a long history. Smith & Glass (1977) 
pioneered the use of mathematical techniques (and coined the term 'meta-analysis') 
in order to synthesise disparate, contradictory and under-powered studies of the 
effectiveness of psychotherapy. This pioneering meta-analysis found no differences 
in effectiveness between different psychotherapeutic techniques. From this early 
start the methods of systematic review and meta-analysis evolved rapidly, and have 
been employed to evaluate the effectiveness of a range of interventions in mental 
health. For example, systematic reviews have been used to examine: the 
comparative efficacy of new drug entities in both depression and schizophrenia 
(NHS Centre for Reviews and Dissemination, 1999a; Song, et al., 1993); the value 
of family based psychotherapeutic interventions in schizophrenia (Mari & Streiner, 
1994); and the relative merits of different methods of organising and delivering care 
to those with severe mental illnesses in the community (Marshall, et a/., 2001; 
Marshall & Lockwood, 2001). 
There are reasons why systematic reviews are especially important in the sphere of 
mental health. Firstly, many interventions in psychiatry have been evaluated within 
randomised controlled trials, but the quality and real world validity of many of these 
data have been shown to be poor (; Hotopf, et aL, 1997; Thornley & Adams, 1998; 
Gilbody, et aL, 2001 e). By bringing a systematic approach, then the highest quality 
and most applicable studies are separated from those that are of limited value within 
an explicit framework, or the dearth of high quality literature within a specific area is 
made explicit - thus identifying the need for primary research. Secondly, mental 
health is bedevilled by the problem of small sample size and under-powered 
research (Hotopf, et al., 1997; Thornley & Adams, 1998). By applying (where 
appropriate) the mathematical technique of meta-analysis, then statistical power is 
brought to an area of enquiry where, in the absence of large-scale trials, this would 
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not otherwise be possible. A clear example of this is in the application of meta- 
analytic pooling to comparative trials of new and older anti-depressants, where in 
excess of 100 randomised trials are known to exist (Hotopf, et a/., 1997), but where 
no individual study has the statistical power to demonstrate the superiority of one 
class of drugs over the other, or their equivalence. 
Stages in a systematic review 
There are several stages in the conception, design and conduct of a systematic 
review. The following section provides a brief overview of the architecture of a 
systematic review, with particular reference to those stages that are especially 
important in the conduct of systematic reviews in both the sphere of mental health, 
and in the evaluation of interventions intended to enhance the quality with which 
healthcare services are delivered or organised. This section draws upon guidelines 
outlined by the NHS Centre for Reviews and Dissemination (2000), and the 
Cochrane Collaboration (Mulrow & Oxman, 1999), and upon personal experience in 
the conduct of systematic reviews in the sphere of mental health. 
Formulation of a question or hypothesis. 
A review begins with a research question or hypothesis, in the same way as a 
rigorous piece of primary research. This question should be capable of being 
examined in detail, and if specified as an hypothesis, capable of being confirmed or 
refuted. The formulation of a focussed question in systematic review contrasts with 
the broad scope or non-explicit question posed in a non-systematic or narrative 
review (Mulrow, 1987). Refinement of the question often involves making explicit 
several facets, including (1) the population of interest; (2) the setting in which 
research should be conducted; (3) the intervention; (4) the type of evidence that 
would provide a robust and believable answer; and (5) the outcomes that would be 
of interest. These form the basis of the inclusion and exclusion criteria of a 
systematic review, and are analogous to the inclusion and exclusion criteria of a 
primary piece of research. 
An example of a clear research question comes from an early systematic review 
conducted by Mari & Streiner (1994), which examined the effectiveness of family 
based interventions for schizophrenia. Previous (non-systematic) reviews of this 
topic had yielded conflicting results and had failed to establish whether this therapy 
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helped those with schizophrenia, or the magnitude of any benefit (Gilbody & 
Sowden, 1999). These non systematic reviews had, amongst other things, failed to 
select the highest quality evidence, and had failed to set explicit criteria regarding 
what constituted family based interventions, leading to confusion of what was in fact 
being reviewed. Mari & Streiner (1994) began their review by specifying a clear 
research question and refining it as follows: 
Population: Persons with schizophrenia, however diagnosed 
Intervention: Any psychosocial intervention with relatives of those with 
schizophrenia that required more than five sessions and was not restricted to an in- 
patient context/environment and compared to a standard care. 
Research design: randomised controlled trials 
Outcomes: 
" Suicide or all cause mortality; 
" Relapse; 
" Hospital admission; 
" Drug compliance. 
Deciding which research design to use 
The type of research design to be included in a review is guided by the question 
being asked. Randomised trials provide the most robust evidence for questions 
relating to therapy or the effectiveness of a health policy intervention (Sackett, et al., 
1991). This is as true in mental healthcare as it is in other specialities (Gilbody, et 
a/., 2001 e; WHO, 1991). This design maximises internal validity, such that observed 
differences can be attributed to the treatment under evaluation, rather than some 
confounding factor inherent in the patient, the clinician or the environment in which 
the treatment is given (Meinert, 1986). However, for questions relating to the best 
method of delivering and organising mental health services or about the best 
method of changing clinical practice for the better, then randomisation may still be 
appropriate, but it becomes either impossible or inappropriate to randomise 
individuals (Campbell, et al., 2000). Instead it is individual hospitals, geographical 
areas, clinical teams or individual clinicians and, consequently, all the patients they 
treat, that should be randomised. When 'clusters' of individuals are randomised in 
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this way, there are profound implications for the design and analysis of studies 
(Campbell & Grimshaw, 1998). 
In the case of interventions targeted at the individual clinician in order to improve the 
care of his or her patients, then there is a real danger that randomising individual 
patients to receive a quality improvement intervention will influence how other 
patients randomised to receive normal care will be managed (Ukoumunne, et al., 
1999b). This 'cross contamination' between subjects can potentially lead to a 
dilution of effect for an intervention, and can result in an effective intervention being 
shown to be ineffective in the context of an individualised clinical trial. For this 
reason, cluster based studies are often the most appropriate design when 
evaluating quality improvement strategies, such as those addressed within the 
current review (Gilbody & Whitty, 2001). 
There are no known reviews that have applied a systematic methods to examine the 
potential for interventions to improve professional practice and the quality of mental 
healthcare specifically. However, there have been several reviews of quality 
improvement interventions across all areas of healthcare. Many of those have been 
conducted under the auspices of the Effective Practice and Organisation of Care 
group (Bero, et a/., 1998), within the Cochrane Collaboration. One early example is 
that of Grimshaw & Russell (1993), who examined the potential of guidelines to 
improve health and healthcare. This review utilised a range of designs - including 
both randomised and q uasi-experi mental designs in order to maximise the scope 
and number of individual studies that evaluated the impact of professional guidelines 
on the quality and delivery of healthcare. Many of the primary studies incorporated 
in this review fell short of the ideal of cluster randomisation in their design, or if they 
did use cluster randomisation, they failed to account for the effect of clustering in 
their design and analysis of results. The importance of cluster randomisation is not 
always realised by primary researchers, and the failure to account for this design 
feature leads to spurious conclusions - particularly type 1 errors in the analysis and 
interpretation of results. This has been termed unit of analysis error (Divine, et a/., 
1992), and has led to calls for a greater acceptance and understanding of cluster- 
based studies (Campbell & Grimshaw, 1998). 
In summary, randomised trials remain the gold standard for considering whether a 
treatment or quality improvement strategy helps or harms, and the cluster based 
study remains the most appropriate form of randomised trial in quality improvement 
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strategies. For this reason, a systematic review of quality improvement strategies 
should consider cluster randomised studies as the gold standard. However, 
experience suggests that this ideal is not always met (Gilbody & Whitty, 2001). 
Searching for studies 
A cornerstone of the systematic approach to reviewing empirical research is the 
explicit aim of including all possible relevant literature, and taking active steps to 
search for this literature. As is the case with primary research studies, flaws in the 
data collection can invalidate the results of a systematic review. As many relevant 
primary studies as possible must be collected in order to minimise random error and 
bias (Counsell, 1998). 
For this reason, systematic reviews involve the search of a diverse range of sources 
in order to maximise the likelihood of finding all relevant studies. This ideally 
involves the following sources 
0 Electronic databases 
0 Manual searches of journal, conference proceedings and books 
Reference lists 
Existing study registries 
Pharmaceutical companies (where relevant) 
Personal contact with colleagues 
The advent of electronic databases has greatly enhanced the ability of researchers 
to have ready access to large amounts of bibliographical information. However, a 
crucial step in conducting a systematic review is ensuring that the required 
information is retrieved efficiently from the huge quantities of data contained in 
bibliographic databases. Two components of a comprehensive search strategy are 
therefore the actual databases searched and the search terms that are chosen. 
The most readily available electronic database is MEDLINE, and many systematic 
reviews use this as their only electronic source of primary studies (Suerez-Almar, et 
al., 2000). There are several problems with this approach. First, MEDLINE does 
not contain the totality of published medical literature, but a selected portion of it. It 
places an undue emphasis on North American and English language publications, 
and ignores many important European journals. Second, MEDLINE incorrectly 
codes many publications, particularly with respect to their study design. For this 
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reason simple searches of MEDLINE only identify less than 40% of relevant studies 
(Adams, et al., 1992; Dickersin, et a/., 1985; Suerez-Almar, et al., 2000). Searches 
must therefore extend their coverage of databases to include ones that are more 
likely to cover Journals excluded from MEDLINE (Suerez-Almar, et a/., 2000). 
EMBASE is another electronic database, which provides a useful complement, since 
it has a more European focus and carries many of the journals excluded from 
MEDLINE. Additionally, electronic searches must incorporate terms that do not 
depend on the incomplete coding structure imposed by the collators of medical 
databases. In the case of randomised trials, this involves inclusive mixtures of free 
text words and medical subject headings. A typical search strategy developed in 
order to identify randomised trials is given in Table 24. 
Locating studies relating to mental health are especially problematic, since 
databases such as MEDLINE and EMBASE fail to carry important mental health 
journals (Adams, et al., 1992; Adams, et al., 1994). For this reason more topic 
specific databases, particularly Psycl-IT, published by the American Psychological 
Association are recommended (Hay, et al., 1996). 
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Table 24: An example of a comprehensive electronic search strategy 
SILVER PLATTER OPTIMAL SEARCH STRATEGY FOR RANDOMISED CONTROLLED TRIALS 
From (Dickersin & Larson, 1996). 
#1 RANDOM IZED-CONTROLLED-TR IAL in PT 
#2 CONTROLLED-CLINICAL-TRIAL in PT 




#7 #1 or #2 or #3 or #4 or #5 or #6 
#8 TG=ANIMAL not (TG=HUMAN and TG=ANIMAL) 
#9 #7 not #8 
#10 CLINICAL-TRIAL in PT 
#11 explode CLINICAL-TRIALS 
#12 (clin* near trial*) in TI 
#13 (clin* near trial*) in AB 
#14 (singl* or doubl* or trebl* or tripl*) near (blind* or mask*) 
#15 (#14 in TI) or (#14 in AB) 
#16 PLACEBOS 
#17 placebo* in TI 
#18 placebo* in AB 
#19 random* in TI 
#20 random* in AB 
#21 RESEARCH-DESIGN 
#22 #10 or #11 or #12 or #13 or #15 or #16 or #17 or #18 or #19 or #20 or #21 
#23 TG=ANIMAL not (TG=HUMAN and TG=ANIMAL) 
#24 #22 not #23 
#25 #24 not #9 
#26 TG=COMPARATIVE-STUDY 
#27 explode EVALUATION-STUDIES 
#28 FOLLOW-UP-STUDIES 
#29 PROSPECTIVE-STUDIES 
#30 control* or prospectiv* or volunteer* 
#31 (#30 in TI) or (#30 in AB) 
#32 #26 or #27 or #28 or #29 or #31 
#33 TG=ANIMAL not (TG=HUMAN and TG=ANIMAL) 
#34 #32 not #33 
#35 #34 not (#9 or #25) 
#36 #9 or #25 or #35 
0 Upper case denotes controlled vocabulary. 
0 Lower case denotes free-text terms. 
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The limitations of electronic databases can be in some way remedied by 
supplementing search strategies with hand searches of key journals - particularly 
those most likely to carry research that is likely to be of relevance. These can be 
specialist journals relevant to the area under review, or journals most likely to carry 
the type of research that is of interest. One of the lasting contributions of the 
Cochrane Collaboration has been the international voluntary effort that has been 
undertaken to hand search important biomedical journals, and to include possible 
controlled trials in a specialist register - the Cochrane Controlled trials register (The 
Cochrane Controlled Trails Register, 2000). Similarly, specific research groupings 
within the Cochrane collaboration have hand searched important journals and 
conference abstracts in order to identify potential controlled trials. Two important 
registers in sphere of mental health are those maintained by the Schizophrenia 
group (Adams, 1998), and the Depression and Anxiety group (McGuire, 1998) within 
the Cochrane Collaboration. 
Appraising the quality of studies 
A crucial step in the conduct of a systematic review is not just the selection of the 
highest quality research design, but is a fundamental consideration of the quality of 
the individual studies and an examination of the potential sources of bias. NHS 
Centre for Reviews and Dissemination (2000) outlines five reasons for examining 
the quality of individual studies in systematic reviews: 
a To determine a minimum quality threshold (study design threshold) for the 
selection of primary studies 
0 To explore quality differences as an exploration for heterogeneity in study results 
0 To weight the study results in proportion to quality in meta-analysis 
To guide the interpretation of findings and to aid in determining the strength of 
inferences 
0 To guide recommendations for future research 
Table 25 provides some important concepts central to the assessment of study 
quality (NHS Centre for Reviews and Dissemination, 2000). 
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Table 25: Terminology used in study quality assessment 
Study quality The degree to which a study employs measures to minimise biases, focussing on 
internal validity. A set of parameters in the design and conduct of a study that 
reflect the validity of the outcome, related to the external and internal validity and 
the statistical model used 
Bias (systematic error) A tendency to produce results that depart systematically from the true results. 
Unbiased results are internally valid. 
Internal validity The degree to which the results of a study are likely to approximate to the truth for 
the group studied. It is a pre-requisite for external validity. 
External validity The extent to which the effects observed in a study are applicable outside of the 
study on a different population (in routine practice). 
Several methods are used in order to protect against biases in primary research, 
and which should be considered in judging the quality of that research within 
systematic reviews. Perhaps the most important is that of ensuring that participants 
in trials are allocated in a truly random manner, and ensuring that allocation is 
concealed, such that the person randomising the individual participant has no 
foreknowledge of which group the participant will be allocated (Jadad, et al., 1996; 
Schulz, et al., 1995). Failure to protect against this bias has been empirically shown 
to be related to the magnitude of effect obtained in primary research (Schulz, et a/., 
1995), with poorly randomised and inadequately concealed trials showing spuriously 
elevated effect sizes. 
Classifying studies according to their level of methodological rigour is important in 
identifying those studies that are of better quality, and should guide the data 
synthesis within a systematic review. This can be done in a number of ways, by for 
example, setting a minimum quality threshold above which studies will be 
considered within a review. Alternatively, methodological quality can be used to 
examine differences obtained between studies, as an exploration of heterogeneity 
(see below). Where heterogeneity exists, then reviewers can place greater weight 
on higher quality studies. 
The consideration of quality can be undertaken in several ways within systematic 
reviews, with the use of (1) individual quality components or items; (2) quality 
checklists, or (3) quality scales. There are pros and cons of each of these 
approaches (Greenland, 1994; Juni, et al., 1999). Ideally there should be both an 
empirical and theoretical basis for the items that are thought to represent quality. 
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The use of scales has been criticised due the fact that they lack psychometric rigour. 
For example, they are unreliable, and remain unvalidated, and contain an arbitrary 
number of items, with weights ascribed without any empirical basis (Juni, et al., 
1999; Moher, et a/., 1996; Moher, et a/., 1998). Of the scales that have been 
developed, that of Jadad, et al. (1996) contains only items that have been 
empirically shown to be related to effect size (Moher, et al., 1999b). Further, this 
scale has been shown to be reliable in its application as a generic measure of study 
quality in randomised trials (Clark, et a/., 1999; Jadad, et al., 1996). The contents of 
this particular scale are shown in Appendix 5. A widely used alternative or 
complementary scale is that adopted within the Cochrane Collaboration (Mulrow & 
Oxman, 1999), which classifies controlled trials on the basis of their likely 
susceptibility to bias. This is outlined in Table 26 
Table 26: Examining likelihood of bias 
Cochrane Handbook classification of bias (Mulrow & Oxman, 1999) 
A. Low risk of bias (adequate allocation concealment) 
B. Moderate risk of bias (some doubt about the results) 
C. High risk of bias (inadequate allocation concealment) 
The Jadad Scale (Jadad, et al., 1996) measures a wider range of factors that impact 
on the quality of a trial. The scales includes three items: 
1. Was the study described as randomised? 
2. Was the study described as double-blind? 
3. Was there a description of withdrawals and dropouts? 
Synthesising research 
The aim of data synthesis in a systematic review is to collate and summarise the 
results of included primary studies. There are broadly two approaches to data 
synthesis. The first is a non-quantitative or descriptive data synthesis, whereby all 
the evidence is collated in a uniform manner, including all the information about the 
characteristics of individual studies, together with their results. This first approach 
allows an overview of the totality of potentially important evidence. The second 
approach involves a quantitative data synthesis, whereby component studies have 
been judged sufficiently similar in their design and choice of outcome to justify a 
statistical pooling, in order to extract some overall measure of effect. The first step 
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of non-quantitative data synthesis is a necessary step for all systematic reviews, but 
the quantitative pooling is not always justified. 
The descriptive or non-quantitative synthesis involves the extraction and 
presentation of data in a rigorous manner, according to a format that had been 
decided a priori, which seeks to summarise important design features and results of 
individual studies in a tabular form. NHS Centre for Reviews and Dissemination 




o Outcomes measures 
o Validity of the evidence 
o Sample sizes and results of the studies included in the review 
By presentation of a descriptive synthesis, those conducting a review should be able 
to assess whether participants, interventions and outcomes allow generalisation of 
the results of the review, or whether there are restrictions or omissions that limit the 
applicability of the results. Similarly, those conducting a review will then be able to 
make some informed comment as to whether the quality of the research is sufficient 
to allow believable conclusions to be drawn on the basis of the results. Lastly, such 
a presentation will allow a decision to be made regarding the use of a formal 
quantitative synthesis, and will give clues as to important differences between 
studies that might explain differing results across studies (heterogeneity). 
A clear example of the potential of non-quantitative data synthesis to provide 
important insights into the general effect of an intervention and to highlight important 
ingredients of an effective intervention comes from the previously mentioned review 
by Grimshaw & Russell (1993). Widely differing guidelines implementation 
programmes in all spheres of healthcare were drawn together using non-quantitative 
data synthesis. Important differences in terms of the intervention and the outcomes 
studied were highlighted. These showed that a number of studies had 
demonstrated that guidelines had the potential to influence practice in a positive 
way, but the setting and choice of outcome precluded the use of formal quantitative 
data synthesis. A number of rigorous studies did show a positive effect, and certain 
features in the nature of the guideline intervention united these positive studies. 
These included the fact that guidelines that had been shown to influence practice 
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when they: are based upon an explicit consideration of the evidence; take into 
account local circumstances; are disseminated by an active educational 
intervention; and are implemented by patient specific reminders relating directly to 
professional activity. 
Where studies are judged sufficiently similar in terms of populations, interventions 
then a formal statistical pooling, known as meta-analysis can at least be attempted. 
If the studies are too heterogeneous to combine, then subgroups of similar studies 
can identified within the descriptive synthesis outlined above, and can be pooled 
separately. When a decision has been made that a meta-analysis is both possible 
and appropriate, reviewers have to decide three things in advance: (1) Which 
comparisons should be made; (2) which outcome measure should be used; (3) 
which effect measure should be used to describe effectiveness. 
Meta-analysis involves the statistical pooling of individual studies using some 
common metric between studies. Commonly used techniques allow individual 
studies to be weighted in some way, such that those which are judged to be of 
greater importance are given greater prominence and contribute to a greater extent 
to the overall summary effect size. The most commonly used weighting function is 
by sample size or study variance, such that larger studies are given greater 
prominence than smaller studies. The measures of effect that are combined are of 
a dichotomous or continuous nature, and specific techniques are available for each 
of these scenarios (Cooper & Hedges, 1994). 
A clear example of the potential for quantitative pooling to be applied when 
examining the organisation and delivery of mental health care comes from a review 
by Marshall & Lockwood (2001). This review begins with an important policy based 
question, relating to the effectiveness of one model of community care that had 
been widely advocated in UK mental health services. Marshall & Lockwood (2001) 
found eleven randomised studies, which were largely underpowered. Common 
outcomes measures between studies were the effect of case management on 
ongoing contact with psychiatric services and admission to hospital. Summary 
pooled odds ratios were calculated showing that whilst case management was 
effective in increasing the ability of psychiatric teams to maintain contact with those 
with severe mental illness (pooled odds ratio = 0.70; 99% Confidence Interval 0.50- 
0.98; n=1210), this also resulted in a much higher rate of psychiatric admissions 
(pooled odds ratio 1.84; 99% Confidence Interval 1.33-2.57; n=1300). 
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Two alternative statistical models used in pooling data are the fixed effects model 
(Mantel & Haenszel, 1959) and the random effects model (DerSimonian & Laird, 
1986), which differ in their underlying assumptions relating to the distribution of 
effect sizes from individual studies and their relation to some underlying 'true' effect 
size (Cooper & Hedges, 1994). In practice there is little difference between these 
two methods, and their application (Sutton, et al., 1999). However, there are 
important differences when heterogeneity between studies is present (see on). 
Examining heterogeneity 
An integral step in any formal data synthesis, either quantitative or non-quantitative, 
is a consideration of the important differences that exist between studies 
(Thompson, 1995). This has been termed 'heterogeneity' and relates to the fact that 
different study results will be expected when different interventions are performed on 
different populations and in different settings. One of the main criticisms that have 
been levelled at the use of systematic reviews in general and meta-analysis in 
particular is the fact that studies that are fundamentally dissimilar are brought 
together when they ought not to be. This represents the vain hope of achieving 
something that is greater than the sum of individual pieces of research literature. 
Alvan Feinstein (1995) has highlighted this concern and termed meta-analysis a 
form of 'statistical alchemy'. Heterogeneity is a reflection of the true nature of 
primary research evidence, and as such evidence should be sought for the 
existence of heterogeneity in outcomes between studies, and causes of these 
differences should be sought. Naylor (1989) outlines some important causes, which 
are given in table 27. 
Table 27: Sources of heterogeneity 
Ways in which apparently similar trials may differ (Naylor, 1989) 
" Differences in inclusion and exclusion criteria 
" Other pertinent differences in baseline states of available patients despite identical selection criteria 
" Variability in control or treatment interventions (e. g. doses, timing, brand) 
" Broader variability in management (e. g. pharmacological co-i ntervent ions, responses to intermediate outcomes 
including crossovers, different settings for patient care). 
0 Differences in outcome measures, such as follow up times. 
0 Variation in analysis, especially handling of withdrawals, dropouts, crossovers, etc. 
0 Variation in quality of design and execution, with bias of imprecision in individual estimates of treatment effect. 
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The preliminary non-quantitative data analysis outlined above should provide 
important insights into any clear differences that exist between studies, both in terms 
of their design, or results obtained. Several steps are recommended for a more 
formal examination of heterogeneity, including a visual inspection of plots of effect 
size, supplemented with more formal statistical tests of heterogeneity (Sutton, et al., 
1999). Where heterogeneity is discovered, then important causes should first be 
sought to explain this effect, and conclusions drawn on the likely importance of 
heterogeneity in the real world application of research evidence. 
An example of the exploration of heterogeneity in mental health services research 
comes from a review of comparative studies of new (and relatively expensive) 
versus old (and relatively inexpensive) anti-schizophrenia drugs (Geddes, et a/., 
2000). Preliminary analysis of the data showed that the choice of comparator was 
almost always haloperidol, one of the oldest typical anti-schizophrenia drugs, with 
perhaps the greatest propensity to cause distressing side effects. Many of the trials 
used comparator doses of haloperidol way in excess of those doses used in routine 
practice, and at dose levels that are likely to cause these side effects in most 
people. An overall benefit for newer drugs in terms of their tolerability was found in 
the meta-analysis, but substantial between study variation was noted. A plausible 
explanation for this between study differences was postulated as being the dose of 
comparator that was chosen. A formal examination of this hypothesis was made in 
two ways. First statistical tests of heterogeneity were made, and found to be 
significant. Second, studies with comparator doses above and below a clinically 
accepted level were pooled separately and were shown to give substantially 
different results. For studies with lower doses of haloperidol, there was found to be 
a much smaller benefit of new over older drugs. 
Statistical pooling of heterogeneous data is therefore potentially misleading, and 
examination heterogeneity can provide important insights into the mode of action of 
an intervention and can reveal aspects that are of use in clinical practice. For 
example, Geddes, et al. (2000) use their meta-analysis and examination of 
heterogeneity to postulate that recommendations for the first line use of new anti- 
schizophrenia drugs have been based on na*fve summaries of the randomised 
evidence. They suggest that a more suitable starting dose of typical drugs should 
be above the level where clinical efficacy is demonstrated, and below the level 
where adverse side effects begins to affect compliance. This dose of older anti- 
psychotic, rather than an expensive newer drug might form the first line treatment of 
185 
schizophrenia. They also suggest that this hypothesis might be usefully tested 
within a prospective randomised trial. 
Examining publication bias 
In addition to unexplored heterogeneity, another threat to the validity of the results of 
systematic reviews is the existence of publication bias. Publication bias is that 
which arises when research fails to be published on the basis of the direction or 
significance of its results (Dickersin, 1990). It has long been recognised that 
research with 'negative' or 'uninteresting' results is less likely to be published 
(Sterling, 1959). One important landmark in the recognition of the potential of 
publication bias to produce misleading results comes from the meta-analyses of 
trials of magnesium following myocardial infarction (Egger & Davey-Smith, 1995). In 
this case a spurious benefit from magnesium was seen from the systematic review 
of a data-set affected by publication bias. There are reasons to suppose that 
psychiatric research is just as prone to publication bias as the research produced by 
other specialities. 
The preceding discussion on the search for trials, particularly through the use of 
electronic databases, places a particular emphasis on the search for published data. 
Much research goes unpublished, and this is particularly difficult to identify. 
Unfortunately there are sound reasons to suppose that psychiatric research is as 
prone to publication bias (Gilbody & Song, 2000; Gilbody, et al., 2000). Mental 
health research displays many of the risk factors for the occurrence of publication 
bias (Dickersin, 1990), particularly: small sample size; commercial influence; and 
poor methodological quality (Thornley & Adams, 1998; Gilbody, et a/., 2000). 
One method by which publication bias can be examined is through the use of funnel 
plots (Light & Pillemer, 1984), which rely on the fact that larger studies are generally 
published, irrespective of their results, whereas smaller studies are only selectively 
published. Funnel plots chart effect size against sample size. In the absence of 
publication bias, when all studies are plotted as individual data points on this graph, 
then a symmetrical funnel should be seen (Figure 11). Results from small studies 
are prone to greater random variation and will consequently be dispersed 
symmetrically (i. e. randomly) about some central overall effect size (i. e. that which 
would be obtained in a well-powered study). As sample size increases then the 
degree of random variation about this central axis decreases, producing a 
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symmetrical inverted funnel. If some smaller studies are excluded non-randomly 
because of their direction of effect, then the funnel will look asymmetrical about its 
base. Funnel plot asymmetry is highly suggestive of publication and related bias 
(Egger, et a/., 1997) and suggests that the research in the area under review should, 
at the least, be treated with suspicion. 
One example of publication bias in the sphere of psychiatric research relates to 
published randomised trials of risperidone, a new atypical anti-schizophrenia drug 
(Kennedy, et a/., 2001). A funnel plot of randomised studies (figure 12) shows that 
the research on this compound is subject to a probable publication bias (Gilbody, et 
a/., 2000). 
Given the inherent dangers of reviewing an area that is subject of a publication bias, 
and the danger that this can produce a biased or misleading result, then reviews 
should at the very least check for the existence of publication or related bias, 
through the use of funnel plots. Publication bias is just one of several potential 
causes of funnel plot asymmetry, and other causes may need to be considered 
(Egger, et al., 1997). These include: 
" Different intensity of intervention; 
" Differences in underlying baseline risk; 
" Poor methodological design of smaller studies, 
" Heterogeneity; 
" Inadequate analysis, 
" Fraud; 
" Chance 
The use of funnel plots should therefore be seen as an extension of the general 
examination of heterogeneity in systematic reviews and the cause of asymmetry 
should be actively sought, before attributing publication bias (Gilbody, et al., 2000). 
Drawing conclusions from reviews 
The forgoing discussion suggests a rigorous and methodically replicable framework 
for reviewing primary clinical research. The endpoint of such a review is a clear 
summary of the strengths and limitations of the existing research knowledge base, 
from which conclusions can be drawn. It is important that these conclusions should 
not make more of the data than is justified. Clear examples exist of both reviews 
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which have produced a clear message for health practice and policy, and which 
have the potential to influence the way in which healthcare is delivered (e. g. 
Marshall, et a/., 2001; Marshall & Lockwood, 2001). An equally valid endpoint of 
systematic review is a clear acknowledgement that the existing research is 
insufficiently strong to guide practice and policy, and that in conclusion more 
research is needed (eg Hotopf, et al., 1997; Song, et a/., 1993). This is not a failure 
of systematic review methodology, but rather an honest reflection of the limitations 
of the research knowledge base. 
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Figure 12: Asymmetrical funnel plot 
Short term clinical improvement in randomised trials comparing risperidone with 
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Chapter 25 Methods of the review 
Having outlined the rationale, general methods and potential difficulties of 
systematic reviews in general, the following section outlines the specific methods 
employed in the review of the use of routine outcomes measurement in mental 
illness. 
The methods employed in this systematic review follow guidelines laid down by the 
NHS Centre for Reviews and Dissemination (2000), and adhere to methods outlined 
in the Handbook of the Cochrane Collaboration (Mulrow & Oxman, 1999). The 
review was conducted under the under the auspices of both the Depression and 
Anxiety Group, and Schizophrenia Group of the Cochrane Collaboration. As such, 
the review has been subject to extensive peer review in addition to that offered by 
the supervisors of this project, and will be published in the Electronic Cochrane 
Library (Gilbody, et a/., 2001 b; Gilbody, et al., 2001 c). Part of this review has also 
been published in paper format (Gilbody, et al., 2001 d). 
Study inclusion criteria 
Patients 
In order to examine the impact of routine outcomes assessment on patients with 
psychiatric illnesses (or with unrecognised psychiatric illness) in all settings, not just 
those being cared for in psychiatric settings, it was decided to make the patient 
inclusion criteria quite broad. 
To be included, studies must have included one of the following patient populations: 
0 Patients in non-psychiatric settings. This includes general hospital patients and 
non-selected general practice patients. 
0 Patients with psychiatric disorders being managed by specialist psychiatric 
services. 
Studies relating to the following patient groups were excluded from this review: 
0 Patient groups whose primary problem is one of substance abuse or who are 
managed in specialist substance abuse services. 
0 Child and adolescent populations 
0 Those with learning disabilities or dementia. 
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Interventions 
To be included, studies must have compared the introduction of a routine form of 
outcome or needs assessment with a normal routine pattern of care. 
Routine care (the control/comparator condition) involved usual patient-doctor 
interaction, with non-standardised history taking, investigation, referral, intervention 
and follow up. This would not usually involve the use of outcome measurement 
instruments by clinicians, but would have relied on the traditional channels of patient 
doctor communication and informal assessment of outcome using clinical history 
taking, psychiatric/physical examination and recording of progress in clinical notes. 
The active intervention should have involved the addition of a standardised outcome 
assessment instrument to routine care. The outcome assessment should have 
been made either by the patient or by the clinician, but the active intervention will 
involve the information from the outcome assessment being fed back to the clinician 
or being incorporated into routine care procedures (such as outpatient assessment, 
hospital admission or routine discharge planning). Hence, standardised outcome 
could have been assessed in both intervention and control conditions, but the active 
component in an intervention involved the feeding back of this information to the 
clinician 
Any potential form of assessment was classified as one of the four following types 
(for definitions see earlier chapters): 
A. An assessment tool measuring psychiatric symptoms. This included 
instruments that measure the core (diagnostic) features of the disorder under 
evaluation. 
B. An assessment tool measuring 'Patient Based Outcome. These tools 
measure more than 'symptom severity' and assess the impact of illness on the 
individual - in terms of all or some the following domains: social functioning; 
role functioning; mental well-being; cognitive functioning (after Ware (Ware, 
1995). 
C. An assessment tool measuring 'patient need'. These tools measure unmet 
emotional, physical, social and financial needs of the individual patient (Brewin 
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& Wing, 1993; National Institute of Mental Health, 1987; Thornicroft, et al., 
1992), and must explicitly identify themselves as 'needs assessment toolsf. 
Whilst there is a potential degree of overlap with 'patient based measures' (as 
defined above) in terms of the domains that are included, these are 
considered separately. Needs assessment instruments have evolved from a 
different tradition within mental health services research and place an explicit 
consideration of the identification of unmet need in their conception and use 
(Thornicroft, 1996), rather than the 'evaluative' approach which is inherent in 
the perspective of 'outcome measurement' (Jenkinson, 1994; van den Bos & 
Triemstra, 1999). However, their similarity to patient based assessments of 
outcome justified their consideration in this review. 
D. Other assessment tools 
Some widely used or heavily promoted measures do not fit easily not any of the 
above mutually exclusive categories, since they often measure combinations of all 
three. For example, the Health of the Nation Outcome Scale (HoNOS) (Wing, 1994) 
combines elements of clinical symptoms and hospital service use, together with 
items that might be considered 'patient based' in their focus (such as social 
functioning). These were included in a final 'miscellaneous' category, and if used, 
their content and focus will be discussed in detail within the review. 
The above instruments defined in A-D, will hereafter be collectively referred to as 
outcome and needs assessment tools. 
Design 
Controlled clinical trials were included. In the absence of randomised evidence, 
then non-randomised or quasi-randomised controlled trials were considered. The 
most rigorous and robust controlled design for this intervention was considered to be 
the cluster based randomised trials, whereby individual clinicians or clinical teams 
form the unit of randomisation (Ukoumunne, et al., 1999b). The degree to which 
authors accounted for clustering in the design and analysis of their trials is 
discussed in the section entitled 'quality assessment' outlined below. 
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Outcomes 
Outcomes were studied as they were defined by the authors of studies, with 
particular attention to the impact of outcome and needs assessment tools on the 
following: 
* Overall clinical improvement (as defined by individual studies) 
a Patient based outcome (including social functioning, role functioning, mental well 
being and cognitive functioning) 
0 Hospital status, either discharge, readmission or length of stay (as defined in 
individual) trials; 
0 Intervention for an identified problem 
0 Resource uses 
" Employment status 
" Independent living 
" Death (both as suicide and other causes) 
" Costs (direct and indirect). 
It should be noted that several of these outcomes potentially included the outcome 
that was the focus of the evaluation - i. e. that which was actively incorporated into 
routine care by being fed back to the clinician. The determination of the success or 
otherwise of the intervention according to this criterion requires that outcome was 
measured in both the intervention and control conditions using the instrument under 
evaluation. In this scenario, the experimental condition differed from the control 
condition in that this information was actively fed back to the clinician in the 
experimental condition. Equally, several of the other outcomes, particularly those 
relating to service use and patterns of referral, could be measured form 
administrative records and sources, and did not require that the outcome instrument 
under evaluation is administered to both intervention and control conditions. 
Outcomes were grouped into those measured in the short term (up to 12 weeks), 
medium term (13 to 26 weeks) and long term (over 26 weeks). 
Additionally, processes of care were described in individual studies if these are 
recorded as a criterion with which to evaluate the success of routine outcome 
assessment. Examples of potentially important processes included: (1) clinician and 
patient perceptions of the usefulness or acceptability of measurement instruments, 
194 
(2) self-reports of the use of outcome information in changing patient management, 
(3) rates of referral to outside agencies. 
Search strategy 
The following bibliographic data bases were searched between September and 
December 1999: Medline; Embase; Cinahl; PsycLit; Cochrane Controlled Trials 
Register. 
The search strategy combined two sets of search terms relating to the target patient 
population and the intervention - full details of the search strategy, and the rationale 
behind its development are given in Appendix 2: 
Patient population: a search strategy is used which captures publications relating 
to all forms of mental illness using MeSH terms (Appendix 2 for development, 
refinement and exact details of this strategy) 
Intervention: an already developed search strategy was used which has been 
shown to have acceptable sensitivity and precision in identifying research which 
relates to outcome and needs assessment (Brettle, et a/., 1998) (see Appendix 2 for 
development, refinement and exact details of this strategy). 
Titles and abstracts from electronic searches were scrutinised and all potentially 
relevant articles were obtained. Reference lists were scrutinised for additional 
studies. The results of these searches are summarised in table 28. 
It will be seen from table 28, that the search strategies were relatively insensitive, 
with search strategies identifying large numbers of studies of which only a small 
portion were relevant. The primary reason for this is the ubiquity of the term 
'outcome' in electronic abstracts. Approximately 17,000 of the identified studies 
(>90%) were in fact primary studies which were of no direct relevance, but which 
were picked up by the electronic searches by virtue of the presence of the term 
( outcome' as part of their structured abstract. Attempts to refine this search were 
unproductive and meant that studies which were already known to exist and fulfil the 
inclusion criteria were not identified in electronic searches. 
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The most fruitful database in terms of potentially relevant studies was MEDLINE, 
with other databases identifying relatively few studies that were eventually found to 
fulfil the inclusion criteria 
In addition the following journals were hand searched: 
0 British Journal of Psychiatry 1976-1999 (no additional studies) 
" American Journal of Psychiatry 1976-1999 (no additional studies) 
" Archives of General Psychiatry (no additional studies) 
" Psychological Medicine (no additional studies) 
" Quality of Life Research (no additional studies) 
" Journal of Psychosomatic Research (no additional studies) 
" Medical Care (four additional studies). 
Data extraction 
The following data were extracted from studies, and were entered in a Microsoft 
Access database (Microsoft Corporation, 1998). 





Routine outcome measure used; 
Intervention and control conditions; 
Length of follow up & outcomes studied; 
Results. 
Quality assessment 
Study quality was assessed in two ways. 
First, studies were judged according to accepted quality assessment criteria, using 
the Jadad scale (Jadad, et al., 1996), the criteria of Schulz (Schulz, et al., 1995) and 
Cochrane criteria (Mulrow & Oxman, 1999). Particular attention was paid to the 
method of randomisation, such that those studies that described themselves as 
randomised, but did not describe an adequate method of randomisation and 
concealment of allocation were distinguished from those that did. Full definitions of 
items and a data extraction sheet are given in appendix 5. 
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Secondly, the unit of randomisation was established. Cluster randomised studies 
were considered to be superior to non-cluster based studies. For those studies in 
which the unit of randomisation was by clinician or clinical population, rather than 
individual patients, evidence was sought that clustering had been incorporated into 
the design and analysis of the study by the authors (Ukoumunne, et al., 1999a). 
Data analysis and synthesis 
First, a non-quantitative data synthesis was applied. Study design features and 
results were tabulated. All results presented by authors were recalculated (where 
possible) from data presented in publications according to the following methods: 
Dichotomous data. Discrete dichotomous outcomes, for example recognition of a 
specific psychosocial problem or admission to hospital, were summarised as rate 
ratios (also known as risk ratios or relative risks), absolute rate differences and 
Numbers Needed to Treat (NNTs) (Mulrow & Oxman, 1999), according to the 
following formulae: 
Outcome present Outcome absent 
Intervention group a b 
Control group c d 
Rate in intervention group = a/(a+b) 
Rate in control group = c/(c+d) 
Rate difference = (a/(a+b))-(c/(c+d)) 
Rate ratio = (a*(c+d))/(c*(a+b)) 
Confidence intervals for rate differences and ratios were calculated using Stats 
Direct version 1.7 (Buchan, 2000). 
For studies that did not provide sufficient data to allow primary calculations to be 
made, then first authors were contacted in search of this information. If this was not 
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forthcoming, then the data presented by authors (such as p values or unverified rate 
differences) were included in tables. Where it was reported in studies that there had 
been losses to follow up, or if patients were randomised but not accounted for in the 
results, then these were assumed to have not had a positive outcome. In other 
words, an intention to treat analysis was reconstructed (Meinert, 1986). 
Continuous outcomes: where continuous outcomes, such as scores on a 
psychometric scale were presented, then change and endpoint scores for each 
group were sought, together with their standard deviations, if available. 
Economic outcomes: Where data were collected on resource use and economic 
outcomes, then these data were presented as reported by the authors of individual 
studies, together with details of the measurement of direct and indirect costs, the 
currency and time frame under which cost data were recorded. Where the authors 
of the individual studies conducted a synthesis of clinical and cost data, then these 
were presented. Further reanalysis of cost data was not attempted. 
Once tabulated, important similarities and differences in terms of design and 
outcome were sought. Individual studies were judged to be overall positive or 
negative according to the following taxonomy: 
a positive -if the majority of major outcomes are statistically significant in favour of 
the intervention, - 
a bordedine positive - if majority of outcomes are positive but non significant or 
have a unit of analysis error, 
a mixed effect; 
* bordelline negative - if majolity of outcomes are negative but non significant or 
have a unit of analysis error; 
e negative - if the majority of major outcomes are negative and statistically 
significant. 
For those studies that were sufficiently similar in terms of their patients, settings, 
intervention and choice of outcome, then a formal data synthesis was attempted 
according to the following method. 
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For data that were felt to be sufficiently similar, a random effects meta-analysis 
using the methods outlined by (DerSimonian & Laird, 1986) was conducted using 
STATA version 6.0 (STATA corporation, 1999). This method can be used to pool 
both dichotomous and continuous data, and weights studies by their individual 
variance or sample size. Random effects meta-analysis assumes that the individual 
studies may be estimating different underlying effect sizes, and that these 
underlying effects are assumed to vary at random within this model. This variation, 
in addition to the variation caused by sampling error is incorporated into an overall 
estimate of effect size and attendant confidence limits. In the absence of substantial 
heterogeneity, then random pooled effect size approximates that obtained from a 
fixed effects model (NHS Centre for Reviews and Dissemination, 2000; Sutton, et 
al., 1999). Where substantial evidence of statistical heterogeneity was found (see 
below), then sources of heterogeneity were sought. For unexplained heterogeneity, 
no formal meta-analysis was conducted. 
Examination of heterogeneity 
Heterogeneity between studies was examined by: 
1. Looking for important differences between studies in terms of their design, 
following the non-quantitative synthesis of tabulated data 
2. Inspection of plots of individual point estimates of outcome (Forrest plots) 
3. Statistical tests of heterogeneity. 
Inspection of plots of individual studies (Forrest plots) usually reveals obvious 
heterogeneity when the 95% confidence intervals of individual studies do not 
overlap (NHS Centre for Reviews and Dissemination, 2000). This can be 
supplemented by formal statistical tests such as Cochran's Q statistic (Cochran, 
2 
1954), which approximates to a, distribution, with k-1 degrees of freedom, where k X 
= number of component studies. Hence, if the Q statistic exceeds some critical 
value expected by k-I degrees of freedom, then the observed variance of the study 
is greater than that which would be expected to occur by chance (Sutton, et a/., 
1999). Where substantial heterogeneity was found, then sources of this 
heterogeneity were sought. Where substantially different groups of studies were 




Where possible, funnel plots of effect size versus sample size were constructed for 
those studies that were judged to be sufficiently comparable. Evidence of 
asymmetry was sought by visual inspection of funnel plots and through the 
application of a statistical method outlined by (Egger, et al., 1997), calculated using 
STATA version 6.0. 
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Chapter 26 Results of the review 
Literature searches 
Of the 19,614 individual studies identified by literature searches, 57 were felt to 
potentially fulfil pre-specified inclusion criteria, and full copies were obtained for 
further inspection. Additional studies were obtained by correspondence (Pignone, et 
al., 2001) following the publication of an earlier version of this review (Gilbody, et al., 
2001d). Of these, twenty-four studies fulfilled the inclusion criteria. The flow of 
studies through the review is summarised in figure 13, according to guidelines laid 
down in the QUOROM statement on the reporting of systematic reviews and meta- 
analyses (Moher, et aL, 1999a). 
The literature searches failed to find any trials of the routine use of outcome 
measures in psychiatric settings. Twentyfour studies conducted in non-psychiatric 
settings were identified. Eleven studies were conducted in primary care settings, 
eight in general medical outpatients, one in general medical inpatients, one in the 
emergency room and one in the antenatal clinic, one in a rheumatology clinic, and 
one in a neurology clinic. Details of these studies are provided in Table 29 (pages 
221-231). 
Table 28: Utility of search strategies and databases in identifying 
relevant studies for the review 
Database/source Number of citations Potentially relevant 
citations 
Citations included in 
review 
MEDLINE 8728 92 7 
EMBASE 3270 36 2 
CCTR 719 56 3 
Cinahl 2160 8 0 
PsycLit 4737 12 1 
Reference lists and 
correspondence with authors 
NA 24 15 
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Figure 13: QUOROM Trail flow diagram 
(Moher, et a/., 1999a) 
Potentially relevant RCTs identified 
and screened for retrieval (n=2960; 
excluding hand searches) 
Potential RCTs excluded (n=2917): 
either clearly not randomised or did not 
fulfil inclusion criteria 
RCTs retrieved for more detailed 
evaluation (n=57) 
Potentially appropriate RCTs to be 
included in the systematic review 
(n=24) 
RCTs included in the systematic 
review (n=24) as a narrative synthesis 
RCTs with usable information to permit 
meta-analytic pooling (n=9) for rates of 
recognition of mental disorders 
Potential RCTs excluded (n=33): either 
early not randomised or did not fulfil 
inclusion criteria 
RCTs not included in meta-analysis 
(n=15): by reason of clinical 
heterogeneity, insufficient reporting of 
primary data, and failure to report 
longer term outcome 
202 
Primary care and general hospital studies 
In total twenty-four randomised and pseudo randomised studies were obtained 
which examined the use of standardised instruments as outcomes measures in 
routine primary care and general hospital care settings. Specific strengths and 
weaknesses and facets of their design and results will now be considered in turn. 
Study design & methodological quality 
All studies described themselves as 'randomised, with very few giving specific 
details of method of randomisation and concealment of allocation. Failure to specify 
these facets of design are important since they have been shown to be sources of 
bias in randomised studies (Schulz, et a/., 1995). Two studies that did give details 
of method of randomisation, used an inadequate and not truly random allocation 
according to odd/even patient reference numbers (Johnstone & Goldberg, 1976), or 
according to alternate allocation (Weatherall, 2000). Two studies were quasi 
randomised, with patients seen in the first half of the study being allocated to 
control, and in the second period being allocated to the active intervention (Gold & 
Baraff, 1989; Street, eta/., 1994). 
In the majority of studies, the unit of randomisation was the individual patient, with 
individual clinicians seeing both intervention and control patients (i. e. using the 
outcome measure for some patients and not using the outcome measure for others). 
This raises problems of 'cross contamination' between subjects and controls and a 
Hawthorne effect, whereby practice is changed for both subjects and controls by 
virtue of participation in a study (Roethlisberger & Dickinson, 1939). The 
implications of this facet of study design are explored in more detail in the 
discussion section. Nine studies used individual clinicians or practices as the unit of 
randomisation (Calkins, et al., 1994; Goldsmith & Brodwick, 1989; Mazonson, et al., 
1994; Reilfer, et al., 1996; Rubenstein, etaL, 1989; Rubenstein, etaL, 1995; Street, 
et al., 1994; Wasson, et al., 1992a; Whooley, et al., 2000), so that cross 
contamination was avoided by single clinicians receiving either the control or 
experimental condition, but not both for their individual patients. None of these 
studies accounted for their clustering in their analysis of results, making them prone 
to a 'unit of analysis error' (Divine, et al., 1992). 
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Sample size varied between 52 and 2209, and three studies (Dowrick & Buchan, 
1995; Weatherall, 2000; Williams, et al., 1999), included a power calculation or 
discussion of the sample size required to detect a specified difference in outcomes 
between treatment and control groups. 
Sefting 
Eleven studies were conducted in primary care settings, eight in general medical 
outpatients, one in general medical inpatients, one in the emergency room and one 
in the antenatal clinic, one in a rheumatology clinic, and one in a neurology clinic. 
Patients 
There were broadly two types of patient populations who underwent randomisation- 
(1) 'unselected populations', where patients were included, irrespective of their 
baseline score on the instrument under evaluation or pre-existing probability of 
having some deficit or disorder as measured on the instrument under evaluation, 
and (2) 'high risk populations', whereby patients were only randomised if they 
scored above a certain level on the instrument under evaluation, or were known to 
have a pre-existing but unrecognised deficit or disorder such as depression. For 
example, an unselected population was recruited by (Hoeper, et al., 1984), who 
administered the General Health Questionnaire (see below) to all attenders at a 
general practice outpatients, and randomised these patients to either have their 
GHQ score fed back to the clinician or to be withheld - irrespective of their score on 
the GHQ. Conversely, Magruder Habib, et al. (1990) recruited only patients with a 
likely pre-existing diagnosis of depression using a two stage procedure. All 
outpatient attenders were first given the Zung SDI (Zung, 1965), and those with high 
scores were then screened using a standardised diagnostic interview schedule. 
Only those with a confirmed diagnosis of hitherto unrecognised depression were 
then randomised to have their Zung SDI score fed back to clinicians in the course of 
the interview. 
Some studies, by the nature of the services under evaluation (e. g. US veterans 
administration hospitals - Magruder Habib, et al., 1990), included a greater 
proportion of elderly patients, or were specifically targeted at elderly patients 
(Whooley, et al., 2000). 
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Outcome instrument used 
The most commonly used instruments were self-completed scales designed to 
detect depression and anxiety (Beck Depression Inventory - BDI (Beck & Ward, 
1961); General Health Questionnaire - GHQ (Goldberg, 1972); Zung SDI (Zung, 
1965). Eight studies (Calkins, et a/., 1994; Goldsmith & Brodwick, 1989, Kazis, et 
a/., 1990; Rubenstein, et al., 1989; Rubenstein, et al., 1995; Street, eta/., 1994; 
Wagner, et a/., 1997; Wasson, et a/., 1992a) investigated the use of generic health 
status measures: the Short Form (SF) 36 (Ware, et a/,, 1993); the functional status 
questionnaire - FSQ (Jette, et a/., 1986); the Dartmouth COOP (Wasson, et al., 
1992b); and the Sickness Impact Profile - SIP (Bergner, et a/., 1981). One study 
(Mathias, et al., 1994) combined an anxiety questionnaire - the anxiety components 
of the Symptom Check List -90 (Derogatis, 1994; Fifer, et a/., 1994), with a generic 
health status questionnaire (the S1736) (Ware, et a/., 1993). Another study (Reilfer, 
et al., 1996) used a self administered diagnostic interview schedule (Broadhead, et 
al., 1995), which gave diagnoses for depression; generalised anxiety disorder; panic 
disorder; alcohol or drug abuse; obsess ive-com pu I sive disorder; and suicidal 
ideation, which were then fed back to the clinician. Instruments were generally 
administered in the waiting room by research assistants prior to consultation. 
Active intervention and choice of control 
The active intervention broadly involved the feedback of instrument test results to 
the clinician - generally in the form of a sheet containing summary scores and an 
explanation of the importance of high scores in terms of the likely presence of a 
psychological disorder. For example, (German, et al., 1987) provided summary 
sheets with GHQ scores together with the following statement. 
'it has been shown that above a critical symptom level, a psychiatrist is likely to 
make a psychiatric diagnosis of a non-psychotic emotional disorder Higher levels 
of GHQ scores indicate increasing probability of current emotional distress. A score 
higher than four is regarded an a 'positive'or abnormal result' 
An alternative approach was the use of visual representations of patient problems 
as identified by the outcome instruments used. For example (Mazonson, et al., 
1994) produced a one page summary sheet, known as the'Mental Health Patient 
Profile', which included summary scores of the SCL-90, highlighting elevated 
scores, together with visual thermometer representations of the various components 
of the SF36- 
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In some studies (e. g. Mazonson, et al., 1994; Rubenstein, et a/., 1995), feedback of 
outcome results was combined with an active educational programme and the 
availability of standardised best practice guidelines on the management. For 
example, in the study by Mazonson eta/. (1994), the active educational programme 
involved an educational session on the importance of deficits in health related 
quality of life and untreated anxiety, together with a description of the psychometric 
instruments and their interpretations. Results of profiles from three of their own 
patients were then discussed in detail and educational materials on the 
management of anxiety were provided in the form of audiotapes and articles. 
Additionally, a toll free telephone number of a study team physician was provided so 
that further questions could be answered. 
The control condition was generally the administration of the outcome measure to 
the patient, without the score on this scale being fed back to the clinician. One 
study (Linn & Yager, 1980a) employed a factorial design that combined the above, 
with a discussion between the researcher and clinician in order to establish the 
clinicians' impression regarding the presence or absence of an emotional disorder. 
One study (Johnstone & Goldberg, 1976) asked the clinician about the likelihood of 
the presence of an emotional disorder for all patients, prior to feeding back the 
results of the GHQ only for those randomised to receive this information. This 
approach potentially increases clinician awareness of the presence of emotional 
problems in both intervention and control conditions. 
Outcome instruments were generally administered only once in each of the studies, 
and were used as case finding instruments, for the purposes of identifying clinical or 
health related quality of life problems at an assessment interview. In most cases, 
the instrument was fed back to the clinician prior to the index clinical encounter, so 
that the clinician would be aware of the results before seeing the patient. In the 
study by Johnstone & Goldberg (1976), the information was fed back following the 
clinical encounter, and in another (Linn & Yager, 1980a), the time of feedback was 
varied between intervention cells, with feedback of Zung SDI results either before or 
following the consultation. In only four studies (Calkins, et al., 1994; Kazis, et a/., 
1990; Mazonson, et al., 1994; Rubenstein, et al., 1989) was the outcome battery 
administered sequentially during the course of care or follow-up - however this was 
done at fixed points by research assistants, rather than at each clinical encounter. 
In seven studies (Callahan, et al., 1994; Dowrick & Buchan, 1995; German, et a/., 
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1987; Johnstone & Goldberg, 1976; Mathias, et a/., 1994; Reilfer, et al., 1996; 
Shapiro, et a/., 1987), the instrument was administered on further occasions, but 
only as a research exercise in order to determine the outcome of the study, rather 
than as an intervention where the instrument was used as part of ongoing patient 
management (i. e. routine outcome measurement). 
Trial endpoints & follow up 
The most commonly collected trial endpoints were: 
0 The detection of depression, anxiety or an emotional problem by the clinician 
during the course of the clinical interview, and; 
0 The initiation of treatment or intervention for depression anxiety or an 
emotional problem. 
In a number of instances, this was established by the use of clinician questionnaires 
or interviews following a patient consultation, whereby the clinician was asked if they 
believed there was an emotional disorder present (e. g. Johnstone & Goldberg, 
1976). In others, it was established by case note review, whereby written evidence 
was sought to determine whether the clinician had noted an emotional disorder as 
being present, or if they had initiated any interventions for an emotional problem 
(e. g. Magruder Habib, et al., 1990). Interventions were fairly consistently and 
broadly defined in studies as: referral to a mental health specialist; prescription of 
psychotropic medication; discussion of depression with the patient and noting the 
presence of depressive symptoms. 
Eleven studies employed a follow up period beyond the initial consultation, which 
included the sequential measurement of scores on the actual outcome measure 
under evaluation, with follow up periods of between three and twelve months 
(Calkins, et al., 1994; Callahan, et al., 1994; Dowrick & Buchan, 1995; German, et 
al., 1987; Johnstone & Goldberg, 1976; Kazis, et al., 1990; Mathias, et al., 1994, 
Mazonson, et al., 1994; Reilfer, et al., 1996; Rubenstein, et a/., 1989; Shapiro, et a/., 
1987). For example (Johnstone & Goldberg, 1976) administered the GHQ to GP 
attenders and measured the changes in these scores at twelve months in both 
intervention and control groups. Similarly, Dowrick & Buchan (1995) assessed the 
effect of feedback of the BDI on subsequent BDI scores in both intervention and 
control groups. Lastly, (Kazis, et al., 1990) administered the FSQ every four months 
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to rheumatology patients and measured endpoint scores for this measure at twelve 
months in both the intervention and control groups. 
In one study (Street, et a/., 1994), the primary study endpoint was the quality of the 
clinical encounter and patient satisfaction with the clinical encounter following the 
administration of the SF36. 
Study results 
Effect of routine outcome measurement on recognition of emotional problems 
and minor psychiatric disorders 
The earliest study is that by Johnstone & Goldberg (1976) which showed a large 
effect for the detection of depression through feedback of the GHQ, increasing the 
rate of detection of depression in unselected patients seen by a single general 
practitioner by 11 %. However, this study suffers a number of problems, including 
inadequate randomisation, differential case ascertainment and difficulties 
generalising beyond the practice style of a single motivated general practitioner. 
Insufficient data were reported in this study to allow the reported absolute difference 
in the detection of depression between groups to be corroborated. 
A subsequent study by Hoeper, et al. (1984) sought to replicate these results in 
sequential attenders in US primary care. No effect was found for feedback, with 
16% of sequential unselected patients being found to have 'mental disorders' 
identified by their clinicians, irrespective of whether scores on the GHQ were fed 
back to the clinician or not. A subgroup analysis conducted by the authors of those 
with GHQ scores >4 (where this specific information and the fact that it'indicated 
probable mental illness'was fed back to the clinician) showed no differential effect 
between controls and those receiving feedback (29% vs. 30%, relative risk of 
detection of depression following feedback = 1.02,95% Cl 0.81 to 1.29). 
Despite being superficially similar, the studies by Johnstone & Goldberg (1976) and 
Hoeper, et al. (1984) have important differences in terms of participating clinicians, 
mode of feedback of outcome measure and identification of psychiatric morbidity. 
Johnstone & Goldberg (1976) studied the effect of feedback on 1000+ consultations 
with one single GP, whereas Hoeper et al includes 14 clinicians and therefore 
potentially reflects a wider range of practice styles. Johnstone & Goldberg, (1976) 
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administered the GHQ prior to the consultation and asked the clinician about the 
likelihood of there being an emotional disorder following the consultation. For 
patients allocated to the experimental group, the GHQ score was then fed back to 
the clinician and the clinician was then allowed to change his mind about whether 
there was a likely psychiatric illness. It was this final clinician diagnosis which was 
taken as 'case ascertainment' in the experimental group, whereas case 
ascertainment in the control group was by retrospective analysis of initial GHQ 
scores at twelve month follow up, with scores >4 defined as 'cases'. The effects of 
different case ascertainment methods between experimental and control conditions 
is potentially reflected in statistically significant differences in baseline scores on the 
GHQ between groups, with more severe disorders being identified in the 
experimental condition. In Hoeper et al's study, the fourteen clinicians received the 
GHQ scores in the experimental group, before making any rating of mental illness. 
Clinician rating of mental illness was the criterion for case ascertainment in both 
intervention and control conditions in Hoeper's study. 
A further study of US outpatients (German, et al., 1987) again shows no difference 
in the rate of detection of depressive illness between those who had their pre 
consultation GHQ fed back to clinicians and those who did not. A number of 
subgroup analyses were performed by the authors which suggested that the non 
significant results mask some potentially important increases in the rates of 
detection amongst those over 65 (63% vs. 41 %), and amongst black and male 
patients. Further subgroup analysis according to GHQ score suggests that the rate 
of detection was increased most amongst those with moderately raised GHQ 
scores, rather than amongst those with high scores. This raises the possibility that 
the GHQ is useful in resolving clinical uncertainty amongst this group and those high 
scorers are detected, irrespective of whether their GHQ scores are fed back. 
Linn et al's (1980) study involves a complex factorial design which allocates 150 
unselected patients to one of six groups which receive either no feedback or one of 
five combinations of feedback before the clinical encounter, feedback after the 
clinical encounter and 'clinician sensitisation' to the presence of emotional problems 
(an interview with the researcher and discussion of the possibility of an emotional 
problem being present). Resultant small numbers of patients in each cell make 
conclusions difficult to interpret in this under-powered study, although pooling 
groups who received some sort of feedback and comparison with groups who 
received no feedback increases the rate of detection of depression (8% vs. 25%, 
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relative risk of detection of depression following feedback = 3.13,95% Cl 1.24 to 
8.33). 
One study by Williams et a/. (1999) used a three arm intervention, comparing: (1) 
CES-D Questionnaire, (2) Single item question 'Have you felt depressed or sad 
much of the time in the past year? ' and (3) usual care. The results of the first two 
arms were combined by the authors in all analyses and showed a non-significant 
positive result on the rate of recognition of depression (39% vs. 29%, relative risk of 
detection of depression following feedback = 1.34 95% CI = 0.79 to 2.43). 
Three studies (Callahan, et al., 1994; Magruder Habib, et al., 1990; Moore, et al., 
1978) use a 'high risk' approach, targeting feedback at a selected population of 
primary care attenders with a probable or confirmed diagnosis of depression (Zung 
score >50; HDRS score >15 or diagnosis by diagnostic interview schedule). All 
these studies showed a positive effect for feedback. 
One study by Mazonson et al. (1994) specifically employed routine outcome 
measurement and active clinician education to increase the rate of recognition and 
improve the outcome of anxiety in primary care. This combined intervention served 
to increase the rate of recognition of anxiety disorders (defined as 'chart notations') 
from 19% in the control arm to 32% in the intervention arm (relative risk of 
recognition of an anxiety disorder = 1.72,95% Cl 1.25 to 2.37). 
Of the studies which employ broader measures of health related quality of life as 
their principle outcome measure (Calkins, et al., 1994; Goldsmith & Brodwick, 1989; 
Kazis, et al., 1990; Rubenstein, et al., 1989; Rubenstein, et al., 1995; Street, et a/., 
1994; Wagner, et al., 1997; Wasson, et al., 1992a), four report the effect of these 
measures alone in improving the overall rate of recognition of emotional problems 
(Calkins, et a/., 1994; Kazis, et al., 1990; Rubenstein, et al., 1989; Rubenstein, et a/,, 
1995). Three of the four studies (Calkins, et al., 1994; Kazis, et al., 1990; 
Rubenstein, et al., 1989) show no differences for any subscale of the FSQ or AIMS 
(including mental health) at 12 months. In contrast, a later study by Rubenstein et 
al. (1995) reports that feedback of the FSQ increases both the rate of recognition of 
depression and anxiety. Symptoms of anxiety or depression were recorded by 
physicians in 30% of case notes over a six month study period by clinicians 
receiving feedback, compared to 21 % amongst those not receiving feedback of 
results (relative risk of detecting anxiety or depression following feedback = 1.42, 
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95% C. 1.0.98 to 2.08). The rate of recognition of anxiety problems was increased 
by the largest magnitude (13% vs. 4%, relative risk of recognition of anxiety 
following feedback = 3.33,95% C. 1.1.40 to 7.92), whilst the rate of recognition of 
depression was subject to a non significant increase in recognition (23% vs. 20%, 
relative risk of recognition of depression following feedback = 1.17,95% C. 1.0.78 to 
1.77). The major limitation of this study is, however, the fact that whilst it is a cluster 
randomised trial (clinicians are the unit of randomisation), it is analysed according to 
individual patients without reference to intra-class correlation coefficients. It is 
therefore subject to a unit of analysis error and the chance of a type 1 error cannot 
be excluded. 
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Statistical pooling of studies intended to increase the detection of depression. 
Several studies involved sufficiently similar interventions and endpoints to allow the 
possibility of a quantitative synthesis of study outcome to be examined (Callahan, et 
a/., 1994; German, et al., 1987; Gold & Baraff, 1989; Hoeper, et al., 1984; Johnstone 
& Goldberg, 1976; Linn & Yager, 1980a; Magruder Habib, et al., 1990; Moore, et al., 
1978; Whooley, et al., 2000; Williams, et al., 1999; Zung, et al., 1983). 
Two studies (Johnstone & Goldberg, 1976; Zung, et a/., 1983) provide insufficient 
raw data to allow the size of the reported result to be confirmed or to be entered in a 
formal meta-analysis. Another study (Linn & Yager, 1980a) provides data on six 
separate arms of a trial, each with a different variant on time and mode of feedback 
of outcomes data to clinicians. Potential inclusion of this study was not felt to be 
justified. One further study by Williams et a/. (1999) used a three arm intervention, 
comparing: (1) CES-D Questionnaire, (2) Single item question 'Have you felt 
depressed or sad much of the time in the past year? ' and (3) usual care, and the 
pooling of essentially different interventions was not felt justified. The study by 
Whooley et al. (2000) followed up only those patients who screened positive for 
depression, rather than all those randomised, making the effect of feedback on the 
whole study population impossible to assess. The study by Gold & Baraff (1989) 
was a non-randomised study, and its inclusion in the presence of randomised data 
was not felt to be justified. The justification for the exclusion of these studies and 
the effect of their reintroduction of potentially useable data on the overall result of 
the meta-analysis is examined below in a sensitivity analysis and examination of 
sources of heterogeneity. 
Visual inspection of a Forrest plot for those remaining studies shows substantial 
between study variations between studies (see figure 14). Evidence of between 
study heterogeneity is further suggested by the application of statistical tests for 
heterogeneity (Q 'non-com binability' for relative risk = 23.4; df = 4; p=0.0001). Of 
note is the observation that larger studies produce non-significant results (German, 
et al., 1987; Hoeper, et al., 1984), whereas smaller size studies produce more 
marked effect sizes in favour of feedback. The differential effect according to 
sample size is confirmed by Funnel plot analysis (Figure 15), where the funnel is 
found to be substantially asymmetrical (p=0.024 using Egger's test (Egger, et a/., 
1997). 
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Figure 14: Forrest plot for studies examining the effect of feedback on 
the rate of recognition of depression 
Cochrane relative risk plot (random effects) 
Hoeper[GHQI 
German [GHQ] 
Magruder Habib [Zung] 
Moore [Zung] 
allaghan 1994 [HDRS] 
0. 0 
Figure 15: Funnel graph of studies examining the effect of feedback on 
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DL pooled relative risk = 1.536116 (95% Cl = 1.021558 to 2.315873) 
It was noted in the previous discussion that broadly two different strategies were 
employed in the provision of feedback in the trials included in this review: Firstly, an 
unselected form of feedback, whereby outcomes measures were administered to all 
patients seen in a clinical service, and their results fed back to the clinician, 
irrespective of their score. Secondly, a high risk form of feedback, whereby 
outcomes measures were administered, and only those with high scores were then 
included in a randomised trial to have their high scores fed back to the clinician or 
not. Examination of the Forrest plot (Figure 14) and funnel plot (Figure 15) shows 
that the larger of the four trials, with largely negative results employ an unselected 
strategy, whereas the two smaller trials with positive results employ a high risk 
strategy. There are plausible reasons why these two forms of feedback are likely to 
have fundamentally different effects in routine practice, since clinicians are 
potentially more likely to act on the results of positive results, when only these are 
fed back. These differential effects are a likely explanation of the heterogeneity 
shown in Figure 14. For this reason two separate meta-analyses were undertaken 
for unselected and high-risk studies. 
Meta-analysis of unselected feedback studies 
Meta-analytic pooling of the two studies by German et al. (1987) and Hoeper et al. 
(1984) suggests that unselected feedback is ineffective in increasing the rate of 
recognition of depression (DerSimonian-Laird pooled relative risk of detection of 
depression = 0.947,95% Cl = 0.825 to 1.088), and that there is homogeneity in the 
results of these two studies (Q = 0.109, df = 1, P=0.74). 
One further study (Linn & Yager, 1980a) also used an unselected approach, but was 
excluded from the main analysis due to the questionable validity of pooling five 
separate arms, which each used a different variation of the timing and mode of 
feedback of questionnaire results. This study was reintroduced into the preceding 
meta-analysis in order to test the robustness of the overall result to the inclusion of 
this positive study (figure 16). It was found that this study increased the level of 
heterogeneity within the analysis (Q = 5.59, df = 2, p=0.0612), but that the overall 
negative result was robust to the inclusion of this study (DerSimonian-Laird pooled 
relative risk = 1.04,95% Cl = 0.78 to 1.39). 
Similarly, the small sized non-randomised study by (Gold & Baraff, 1989) used an 
unselected approach. The introduction of this study did not alter the overall 
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conclusion of the meta-analysis (figure 17) - DerSimonian-Laird pooled relative risk 
= 0.97,95% Cl = 0.86 to 1.08 (Q = 0.298, df = 2, p=0.861). 
Figure 16: Meta-analysis of studies employing unselected feedback, 
with the inclusion of Linn et al, as a sensitivity analysis 




Q ("non-com binability" for relative risk) = 5.586 (df = 2) P=0.0612. 
Figure 17: Meta-analysis of studies employing unselected feedback, 
with the inclusion of Gold et al, 1989, as a sensitivity analysis 




Q ("non-com bi nability" for relative risk) = 0.298 (df = 2) P=0.861 
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Meta-analysis of high risk feedback studies 
Meta-analysis of the three studies by Moore eta/. (1978), Magruder Habib eta/. 
(1990) and Callahan et al. (1994) show that this high risk strategy was a largely 
effective in increasing the rate of recognition of depression (DerSimonian-Laird 
pooled relative risk = 2.641,95% Cl = 1.78 to 3.94, Q=0.02, df = 1, p=0.887) - 
see figure 18. This intervention increased the rate of detection of depression by 
27% (DerSimonian-Laird pooled risk difference = 0.270,95% Cl = 0.144 to 0.397), 
with an equivalent number needed to treat (NNT) of 4 (95%Cl 3 to 7) suggesting 
that the results of four high scoring questionnaires need to be presented to clinicians 
in order that one extra case of depression is detected. 
Figure 18: Meta-analysis of studies employing high-risk feedback 
Cochrane relative risk plot (random effects) 
Magruder Habib [Zung] 
Moore [Zung] 
allaghan 1994 [HDRS] 
DL pooled relative risk = 2.650146 (95% Cl = 1.781477 to 3.942388) 
Q ("non-combinability" for relative risk) = 0.020 (df = 1) P=0.887. 
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Effect of routine outcome measurement on initiation of treatment for 
emotional problems 
Nine studies investigated the effect the feedback of questionnaire results on the rate 
of intervention for emotional problems (Callahan, et a/., 1994; Dorwick, 1995; 
German, et a/., 1987; Lewis, et a/., 1996; Linn & Yager, 1980a; Magruder Habib, et 
a/., 1990; Mazonson, et a/., 1994; Weatherall, 2000; Whooley, et a/., 2000; Williams, 
et a/., 1999) and all but two (Callahan, et al., 1994; Magruder Habib, et al., 1990) 
showed non significant results. Heterogeneity of methods and definition of an active 
intervention meant that overall pooling was not justified. 
Interestingly, whilst Linn et al (1980) showed that feedback increased the rate at 
which clinicians recognised depression, but the likelihood of making an intervention 
Oudged from case note review) was not altered (RR 0.93,95% Cl 0.83 - 1.05). 
German, et a/. (1987) similarly showed no effect of feedback for all patients on 
management (RR=1.02,95% Cl 0.93 - 1.13). The subgroup analyses carried out by 
German, et al. (1987), which suggested a greater recognition of depression amongst 
the elderly, men and blacks when feedback is received, did not show any increase 
in the rate of intervention amongst these groups. 
The study by Mazonson, et a/. (1994), which specifically targeted the recognition 
and intervention for anxiety showed a marked increase in the rate of mental health 
referrals (10% vs. 3%, relative risk of outside referral for an anxiety problem = 2.94, 
95% Cl 1.33 to 6.51). This increased rate of intervention was not accompanied by 
an increased rate of initiation of psychotropic prescriptions (13% vs. 13%). 
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Effect of routine outcome measurement on subsequent outcome of emotional 
disorders 
Eleven studies examined the effect of outcome measurement on the actual outcome 
of the patient over time (Callahan, et a/., 1994; Dowrick & Buchan, 1995; Johnstone 
& Goldberg, 1976; Kazis, et a/., 1990; Lewis, et a/., 1996; Mazonson, et a/., 1994; 
Reilfer, et a/., 1996; Rubenstein, et a/., 1989; Rubenstein, et al., 1995; Whooley, et 
al., 2000; Williams, et al., 1999). Results from Johnstone & Goldberg (1976), using 
retrospective patient recall, showed that patients with hidden psychiatric morbidity, 
on whom GHQ feedback was given, have a shorter duration of illness (2.8 months 
vs. 5.3 months). Final 12 month GHQ scores of patients found to be positive at their 
index episode were broadly similar for those on whom feedback was given 
compared to controls. However, a subgroup analysis suggests that feedback was 
associated with improved GHQ scores amongst those with a 'severe' but 
unrecognised disorder at inception. 
No overall effect of outcome measurement on outcome was detected in nine of the 
eleven studies. For example, the study by Dowrick & Buchan (1995), who re- 
administered the Beck Depression Inventory at 12 months and found there to be no 
significant difference between those in whose scores were fed back and controls. 
This study suggests that unrecognised depressive symptoms resolve over a twelve 
month period, irrespective of whether feedback was employed or not. Similarly, 
Lewis, et al. (1996) show a lack of overall effect of GHQ feedback on subsequent 
GHQ scores. 
Of the two studies that showed a positive effect of routine outcomes measurement, 
the study by Mazonson et al. (1994) involving an intensive educational and feedback 
intervention targeted at anxiety problems found no overall improvement in either 
total scores on the anxiety components of the SCL-90, nor the mental health 
component of the SF36. The only positive effect that was found in this study was on 
a self report scale of anxiety, used in conjunction with the SF36 and the SCL-90. 
The other positive study by Rubenstein et al. (1995) resulted in a small, but 
statistically significant change in the mental health component of the FSQ (endpoint 
mean change difference = 4.5 points, 95%Cl 0.5-8.3, on a 100 point scale). Of the 
four component scales of the FSQ (activities of daily living; mental health; social 
activities; work performance), mental health was the only scale to show a between 
group difference at the end of a six month study period. As mentioned previously, 
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this cluster-randomised trial was prone to a unit of analysis error and the possibility 
of a spurious positive result cannot be excluded. 
Effect of routine outcome measurement on consulting behaviour 
Johnstone & Goldberg (1976) examined the effect of feedback of outcome data on 
subsequent GP consultation over 12 months and found that the increased rate of 
recognition of depression and improved outcome was not followed by an increased 
number of consultations with their general practitioner. There had, however, been a 
change in the pattern of consultation behaviour. Feedback had increased the 
proportion of consultations that had been labelled 'psychiatric' in their content by the 
general practitioner. This overall trend is replicated by the more recent and rigorous 
study by Lewis et a/. (1996), which also showed that rates of psychiatric and non- 
psychiatric referrals were unchanged as a result of feedback. 
The study by Mazonson et al. (1994) reported brief data on non-mental health 
utilisation and consulting behaviour. There was no difference in the rate of non- 
psychiatric hospitalisations between feedback and control groups (9% vs. 10%), 
however there was an average of 0.6 more primary care visits (for any reason) 
between feedback and control groups. (3.3 visits over six months vs. 2.7 visits, 
p=0.054). 
In contrast the study by Reilfer et al. (1996) showed a reduction in health utilisation 
in the intervention group (referrals to non mental health specialists reduced 0.9 vs 
2.1 visits, p<0.005). 
Effect of routine outcome measurement on patient satisfaction with care and 
patient - doctor communication 
The study by Street et al. (1994) examined the effect of the administration and 
feedback of the generic health status questionnaire, the SF36 on the patient 
satisfaction and communication in the ante-natal clinic. 
Their patient survey showed that patients generally wanted to be asked about 
'health status overall', and listed the components of the health status which they 
wanted to be asked about. All patients wanted to be asked aboutpain' and 
( perceptions of health', fewer expressed a preference to be asked about 'social 
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functioning' and 'mental health' (<70%). The administration of the SF36 increased 
the patients' satisfaction with care, but feedback of these instruments did not affect 
the degree to which physicians were perceived as having asked about'health status 
overall'. No data were presented to examine the degree to which feedback of SF36 
results increased the degree to which mental health problems were discussed or 
detected. 
Another study, by Reilfer et a/. (1996) showed no change in either clinician or patient 
satisfaction with care following the administration and feedback of the diagnostic 
interview schedule. Similarly, the study by Williams et a/. (1999) showed no effect 
on patient satisfaction with the care they received, although clinicians who received 
feedback, generally said that they had found the information useful (although no 
direct comparison with control physicians was possible). 
The study by Mazonson et al. (1994) included a patient interview amongst those 
who received treatment for anxiety. Feedback seemed to increase the tendency of 
clinicians to be more proactive in raising the problem of anxiety and need for 
treatment. Amongst those who had their scores fedback and received treatment, 
67% reported that their physicians had been proactive in initiating treatment, 
whereas amongst those whose scores were not fed back, only 33% reported that 
the physicians had taken the first step in suggesting treatment. 
Other outcomes 
No study examined the costs and resource use associated with routine outcome 
measurement. No study examined patients' views about the usefulness or 
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Chapter 27 Discussion of the main results of the review 
This review set out to examine the effect of routine outcome measurement on the 
actual outcome of those with mental health problems. However, it has only 
succeeded in identifying evidence relating to one aspect of this: viz, the effect of 
routine outcome measurement on the detection and management of minor 
psychiatric disorders in general practice and the general hospital. There is no 
robust research evidence on the effect of outcome measurement on the 
management of patients in psychiatric settings. The significance of the available 
research will now be examined, together with a discussion of the reasons for and 
implications of the paucity of research into routine outcome measurement in 
psychiatric settings. 
Methods of the review 
Traditional (non-systematic) review articles in this area (Meakin, 1992; Wright, 
1994a) have produced contradictory recommendations without any clear indication 
as to how their authors have arrived at their conclusions. The present review, in 
contrast, produces a series of conclusions with a clear and explicit outline of the 
methods by which those conclusions were arrived at. This demonstrates the major 
advantage of systematic reviews over traditional review articles. The present 
research is also novel in that it represents the application of a systematic review 
methodology to an area that has hitherto not been widely examined in this way - Viz 
quality improvement strategies for mental healthcare. 
The review has used both quantitative and non-quantitative methods to summarise 
this research, demonstrating that there is a place for the application of techniques 
such as meta-analysis, alongside a systematic description of the relative strengths, 
limitations and results of individual pieces of primary research. A number of 
methodological aspects of this review deserve further discussion. 
Literature searches. 
Large amounts of literature needed to be searched in order to obtain only a 
relatively small number of relevant studies. This demonstrates the difficulties that 
are inherent in searching for literature in this area, and the need to search multiple 
databases, and to use broad search strategies, with the expectation that searches 
will still be relatively insensitive. Medline proved to be the most fruitful of the 
databases searched, although important studies would have been missed if this 
database had been the only source of references. The present study has built upon 
existing search strategies for literature pertaining to outcomes (Brettle, et al., 1998), 
and adapted them for use in other important databases. Further research is needed 
in order to establish the precision and recall of these strategies in identifying mental 
health outcomes studies. 
It is possible that further research exists which was not identified within the literature 
search strategies. Some of this emerged following the publication of this review in a 
paper journal, and highlights the advantages of publication in peer reviewed journals 
in enhancing the quality and comprehensiveness of the review. Similarly, data 
were left unreported in several studies, but which potentially could have been 
included in this review. The present review is therefore still likely to incomplete, but 
will be published and updated in line with existing and emerging data as reviews 
within the Cochrane library. For example, the study by Lewis, et a/. (1996) contains 
unreported data on the rates of recognition of depression by general practioners, 
which the first author has pledged to make available, but which were not available at 
the time of writing. 
Examination of heterogeneity and publication bias 
The research included in the present review was subject to a large degree of 
heterogeneity. This became apparent when the methods and results of individual 
studies were described in a systematic way. For example, some studies were so 
radically diverse in their choice of population, setting, and intervention as to be too 
heterogeneous to consider for inclusion in a quantitative synthesis. One of the 
leading authorities on the examination of heterogeneity within meta-analyses has 
asserted that it is not just sufficient to test for heterogeneity, but the point is to look 
for causes (Thompson, 1995). 
Important sources of heterogeneity that might not have been predicted in advance 
were those relating to the mode of administration and feedback of outcomes 
measure (the 'unselected' versus 'high risk' approach). The present study illustrates 
the complementary nature of quantitative and more qualitative approaches to the 
examination and exploration of sources of heterogeneity. The use of separate 
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statistical pooling for divergent approaches to feedback can be defended on both a 
statistical and an intuitive basis. The clinical implications of 'unselected' versus 'high 
risk' feedback are explored in more detail in the following sections. 
An important strength of the present study was also the steps that were taken to test 
the robustness of some of the meta-analyses that were performed. Where the 
inclusion or exclusion of some methodologically heterogeneous studies might be 
subject to debate, the robustness of the overall meta-analytic result to the presence 
or absence of these studies was tested. The results of the meta-analysis of 
unselected feedback of psychological outcomes measures to non-specialists can, 
with some certainty, be said to be a consistent and robust finding. It will be 
interesting to know how this result stands up to the inclusion of further data that will 
be included in further versions of this review. 
It was noted in the method section that an important though often overlooked step in 
the conduct of a review is the examination of publication bias. The present review 
has highlighted two problems in the examination of the influence of publication bias- 
the difficulty in applying tests for publication bias, and the difficulty in interpreting the 
tests that are used. 
All published forms of research are potentially subject to publication bias, and there 
are reasons why psychiatric research is likely to be just as susceptible as research 
in other areas and specialities (Gilbody & Song, 2000). Conventional tests for 
publication bias, such as the funnel plot, rely upon two criteria being satisfied: First, 
studies must be sufficiently similar in terms of participants and interventions to justify 
a formal statistical pooling in the form of a meta-analysis. Secondly, the published 
literature must include a sufficient number of studies with a wide range of sample 
sizes, providing a mix of smaller studies and one or more larger studies with which 
to construct a funnel plot. 
When applying this method of analysis to the group of studies that included the 
detection of mood disorders as an outcome following feedback, then the second 
criterion was fulfilled, with a range of study sizes between 80 and 1996. However, 
for reasons outlined previously, there was felt to be substantial heterogeneity 
between studies, making the overall application of meta-analysis difficult to justify. 
When a funnel plot was applied, then the asymmetrical plot that was obtained was 
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likely to be a reflection of underlying heterogeneity, where this was also a function of 
sample size. Egger, et al., (1997) urges caution in making the assumption that 
asymmetrical funnel plots are only indicative of publication bias, and the present 
review provides an interesting example of this. Petticrew, et a/., (1999) have also 
demonstrated the potential for heterogeneity to produce asymmetrical funnel plots, 
where differences in effect size were related to the underlying quality of 
observational research in the area of heart disease. 
Cluster randomised studies 
Studies designed to evaluate quality improvement strategies should ideally use 
randomisation by cluster (Ukoumunne, et al., 1999b). In the case of studies 
designed to answer the question addressed in the present review, it should be 
individual clinicians or clinical teams who are randomised to receive feedback of 
outcomes measures, in order to prevent cross contamination between individual 
patients. Nine of the twenty four studies randomised by cluster, but were not 
correctly analysed, with analysis taking place at the level of the individual patient, 
without due consideration of the effect of clustering. None of the studies included in 
the quantitative syntheses used cluster randomisation. The clinical implications of 
the failure to conduct clustered studies when this was the appropriate design to use, 
and the inclusion of potentially clustered data in systematic reviews deserves further 
comment. 
Previous reviews of quality improvement strategies (eg Grimshaw & Russell, 1993) 
have also generally found that these studies either fail to randomise by cluster when 
they should, or fail to analyse these data appropriately when they do randomise by 
cluster. The difficulties in handling clustered data stem form the fact that individuals 
within clusters share common socio-demographic features such as age, sex or 
social class - all of which are potentially related to outcome (Rice & Leyland, 1996). 
Traditional statistical approaches make certain assumptions, including the 
assumption that outcomes or events for different patients are in some way 
independent of each other. When randomisation by cluster occurs and outcomes 
are analysed at the level of the individual patient, then this assumption breaks down. 
Failure to recognise this fact in the analysis of data has been termed 'unit of analysis 
error' (Divine, et al., 1992), and leads to over optimistic estimates of sample 
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variance, unduly narrow confidence intervals and potential type 1 errors (finding an 
effect or association, when one does not exists). 
A number of approaches have been advocated in the inclusion of potentially 
misleading clustered studies in systematic reviews. Firstly one approach used by 
Grimshaw & Russell (1993) is to draw attention to the unsound nature of studies 
subject to a unit of analysis error. Another approach is to seek to correct for unit of 
analysis errors by seeking to find the level of correlation within clusters (expressed 
as the intra class correlation coefficient) from authors of studies, and to seek to 
correct the unit of analysis error by reanalysing the results of the study (Ukoumunne, 
et a/., 1999b). However, there remains substantial difficulty in subjecting clustered 
data, even when corrected, to meta-analytic pooling, since individual study variance 
estimates in conventional meta-analytic methods (eg DerSimonian & Laird, 1986; 
Mantel & Haenszel, 1959) do not allow for clustering. There remains no consensus 
regarding the appropriate way to proceed in the meta-analysis of potentially 
informative groups of studies, and this issue is currently being investigated by a 
methodological workgroup within the Cochrane Collaboration {Professor Mike 
Campbell, University of Sheffield, Personal communication November 2000). 
Attempts to deal with clustering in the present review were limited, since the authors 
of clustered studies in the present review did not reply to a request to provide intra- 
class correlation coefficient in order to correct a unit of analysis error. No studies 
included in the meta-analysis had utilised cluster randomisation, making the problem 
of how to handle these data in a quantitative analysis of academic interest only. The 
emergence of further studies, some of which may be clustered will necessitate re- 
evaluation of this approach and are likely to make the use of meta-analysis 
untenable for this set of studies. 
The negative result that was found for many outcomes (especially the effect of 
feedback on the rate of recognition of mood disorders) could have also resulted from 
the failure to use a correct unit of randomisation i. e. individual patients rather than 
individual clinicians. The cross contamination which potentially might have occurred 
between patients might have resulted in a dilution of effect, and a spurious negative 
result (type 2 error). It is likely that the very act of receiving feedback of outcome 
measures on some patients will influence how other patients, who do not have their 
outcome score fed back, will be managed. The following results, which are 
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discussed in more detail below, must therefore be considered alongside this 
inherent weakness of the research surveyed in the present review. 
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Clinical implications of the review 
Mood disorder questionnaires in non-psychiatric settings 
It is perhaps surprising that the uniform administration of well validated case finding 
instruments, such as the GHQ, with sensitivities and specificities of over 70 and 
90% respectively in their ability to detect psychiatric disorders (Goldberg, 1972; 
Goldberg & Williams, 1988), has not been found to influence actual clinician 
behaviour. Routine outcome measurement only becomes effective in increasing the 
rate of recognition of emotional disorders when there is some form of screening 
procedure, whereby an instrument is administered, scored by someone other than 
the clinician, and only those with high scores have their results fed back to the 
clinician (e. g. Rubenstein, et a/., 1995). Routine administration combined with 
selective feedback is, however, unlikely to form a model for routine practice, nor 
does it reflect current UK practice, since this strategy is likely to require that an 
additional person be employed in order to administer score and feedback outcomes 
measure to the clinician. 
There are a number of possible explanations for the observed result. First, it is 
predictive value (rather than sensitivity and specificity) which is of most interest to 
clinicians in the context of routine care - i. e. the proportion of those predicted by the 
test as having the disease who turn out to have the disease (Sackett, et a/., 1991). 
Crucially, positive predictive value increases according to the prevalence of a 
disorder in the population tested. Whilst unrecognised emotional disorders form a 
significant portion of the clinical caseload in non-psychiatric services, this is rarely 
going to exceed 15%. The consequence is that of those patients with a positive 
screening result, only 50% will turn out to actually have an emotional disorder (i. e. 
be 'true positives) (Hoeper, et al., 1984). Equally, the workload and outside referral 
rate is likely to rise dramatically if all positive test results are acted upon when 
positive predictive value is much lower than quoted sensitivities and specificities. 
Clinicians may intuitively recognise this fact and will be unwilling to act on positive 
test results (Goldberg, 1986). 
A major limitation of the research presented in this review is the fact that case 
definition of an emotional disorder (such as depression or anxiety) is generally 
based upon a questionnaire score above a certain cut off point, rather than some 
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gold standard, such as a standardised research interview. Thus, the principle trial 
endpoint - rates of recognition of emotional disorders - uses this imperfect form of 
case definition. Research shows that questionnaires consistently overestimate the 
true prevalence of clinically important emotional disorders (i. e. those worthy of 
intervention) e. g. (Feldman, et a/., 1987). It should perhaps therefore be less 
surprising that clinicians in this review uniformly ascribed far fewer patients as 
having emotional problems than did questionnaires. However, the negative result 
for feedback suggests that questionnaire results, in effect, add nothing to the clinical 
encounter. Calls for the routine application of such questionnaires in non-psychiatric 
settings (Wright, 1994a) are therefore not supported 
A second explanation is that non-psychiatrists do not feel best equipped to deal with 
emotional disorders, even when these are uncovered using screening 
questionnaires. Screening is therefore a necessary, but not sufficient, condition in 
facilitating the appropriate management of these psychological problems. 
Supporting this conclusion is the observation that feedback is most effective when it 
is accompanied by an educational programme and the provision of a dedicated 
outside referral agency who will readily assume responsibility for management 
(Mazonson, et a/., 1994). The results of the present review also complement recent 
research which shows that simple educational interventions, such as the provision of 
guidelines on the detection and management of depression in primary care have 
little impact (Thompson, et al., 2000). 
Worthy of further research is also the suggestion that some patient groups might 
benefit from the routine administration of psychiatric screening questionnaires more 
than others. For example the subgroup analysis by German, et al., (1987) suggests 
that the elderly may benefit more from routine administration and feedback of 
psychiatric questionnaires, as do men. Depressive disorders in these populations 
often present with non-specific somatic complaints (Goldberg & Bridges, 1988), 
which can prevent or delay the detection of mood disorders. However, whilst routine 
outcome measurement may increase the rate of detection of depression, this does 
not generally translate into increased rates of intervention. The ultimate goal of 
routine outcome measurement is to improve outcome, and the research strongly 
suggests that there is no benefit in this respect 
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Do available studies examine 'routine' outcome measurement? 
A key aim of the review was to examine the use of standardised instruments as 
outcome measures in routine care settings, and several of the studies in fact identify 
themselves as examining this question. However, as discussed in section 1 of this 
thesis, the measurement of 'outcome' is generally taken to mean the measurement 
of some facet of health status over time. In the context of routine care this would 
involve the serial application of the instrument, so that changes in the score might 
be incorporated into patient management in some way. However, all the studies in 
the current review involve the single administration of an instrument at an initial 
index episode, with no further application by the clinician at subsequent 
consultations. The use of outcome instruments in this context is essentially a form 
of screening (Fitzpatrick, 1994; Fitzpatrick, etaL, 1992a). 
Screening tests can only be justified if the instrument is (1) accurate; (2) results in a 
more effective treatment than would otherwise be the case and; (3) does so with a 
favourable ratio of costs to benefits (Cochrane & Holland, 1971; Mant & Fowler, 
1990). The accuracy of an instrument is traditionally determined by the examination 
of sensitivity, specificity and predictive value. Several of the authors justified the 
choice of their instrument with reference to its sensitivity and specificity as 
determined in prior validation. Only one examined or published these key 
psychometric properties within the populations that were recruited or randomised 
(Williams, et al., 1999). However, it is predictive value which is of most interest to 
clinicians in the context of routine care - i. e. the proportion of those predicted by the 
test as having the disease who turn out to have the disease (Sackett, et a/., 1991). 
Predictive value increases as the incidence of disease in the population under 
investigation increases and this is essentially what is happening when the 
instrument is administered to all patients and only those with positive score have 
their results 'fed back'. This is a likely explanation of the improved recognition by 
clinicians when feedback occurs with only 'high risk' patients as opposed to 
feedback with all patients. Further research might seek to evaluate the routine use 
of outcome measures using basic psychometric criteria such as sensitivity, 
specificity and predictive value. 
The second criterion which must be fulfilled for a screening instrument is that its use 
should result in effective treatment. The evidence outlined in the present review 
shows that this is under researched, and the research that has been conducted is 
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not generally supportive. Routine feedback generally does not change clinical 
management and when actual outcome is studied, then this is generally not shown 
to improve (e. g. Dowrick & Buchan, 1995). The last criterion to be satisfied is that 
the benefits of screening should outweigh cost. Cost can include the costs 
(monetary, time and forgone opportunity) incurred through the introduction of routine 
outcome measurement, and no studies in this review measured this. Additionally, 
cost involves the harm which might be done through routine outcome measurement 
in terms of the initiation of treatment for those wrongly identified as having some 
psychological disorder ('false positives'), or the initiation of resource intensive 
referral or intervention for those who might be identified as having some emotional 
problem, but which might be self limiting. Further research is needed in all these 
respects and in the absence of such research, then it would be imprudent to 
recommend the introduction of routine outcome measurement in routine care 
settings. 
The use of generic patient based measures. 
Despite the enthusiasm for recently introduced generic health status measures, 
such as the SF-36, there is no robust research evidence to support their value as 
routine measures of outcome in psychiatric settings. However, there is some 
tentative research evidence to support their use to facilitate the recognition of mental 
health problems in non psychiatric settings (Rubenstein, et al., 1995). As is 
discussed above, the adoption of routine outcome measure in individual patient care 
is not without cost, and there is at present insufficient evidence to justify this. It is 
possible that benefit cannot and will not ever be demonstrated for the routine use of 
these measures in individual patient decision making, since this is a purpose for 
which generic instruments are not designed. In particular, the psychometric 
properties of such measures are such that scores on these instruments are un- 
interpretable at an individual patient level (McHorney & Tarlov, 1994). Generic 
outcomes measures are essentially designed to evaluate healthcare and to identify 
need at a population level (Ware, 1995), and extrapolation of use beyond this is not 
justified. 
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Routine measurement of outcome in psychiatric settings. 
National mental health research and policy initiatives, such as the development and 
adoption of the Health of the Nation Outcome Scales (HoNOS) (Wing, 1994) are 
dependant upon individual clinicians collecting these data in the context of routine 
care (Stein, 1999). For clinicians to be willing to collect such data for each and 
every patient there must be some value in terms of improving the management of 
the individual patient. No such evidence was found to support its implementation in 
the context of routine care 
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Section 4 Overall discussion of the use outcomes 
measures in psychiatry 
The thesis began by presenting an overview of the wider outcomes movement 
in healthcare; examining the origins of this movement and the implications of 
this shift towards outcomes measurement and the introduction of more patient 
based measurement instruments. The original research presented in this 
thesis has largely been an exploration of this outcomes movement and patient 
based outcomes measurement within psychiatric research and practice. 
Surveys of psychiatric research found that outcomes measurement in 
psychiatry is dominated by the measurement of symptoms, with little explicit 
adoption of patient based measures. Interestingly, it was found that a minority 
of trials has for some time incorporated the measurement of domains of patient 
based outcome - such as social functioning. 
A survey of the measurement of outcome within a less well-known or less 
widely used research design - outcomes research - was conducted. 
Outcomes research is purported to bridge the gap between psychiatric 
research and practice, since it incorporates those outcomes collected in the 
context of routine practice in order to provide an alternative to randomised 
trials. With notable exceptions, similarly limited sets of outcomes were found 
to be used in outcomes research as were found in clinical trials. The primary 
problem with outcomes research is the time and expense involved in the 
collection of a diverse and comprehensive set of outcomes in routine care 
settings. 
The difficulties inherent in collecting outcomes data in the context of routine 
care settings was further explored in a large-scale survey of UK consultant 
psychiatrists. This survey presented the first overview of current UK practice, 
and found that clinicians do not routinely measure outcome (patient based or 
otherwise) in the context of their routine practice. Substantial practical and 
attitudinal barriers were identified to the collection of standardised outcomes 
that will need to be addressed if current UK mental health policy is to be 
implemented. 
Lastly, the first systematic review was undertaken in order to examine what 
evidence, if any, exists to support the benefits of routine outcomes 
measurement in improving the quality of care that is offered to those with 
psychiatric illness. There is no evidence to support the routine collection of 
outcomes measures in routine psychiatric care settings. When evidence to 
support the use of routine outcomes measures in non psychiatric care settings 
is explored, largely in the form of psychiatric case finding instruments, then a 
substantial body of research shows this to be an ineffective strategy. 
The implications of the original research presented in this thesis will now be 
considered, with reference to psychiatric practice, policy and research. 
Implications for mental health practice 
Clinicians are increasingly encouraged to incorporate research evidence, such 
as the results of randomised trials, into their everyday practice (Sackett, et al., 
1991). A key finding of the surveys of how outcome is measured in clinical 
trials and what clinicians actually collect and use in their own practice is that 
there is little correspondence between practice and research. Outcome in 
clinical trials, particularly in drug trials, is measured using complex 
psychopathological rating scales. These are rarely used in clinical practice, 
and it is doubtful that clinicians who have little familiarity with these instruments 
can interpret the meaning of small changes on these rating scales. Small 
changes on symptom based psychopathology rating scales are the major 
criterion for success or otherwise of interventions in randomised trials. The 
uptake of new technologies, such as new drug entities, therefore happens for 
reasons other than the results of evidence from randomised trials, when this 
evidence is based upon unfamiliar outcomes that are difficult to interpret. A 
greater correspondence between research and practice will therefore require 
either clinicians to begin using the outcomes instruments that are used in 
clinical trials or researchers to begin collecting and reporting those outcomes 
that are of genuine interest to clinicians. From the results of the survey of 
clincians, these measures are unlikely to be complex psychopathological rating 
scales. 
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The survey of clinical practice showed a general reluctance amongst clinicians 
to collect outcomes and gave insight into the reasons behind this. It was clear 
from some of the comments made by clinicians that they perceived 
standardised outcomes measures to be 'research tools', rather than 
instruments that could be easily incorporated into their routine practice. 
Unfortunately, the surveys presented in this thesis did not explore what 
outcomes clinicians would like to see collected in evaluative research. This is 
topic for further research, and is explored in more detail below. 
The rhetoric of outcomes measurement outlined in section 1 and highlighted in 
important mental health policy formulations (Department of Health, 1991; 
Department of Health, 1998; Marks, 1998; Secretary of State for Health, 1999, 
Slade, et a/., 1999) has not permeated clinical practice. Standardised 
measures do not generally form a part of the routine care of those with 
psychiatric disorders such as schizophrenia, nor are they used as measures of 
outcome by their serial application over time in order to measure change. The 
development of patient based measures and measures of psychosocial need 
has generally not resulted in these measures and instruments being used in 
the day to day care of those with common mental disorders being looked after 
in UK mental health services. This represents a major disparity between 
mental health policy and actual clinical practice, which had previously been 
alluded to (Slade, et al., 1999), but which had not otherwise been empirically 
demonstrated. 
Substantial barriers to the routine use of outcomes were identified and include: 
lack of familiarity with instruments; the length of time taken to complete 
measures; lack of resources made available with which to adopt routine 
outcomes measures and a lack of faith in the basic psychometric properties 
and real world relevance of available measures. Importantly, some clinicians 
questioned the clinical and cost effectiveness of routine outcomes 
measurement as a technology. 
Clearly, if psychiatrists are going to use standardised measures of outcome, 
including patient based measures, in the course of their day to day practice, 
then each and every one of the barriers identified in the survey will need to be 
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addressed. Importantly, the resources required in implementing routine 
outcomes measurement have not been made available in UK mental health 
services. This lack of investment in outcomes measurement was highlighted 
by a number of clinicians within the survey of the UK practice. However, in 
advance of the investments that would be need to be made in order to make 
routine outcomes measurement work, a more fundamental question about 
whether outcomes measurement is a worthwhile activity needs to be asked. 
The research presented in this thesis explicitly demonstrates for the first time 
the fact that mental health policy with respect to routine outcome measurement 
is being formulated in the absence of robust evidence of effectiveness in 
influencing practice or patient outcome. When research evidence was sought 
in order to answer this question, then none was found to have been conducted 
in psychiatric care settings. An important body of research evidence was 
found that showed that such an approach has not proved to be useful in non- 
psychiatric care settings. In the absence of a robust body of research, then the 
value of routine outcomes measurement remains unproven. The research that 
would be needed in order to demonstrate this benefit was discussed in some 
detail in Chapter 26, and further explored below. Similarly, the reasons for the 
major disparity between mental health practice and policy formulation are 
explored in more detail below. 
We can speculate as to whether the investment in outcomes measurement as 
a technology would result in its adoption by clinicians. Clinicians are unlikely to 
change their practice unless they perceive some benefit to themselves or to 
the patients in the care that is delivered. Similarly, patients are unlikely to 
comply with the collection of repetitive and complex questionnaires unless they 
see some benefit to the care that they receive. Whilst available instruments 
are perceived as unwieldy, irrelevant and uninformative, then they will continue 
to represent a threat to effective care, rather than a tool with which to improve 
the quality and outcome of care. 
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This view was expressed by Alvan Feinstein (1967) more than 30 years ago, 
when he wrote: 
'The care of the patient is the ultimate specific act that characterises the 
clinician, and any classificatory system that cannot help in that will fail to gain 
acceptance' 
Feinstein stressed that the unless the clinician believes that an intervention 
would directly help the patent in the consulting room, or at the very least, in 
assisting in the diagnostic or clinical process, then the intervention will not be 
undertaken. 
Implications for mental health policy 
Recent mental health policy encourages the measurement of outcome. 
However, policy formulations to measure outcome on a routine basis have 
essentially been 'top down', with little consideration of the time and resources 
involved. Two high cost and high profile research and development activities 
serve to illustrate this approach. The Health of the Nation Scale has been 
developed at substantial cost as a tool to evaluate the success or otherwise of 
health policy formulations (Wing, 1994). The HoNOS forms a core component 
of a battery of outcomes measures that all clinicians and Trusts are (at the time 
of writing) to be forced to collect as a matter of routine - this battery is known 
as 'the minimum data set' (Glover, et al., 1997). 
The survey of UK consultants in this thesis has shown that they are less than 
keen to collect these data, and that Trusts have little experience or success in 
encouraging their clinicians to collect data as a matter of course. What Trusts 
seem to have uniformly done is collect those administrative outcomes that are 
easy to collect (such as length of stay and readmission rates), and which form 
part of the Performance Management Framework outlined in recent health 
policy documents (Department of Health, 1998; Secretary of State for Health, 
1999). Similarly, it is these data that are fed back to clinicians and form the 
mainstay of audit activities, despite the aspiration that audit would be a more 
patient centred approach (Frater & Costain, 1992). Recent evidence on the 
collection and publication of routinely collected performance data in Scotland 
suggests that such data are largely ignored in the planning and improvement 
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of clinical services (Mannion & Goddard, 2001). The survey of UK consultants 
provides empirical support that this observation is also true in the planning and 
improvement of mental health services. UK psychiatrists gave few examples 
of positive experiences or knowledge of routinely collected outcomes data 
being used in the planning or improvement of clinical services, and many 
believed that the data they were asked to collect was a bureaucratic exercise. 
Mannion & Goddard (2001), in their exploration of the impact of routinely 
collected outcomes in changing clinical practice and in improving the quality of 
care identify several major themes which are germane with those highlighted in 
the present thesis. Outcomes data have little impact when they are not 
perceived as being credible in terms of their quality or relevance. Similarly, the 
timeliness of outcomes data, when there is a substantial delay between their 
collection and feedback hampers their impact. The absence of any 
programme of training and facilitation in the interpretation and appropriate use 
of outcomes data also makes their collection and feedback a bureaucratic 
exercise. 
This distortion of the behavior of organisations that also occurs when there is a 
pre-occupation with a small number of easy to measure outcomes indicators 
was discussed in Chapter 22 (see Davies & Lampel, 1998; Smith, 1996a). It is 
clear from the survey of clinical practice that those measures that are collected 
by Trusts are those that are easy to measure, rather than those that are of 
importance or value. This was a widely held perception amongst clinicians. 
There is a very real danger that the elevation of easy to collect data, rather 
than clinically meaningful data, to the position of a performance indicator will 
adversely affect the outcome of patients, or will at best, confer little advantage. 
The perverse consequences of the limited focus on routinely collected 
outcomes measures are summarised in table 30. Davies & Crombie (1997) 
have highlighted the need for studies that examine the impact on organisations 
and individuals of the regular feedback of outcomes data. 
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Table 30: Perverse consequences of a limited focus on outcomes 
measures 
(after Davies & Crombie, 1997; Smith, 1996a) 
Tunnel vision Concentration on those areas in the outcome set, to the exclusion of 
other important areas 
Suboptimisation The pursuit of narrow objectives within a unit or organisation at the 
expense of strategic co-ordination with others 
Myopia Concentration on short term issues to the exclusion of long term criteria 
Ossification A disinclination to experiment with new and innovative practices 
Convergence An emphasis on not being exposed as an outlier rather than a desire to 
be outstanding 
Gaming The alteration of behaviour to gain strategic advantage 
Misrepresentation Including creative accounting and fraud 
The survey of UK psychiatrists identified substantial barriers to the routine use 
of outcomes measures by clinicians that will have to be addressed if current 
mental health policy is to be implemented. Most importantly, the whole value 
of routine outcomes measurement is called into question by the research 
presented in this thesis. On the basis of the research, there are very good 
reasons to suppose that mental health policy that involves and relies upon the 
routine collection of standardised measures is likely to be unsuccessful. 
Further research (see on) should precede the further implementation of this 
strategy. 
Mental health policy, with respect to routine outcomes measurement, is 
therefore formulated either in the absence of evidence or in the face of 
evidence that shows it to be ineffective. The drivers of this urge to measure 
outcomes are therefore political and sociological. The reasons for this urge to 
measure outcomes were discussed in detail in section 1, and included the 
pressure to be seen to measure things in order to establish what works, and to 
be seen to be improving the quality of care that is delivered. Michael Power 
(1997) places the urge to collect and measure things within a wider context of 
increased accountability of professions and institutions, and the need to 
demonstrate value and worth. He outlines 'rituals of verification' which have 
sprung up in all spheres of the public sector, with little thought about the 
effectiveness or consequences of these changes. 
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Implications for mental health services research 
Limitations of existing random ised-controlled trials are all too evident in 
psychiatry. These include limited external validity, and the collection 
uninformative outcomes. These limitations are highlighted in the survey of 
randomised trials in the present thesis. The need to address these 
shortcomings was one of the motivating forces behind the development of 
techniques such as outcomes research, whereby routinely collected data are 
harnessed in order to establish what works and for whom within routine care 
settings (Wennberg, 1991). The present thesis has highlighted both the 
potential and the limitations of this approach. Within the context of UK mental 
health services, there is little prospect of the successful adoption of outcomes 
research when clinicians are demonstrably so reluctant to collect outcomes, 
and when the outcomes that they do collect fall so far short of the patient 
centred approach advocated by proponents of outcomes research. Outcomes 
research in mental health, as expounded by Wells (1999) and Marginson eta/., 
(2000) will not become viable until the barriers to the collection of routine 
outcomes measures, outlined above, have been addressed. In the meantime, 
outcomes research that utilises the limited clinical data collected within UK 
mental health services should be interpreted with caution. 
Two major strands of further research are identified as priorities by the 
research presented in this thesis. The first relates to the use of patient based 
outcomes as instruments in psychiatric research. The second relates to 
important research that needs to precede the implementation of outcomes 
measurement in routine clinical care settings. 
The diversity and lack of coherence in outcomes measurement that has been 
demonstrated in the surveys of clinical evaluations deserves clear thought 
about what instruments should be used, for whom and in what settings. 
Psychiatric research has a strong tradition of patient based outcome 
measurement, as evidenced by the measurement of social functioning. 
However, more recently developed measures of patient based outcome, such 
as health profiles and health utility measures, have not been widely used. 
Basic research is needed to judge the potential of these measures to be used 
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within clinical evaluations in psychiatry. Recent methodological reviews 
conducted under the auspices of the NHS Health Technology Assessment 
Programme provide a source of guidelines as to how these questions should 
be tackled (Brazier, et al., 1999; Fitzpatrick, et a/., 1998). Table 31 provides 
the key properties and dimensions which must be satisfied by patient based 
outcomes measures in order that be used within clinical trials. 
Table 31: Essential properties of a patient based outcome measure 
(Fitzpatrick, et a/., 1998) 
Appropriateness Is the content of the instrument appropriate to the question that 
the clinical trial is intended to address? 
Reliability Does the instrument produce results that are reproducible and 
internally consistent? 
Validity Does the instrument measure what it claims to measure? 
Responsiveness Does the instrument detect changes over time that mater to 
patients? 
Precision How precise are the scores of the instrument? 
Interpretability How interpretable are the scores of the instrument? 
Acceptability Is the instrument acceptable to the patients? 
Feasibility Is the instrument easy to administer and process? 
The wide variety of standardised outcomes measures that are available and 
are used in clinical trials in psychiatry also deserves further consideration. 
Rheumatology is a speciality that found its research evidence to be bedevilled 
by similar problems to psychiatry, particularly the abundance of disparate 
measurement techniques and instruments. A key stage in the evolution of 
outcomes measurement in rheumatology was the construction of a core 
battery of outcomes measures, the use of which was widely prompted as good 
practice by leading researchers (Felson, et al., 1993; Tugwell & Boers, 1993). 
Unfortunately, the choice of method and outcomes that are explored in 
psychiatric research is largely influenced by the main sponsor of research (the 
pharmaceutical industry) and its needs. This is in turn dictated by drug 
regulation bodies and the outcomes that they demand as sufficient evidence of 
efficacy in order that a drug is granted a licence. A clear indication by the 
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major drugs licensing bodes, such as the Food and Drug Administration and 
the Medicines Control Agency, that they will demand evidence of benefit in 
terms of patient based outcomes would encourage the adoption of these 
measures. 
The lack of evidence to support the adoption of routine outcomes 
measurement is perhaps the most important finding of the current thesis. 
Having described the importance of the questions, and having laid out a clear 
argument both for and against the collection of outcomes data, then a 
systematic review was conducted. In advance of conducting the research 
contained in this review, it was taken as an article of faith by the present author 
that outcomes measurement was a 'good thing', and a worthy activity. It was 
anticipated that the important gaps in the research knowledge base that would 
be identified would be those surrounding the basic implementation of 
outcomes measurement as an activity or technology. 
The argument was thought to be germane to that of guidelines in healthcare. 
Guidelines have come to be seen as a 'good thing', that have potential to 
influence practice for the better. The important questions relating to guidelines 
are about their construction such that they are credible and evidence based, 
and about how they should be adopted or implemented in order that they 
change practice (NHS Centre for Reviews and Dissemination, 1994; NHS 
Centre for Reviews and Dissemination, 1999b). 
This is clearly not the case for routine outcomes measurement. Given the 
enormity of the task involved in encouraging reluctant clinicians to collect 
outcomes, then there needs to be demonstrated benefit in terms of the 
potential of routine outcomes measurement, as an intervention, to benefit both 
clinicians and patients. Chapter 27 has outlined what sort of evidence would 
be needed in order to demonstrate or refute the value of routine outcomes 
measurement, viz cluster-randomised trials conducted in routine care settings. 
In the absence of this evidence, then health practice and health policies are 
unlikely to shift from their current position of reluctant and ineffective collection 
by clinicians and healthcare systems and inevitable policy failures. 
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Background 
In order to determine whether a treatment or intervention is effective, it is 
necessary to systematically measure the outcome of that intervention - ideally 
in the context of a robust clinical experiment, such as a randomised trial. 
Outcome in medicine has traditionally been measured in terms of mortality and 
biophysical parameters, such as radiological, clinical and laboratory 
assessments. However, there is a growing body of opinion that such 
traditional measures are inadequate, since they do not reflect the impact of 
diseases or illness on the individual, nor do they reflect the experience of 
illness form the patients' perspective (Jenkinson, 1995; Lohr, 1988). Patient 
based instruments have emerged to augment this perceived inadequacy of 
traditional outcome measurement (Fitzpatrick, et al., 1984). These patient 
based instruments have been variously called Quality of Life measures; Health 
Status measures; Health Related Quality of Life measures; and functional 
status measures (Bowling, 1997). A unifying feature is that they tend to 
examine some combination of the following domains: physical functioning; 
social functioning, - role functioning, - mental well being; and general health 
perceptions (Ware, 1995). Such measures also give prominence to the 
patients' own evaluation of these domains, in that they are often (but not 
always) completed by the patient, rather than the clinician. 
There is a strong tradition of measurement in psychiatry, where standardised 
measures have evolved, often as the basis of diagnostic classification systems 
which record or count clinician-elicited symptoms in order to form a psychiatric 
diagnosis in a reproducible manner (Hamilton, 1976). This tradition has 
facilitated important research into, for example, the population incidences and 
natural history of common psychiatric disorders (e. g. (Reiger & Kaelber, 1995, 
Sartorius, et al., 1986)) and their aetiological risk factors (e. g. (Shepherd, et a/., 
1989)), However, the measurement of psychiatric symptoms has also become 
the basis of how outcome is measured in evaluative research in psychiatry. 
For example, trials investigating drug treatments for depression almost 
uniformly use symptom based measures of depressive disease severity (such 
as the Hamilton Depression Rating Scale (Hamilton, 1967)) as their primary 
measure of outcome (Song, et al., 1993), whilst patient based outcome is 
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largely ignored (Hotopf, et al., 1997). Similarly, evaluative research in 
schizophrenia gives primacy to the measurement of symptoms such as 
delusions and hallucinations (Thornley & Adams, 1998) using instruments such 
as the Positive and Negative Syndrome Scale (Kay, 1991), but generally fails 
to measure patient based outcomes, such as health related quality of life 
(Awad, 1992; Collins, et al., 1991; Meltzer, 1999). The research knowledge 
base in psychiatry therefore generally uses symptom reduction as its primary 
outcome and judges the value of its treatments according to this criterion. 
Despite this general trend a number of patient based measures have been 
developed or applied in psychiatry to supplement symptom based measures. 
For example important disease specific patient based measures are available 
for use in psychiatric populations (e. g. (Lehman, 1983b)). Similarly, generic 
patient based measures such as the Short Form 36 (Ware, et a/., 1993) have 
been developed to be applied across different patient populations and different 
diseases in order to provide a common metric of health related quality of life. 
Measures such as the SF36 have been shown to be applicable to psychiatric 
populations (Russo, et al., 1998), and have been adopted as outcome 
measures in psychiatric research (e. g. (Simon, et a/., 1996; Tunis, et al., 
1999)). 
The theoretical foundation of the recent enthusiasm for patient based 
measures is the assertion that they examine a potentially different facet of 
outcome from conventional measures. Consequently, the results obtained 
from a patient based measure may not be the same as the results from a 
conventional measure. Thus, for example, a person may report improvement 
on a patient based outcome measure, whilst showing no improvement on a 
conventional measure of psychiatric symptomatology (or vice versa). 
We therefore decided to examine the empirical basis of this assertion in 
psychiatry by examining whether a different result or answer is obtained in 
evaluative research when a patient based measure is used alongside a 
conventional symptom based measure of outcome. 
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Aims and objectives 
The aim of the present study is to examine the inter-relationship between 
patient based and symptom based outcome in high quality evaluative 
psychiatric research. 
The specific objective is to examine whether the results which are obtained 
from patient based measures differ in direction or magnitude from the results 
that are obtained from symptom based measures. 
Methods 
In order to examine the relationship between patient based and symptom 
based outcome, we sought all examples of high quality research which used a 
patient based measure alongside a symptom based measure. The following 
inclusion criteria and operational definitions were adopted. 
Study inclusion criteria 
Randomised trials form the least biased method by which differential outcome 
can be assessed between competing interventions (WHO, 1991). We 
therefore sought English language reports of randomised trials of psychiatric 
interventions that fulfilled the following criteria- 
1. Truly randomised (not q uas i-experi mental or non-randomised control 
design) 
2. Measuring the efficacy or effectiveness of an intervention. 
3. Includes a psychiatric population (i. e. where the primary reason for 
inclusion in the study is the presence of a common functional 
psychiatric disorder such as depression, anxiety, schizophrenia or 
manic depressive illness). 
4. Uses both a patient based measure and a symptom based measure to 
record outcome (see below for definitions). 
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Patient based outcome measures 
A study was defined as having employed a patient based outcome measure if 
the measure was explicitly referred to as a measure of Health Status; Quality 
of Life; Health Related Quality of life; functional status. 
Additionally, any measures which could not be clearly classified as patient 
based outcomes according to the above were included if they contained two or 
more of the following domains: physical functioning; social functioning; role 
functioning; mental well-being; cognitive capacity; general health perceptions & 
subjective well-being. A series of operational definitions for these domains 
were adapted from (Ware, 1987; Ware, 1995). The content of individual 
measures was first ascertained from the text of the study, and if it's eligibility 
was still unclear, then its content was established from the cited reference 
supporting the instrument or a standard text summarising the content of many 
patient based measures of outcome (Bowling, 1997). 
Instruments that examined only one of these domains were excluded. For 
example, instruments that measure only social functioning were not considered 
to be patient based measures, since they are limited in their scope. Similarly 
instruments which measure symptoms of common psychiatric disorders such 
as depression or anxiety have been classified as patient based measures by 
some authors (e. g. (Sanders, et aL, 1998)), but are not classified as such here, 
since these are both limited in scope and also dominated psychiatric 
symptoms. 
Studies which employed unpublished scales (i. e. those which did not have a 
supporting reference to outline its basis and psychometric properties) were not 
included, since they have recently been shown to be an important source of 
bias, and therefore potentially confounding influence (Marshall, et a/., 2000). 
Symptom based measures 
A study was defined as having employed a symptom based measure if it 
contained a standardised measure that was broadly made up of items which 
measured symptoms and signs associated with the underlying psychiatric 
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disorder under investigation. Core symptoms were taken from standard 
textbooks of psychiatry and the DSM (American Psychiatric Association, 
1994), where this was unclear. Again, only studies that employed published 
scales were included to eliminate this source of bias (Marshall, et al., 2000). 
The literature search. 
Electronic searches were undertaken of the following databases in order to 
identify potentially relevant trials: Medline; Embase; Cinahl; Psycl-it; Cochrane 
Controlled Trials Register. 
The search strategy used combined two sets of search terms relating to the 
target patient population and the use of patient based measures. - 
Patient population: a search strategy is used which captures publications 
relating to all forms of mental illness using MeSH terms. 
Patient based measures: an already developed search strategy is used which 
has been shown to have acceptable sensitivity and precision in identifying 
research which relates to or includes patient based outcome measures 
(Brettle, et al., 1998). 
The Cochrane controlled trials register contains records of randomised trials 
identified by handsearches of a number of psychiatric journals. In addition we 
hand searched the following journals, which regularly publish evaluative 
research that employs patient based outcome measures: Medical Care (1972- 
2000); Quality of Life Research (1993-2000). 
A further source of trials was the Cochrane database of systematic reviews. 
All reviews published by the Cochrane Schizophrenia Group and the Cochrane 
Depression, Anxiety and Neurosis Group were examined to check for included 
trials which reported the use of patient based outcomes. Lastly, we searched 
an ongoing database of trials maintained by the Cochrane Schizophrenia 
Group which includes a brief summary of the scope of the specific outcomes 
measures which are employed in each trial (Adams, 1998). 
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Data extraction 
The following data were extracted from each eligible trial, and entered into 
standardised electronic data extraction form: 
0 Background information 
Patient population and underlying psychiatric problem 
" Type of intervention 
" Setting 
" Name of patient based measure 
" Content of patient based outcome measure (domains which are 
included) 
" Mode of completion of patient based outcome measure (interviewer 
completed, patient completed) 
" Name of symptom based measure 
" Mode of completion of symptom based measure (interviewer 
completed, patient completed) 
Study results 
For both symptom based and patient based outcomes the following were 
extracted where possible. 
Significant/non significant result 
A result was said to be significant if it reported a between group difference at 
less than the p=0.05 significance level, or reported a 95% confidence interval 
which did not include a null result at some point in the trial. Results based on 
overall (summary) scores from a scale were considered in the first instance. 
Claims of significance based upon analyses of individual items or sub- 
components of a scale were ignored. However, several measures were found 
to report a 'profile' of their various component domains of outcome. For 
example, the SF36 is generally presented as a profile of its eight components 
of health related quality of life, as is the Duke health profile (Parkerson, et al., 
1990). Where only profiles were presented, then a significant result was 
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operationally defined as being present when half or more of the individual 
profile items were significant at less than p=0.05. 
Favours treatment or control. 
For those studies that reported a significant result, the direction of that result in 
terms of favouring either treatment or control was established. Additionally, for 
studies where it was not clear what represented the treatment or the control, 
this was recorded. 
Magnitude of effect sizes. 
Where possible, data were extracted pertaining to the magnitude of change 
and between group differences for the scale under consideration. The 
following data were sought: 
Control group change scores and standard deviations 
Treatment group change scores and standard deviations 
Control group endpoint scores and standard deviations 
Treatment group endpoint scores and standard deviations. 
Between group differences in change scores (and standard deviations) 
Where standard errors or confidence intervals were reported, these were 
converted to standard deviations, according to accepted methods ((Altman, 
1991; Cooper& Hedges, 1994)). 
Choice of outcome measures. 
Where studies employed more than one potentially relevant symptom based or 
patient based outcome measure, then the following hierarchical decision rules 
were employed to determine which outcome should be included in the data 
analysis. 
1. If the authors clearly indicated which was the primary outcome of 
concern, then this was used. 
2. If only one outcome presented sufficient data to be extracted, then this 
was used. 
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3. If several outcomes were presented in sufficient detail to allow data to 
be extracted, then the first outcome to be reported (either in the text or 
in tabular form) was used. 
4. In cases where there was still confusion, then an outcome was selected 
at random; using computer generated random number tables. 
Reliability ofjudgements 
The reliability with which studies were included, outcomes chosen, and 
statistical significance established were examined in a subset of 10% of the 
potentially relevant studies by a second rater. Cohen's weighted kappa was 
calculated for each of these judgements (Cohen, 1968). 
Data analysis 
The effect of choice of outcome measure and the outcome observed in RCTs 
was examined in two ways. First by examining whether the choice of outcome 
measure influenced the chance of a treatment being shown to be statistically 
superior to a control condition. Second, by examining whether the magnitude 
of effect size was different according to whether a patient based outcome or a 
symptom based outcome measure was selected. 
Is the choice of outcome related to the chance of a significant result? 
The chance of a significant result being obtained was calculated by 
establishing a relative risk and attendant 95% confidence intervals from the 
following contingency table (Gardiner & Altman, 1989). 
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Favours treatment (p<0.05) nonsignificant result 
Patient based outcome ab 
measure 
Symptom based outcome cd 
measure 
What is the relationship between patient based outcome measures and 
symptom based measures in terms of magnitude and direction of effect? 
We obtained a standardised measure of effect size for both symptom based 
and patient based outcome measures from each trial, by calculating Cohen's d 
(Cohen, 1988) for the ith study, according the following formula: 
di=(Mexp 
-Mcont)/SDpooled 
Chosen means (Mexp -Mcont)were those which were most frequently reported in 
the included trials - i. e. either endpoint scores or mean change scores. 
A convention was adopted such that positive standardised effect sizes 
indicated benefit for the treatment group and the larger the magnitude of the 
standardised effect, the greater the magnitude of benefit. This generally 
required sign changes for symptom based measures, since higher scores 
indicate clinical deterioration and worse outcome. Conversely, high scores for 
patient based measures generally indicated patient improvement, and required 
no sign change. 
The relationship between standardised patient and symptom-based scores 
was examined graphically by constructing a scatterplot, and statistically using 
regression analysis. Since each point on this scatterplot represents the 
standardised estimate from a single study of variable sample size and 
dispersion (and therefore with variable precision of estimate) then a weighted 
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regression analysis was used. Studies were weighted according to the inverse 
of their variance (Hedges, 1982): 
weighti = l/variancei 
The variance for each individual study was estimated using the approximation 
of (Rosental & Rubin, 1982), where the variance for the Ah study was found 
according to the following formula: 
variancei = 2Nj/(8+dlý) 
Where Ni is the total sample size and di is estimated as previously. Thus, the 
largest studies and those with least dispersion contribute the greatest weight to 
this regression model. This approach is robust when sample sizes are 
approximately equal and greater than 10 in control and experimental groups 
(Hedges, 1982). Data that deviated from this assumption were excluded from 
the analysis. All calculations were conducted using STATA software (STATA 
corporation, 1999). 
Sensitivity analyses 
A number of 6 priori specified sensitivity analyses were conducted where there 
were sufficient data to allow this. The relationship between patient and 
symptom based outcome were examined separately for: 
0 Different mental disorders (e. g. depression and anxiety versus 
Schizophrenia and related disorders) 
0 Outcomes measures completed by different methods (e. g. patient 
completed versus physician completed measures). 
293 
Appendix 2: Electronic search strategies 
Search strategies for the thesis 
The search strategies employed in this thesis were designed and conducted in 
collaboration with an experienced information expert, Ms Kate Misso, at the 
NHS Centre for Reviews and Dissemination between 1998 and 2000 
The primary purpose of the literature searches was to collect primary research 
and review articles pertaining to patient based clinical outcomes in the sphere 
of psychiatry and mental health. 
Several sections of the present thesis draw upon searches of published 
literature. The literature searches were therefore designed to meet each of the 
overlapping requirements of several different reviews in different sections of 
the thesis 
In particular, the following were sought: 
1. Background papers, such as review articles, journal editorials, or 
opinion pieces, which discussed the use of patient based outcomes in 
the sphere of mental health. These form the basis of the literature used 
in Section 1. 
2. Outcomes research conducted in the sphere of mental health. These 
form the basis of the studies used in section 2. 
3. Controlled trials that examine the impact of the use of routine outcomes 
measures in the care of those with mental illness. These form the 
basis of studies used in section 4. 
Components of the search strategies - general comments 
A search strategy usually contains two elements (NHS Centre for Reviews and 
Dissemination, 2000): 
1. Search terms specific to the clinical area and type of intervention under 
consideration - such as disease type, intervention or area of speciality. 
2. Search terms specific to the study type under consideration - such as a 
controlled trial in the case of reviews of effectiveness 
The search strategies employed in this review concentrated on the former 
rather than the latter, since a wide variety of research designs and publication 
types were potentially needed in the series of reviews contained in this thesis. 
An initial decision was taken to be as inclusive as possible or practical in the 
conduct of search strategies. Traditional search strategies which are 
employed in systematic reviews using well honed search terms designed to 
identify randomised trials with maximum specificity and sensitivity were 
therefore not employed. 
Simple search strategies which employed the term 'outcome(s)' as a free text 
term produced unmanageable numbers of references, and were likely to miss 
studies which used one of the many synonyms for patient based outcome, 
such as quality of life and health status. This is likely to be due to the ubiquity 
of the term outcome in primary and secondary research, and the fact that this 
is a common subheading in the structured abstract of many journals 
(Anonymous, 1987). A level of refinement was therefore required. 
An initial scoping review of the literature revealed that some empirical research 
into the utility of various search strategies and databases relating either to 
outcomes or mental health had been conducted. 
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Searching for literature on outcomes 
Brettle, et a/., (1998) reported a series of iterations of search strategies 
developed in assembling databases for the now extinct UK Outcomes Clearing 
House, formerly based at the Nuffield Institute at the University of Leeds. 
Brettle, et a/., (1998) produced a series of 'filters' to be used by clinicians and 
librarians in order to retrieve information from MEDLINE pertaining to 
outcomes measurement. Three types of filter were produced which varied in 
their degree of efficiency in identifying literature on outcomes. These were 
termed basic, intermediate and comprehensive search strategies. The 
efficiency of search strategies is traditionally described in terms of precision 
and recall (McKibbon & Walker-Dilks, 1995), which are terms analogous to 
sensitivity and specificity in medical screening (Sackett, et al., 1991). 
Precision refers to the proportion of citations in a given search that are relevant 
to the search question, whereas recall refers to the proportion of relevant 
citations in a given search among the total possible relevant citations. Basic 
searches produce fewer references, but the proportion of those that are 
relevant to the underlying question is high - these are therefore precise, but 
have lower recall. More comprehensive searches obtain a large number of 
references, and include a greater number of total relevant references, but 
contain a large number of redundant citations - these are therefore less 
precise, but have greater recall. 
When the three search strategies were used on MEDLINE, in combination with 
mental health specific search strategies, an unmanageable number of 
references were obtained with the comprehensive strategy (see table 1). The 
strategy adopted in all searches was therefore based upon the 'intermediate' 
strategy of Brettle, et al., (1998). 
The three filters contained combinations of text words and medical subject 
(MeSH) terms relevant to outcomes measurement. Common to the three 
search strategies are the three MeSH healthings: health status indicators/, 
outcome and process assessment (health care)/; and outcome assessment 
(healthcare)/. These searches, together with their precision and recall are 
given in are given in full in table 1. 
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Results obtained from basic, intermediate and comprehensive 'outcomes' 
searches of MEDLINE 




Unfortunately Brettle, et a/., (1998) do not give any guidance regarding the use 
of similar filters in searching other databases (such as EMBASE and Psycl-IT), 
nor do they make recommendations about the value of other databases in 
identifying literature not held in MEDLINE. There are sound theoretical 
reasons why additional databases might need to be searched, particularly in 
relation to mental health (Adams, et al., 1992; Adams, et al., 1994). The filters 
described by Brettle, et al., (1998) were therefore adapted for use in other 
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Searching for literature on mental health 
A substantial amount of work has been conducted into the databases that are 
required to identify research literature (primarily controlled trials) for inclusion in 
systematic reviews in the sphere of mental health in general, and schizophrenia in 
particular. Hay, et a/., (1996) and Adams, et aL, (1994) recommend the use of 
MEDLINE, EMBASE and Psycl-IT, in searching for trials relating to eating disorders 
and schizophrenia. These databases were searched, in addition to three other 
databases that are likely to contain literature of relevance to a review of outcomes 
measures. Specific details of each of these databases are given below- 
9 Cinahl 
0 British Nursing Index 
0 Cochrane Controlled Trials Register 
Search terms have also been developed which are maximally sensitive in retrieving 
literature related to schizophrenia and depression as distinct conditions. The 
reviews presented in the thesis do not restrict themselves to specific conditions, and 
these specialist filters were not deemed appropriate. Instead, a series of search 
strategies were developed in order to obtain literature relevant to psychiatry and 
mental health. These search strategies generally comprised medical subject 
headings for literature related to psychiatry and mental health. 
For example, three major Medical subject headings in MEDLINE were relevant: 
0 "Mental- Health"/ all subheadings 
0 "Psychiatry"/ all subheadings 
0 "Menta I- Disorders"/ all subheadings 
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In addition, free text words were added to capture literature not classified under 
these subheadings: 
" (mental health) in ti, ab 
" (mental* illness*) in ti, ab 
" (mental* ill) in ti, ab 
" psychiatry in ti, ab 
" (mental* disorder*) in ti, ab 
" psychiatric in ti, ab 
" (mental* ill-health) in ti, ab 
The specific 'mental health' and 'outcomes' search terms varied and were adapted 
for each specific database, and are given below: 
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IVIEDLINE 
This database corresponds to three print indexes: Index Medicus; Index to Dental 
Literature and the International Nursing Index. Additional materials not published in 
Index Medicus are included in MEDLINE in areas of communication disorders, 
population and reproductive biology. MEDLINE is the National Library of Medicine's 
premier bibliographic database covering the fields of medicine, nursing, dentistry 
and the pre-clinical sciences. Each record is indexed using NLM's controlled 
vocabulary, MeSH (Medical Subject Heading. Coverage is from 1966 to date. It is 
produced by the National Library of Medicine, Bethesda MID, USA. 
MENTAL HEALTH TERMS 
1. explode Wental- Health"/ all 
subheadings 
2. explode "Psychiatry"/ all 
subheadings 
3. explode Wental- Disorders"/ all 
subheadings 
4. (mental health) in ti, ab 
5. (mental* illness*) in ti, ab 
6. (mental* ill) in ti, ab 
7. psychiatry in ti, ab 
8. (mental* disorder*) in ti, ab 
9. psychiatric in ti, ab 
10 . 
(mental* ill-health) in ti, ab 
OUTCOMES TERMS 
1. "H ealth-Status- Indicators" 




Care)"/ all subheadings 
4. "Quality-of-Life"/ all subheadings 
5. (outcome measure*) in ti, ab 
6. (health outcome*) in ti, ab 
7. (quality of life) in ti, ab 
8. measure* in ti, ab 
9. assess* in ti, ab 
10. (score* or scoring) in ti, ab 
11. index in ti, ab 
12. indices in ti, ab 
13. scale* in ti, ab 
14. monitor* in ti, ab 
15. #8 or #9 or #10 or #12 or #11 or 
#13 or #14 
16. outcome* in ti, ab 
17. #16 near3 #15 
18. #1 or #2 or #3 or #4 or #5 or #6 
or #7 
19. #17 or #18 
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EMBASE 
EMBASE is a major bibliographic database, which covers world-wide medical journals, 
with particular emphasis in the areas of drugs and toxicology. Inclusion of European 
material is particularly strong. Produced by Elsevier Science B. V., Amsterdam, 
Netherlands. 
MENTAL HEALTH TERMS 
1. explode "mental-health"/ all 
subheadings 
2. explode "psychiatry"/ all 
subheadings 
3. explode "mental-disease"/ all 
subheadings 
4. mental health in ti, ab 
5. mental* ill in ti, ab 
6. mental* illness* in ti, ab 
7. mental* ill-health in ti, ab 
8. psychiatry in ti, ab 
9. psychiatric in ti, ab 
10 . mental* 
disorder* in ti, ab 
OUTCOMES TERMS 
1. "health-survey"/ all subheadings 
2. explode "quality-of-life"/ all 
subheadings 
3. "outcomes-research"/ all 
subheadings 
4. health outcome* in ti, ab 
5. quality of life in ti, ab 
6. outcome measure* in ti, ab 
7. measure* in ti, ab 
8. (score* or scoring) in ti, ab 
9. index in ti, ab 
10. indices in ti, ab 
11. scale* in ti, ab 
12. monitor* in ti, ab 
13. assess* in ti, ab 
14. #7 or #8 or #9 or #10 or #11 or 
#12 or#13 
15. outcome* in ti, ab 
16. #15 near3 #14 
17. #1 or #2 or #3 or #4 or #5 or #6 
18. #16 or #17 
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PsycLIT 
This database provides access to the international literature in psychology and related 
behavioural and social sciences, including psychiatry, sociology, anthropology, 
education, pharmacology, and linguistics. Psycl-IT contains all records from the printed 
Psychological Abstracts, plus materials from Dissertation Abstracts International and 
other sources fo publication types indexed to include journal articles, dissertations, 
reports, books, and book chapters. Coverage 1887 to date. Produced by the American 
Psychological Association, Washington, DC, USA. 
MENTAL HEALTH TERMS 
1. explode "Mental- Health" 
2. explode "Psychiatry" 
3. explode Wental- Disorders" 
4. mental health in ti, ab 
5. mental* ill* in ti, ab 
6. mental* ill-health in ti, ab 
7. psychiatry in ti, ab 
8. psychiatric in ti, ab 
9. mental* disorder* in ti, ab 
OUTCOMES TERMS 
1. explode "Treatment-Outcomes" 
2. explode "Psychological- 
Assessment" 
3. explode "Qua I ity-of- Life" 
4. (outcome* or process*) near3 
assessment* 
5. health status indicator* 
6. health status 
7. health outcome* in ti, ab 
8. quality of life in ti, ab 
9. outcome measure* in ti, ab 
10. measure* in ti, ab 
11. assess* in ti, ab 
12. (score* or scoring) in ti, ab 
13. index in ti, ab 
14. indices in ti, ab 
15. scale* in ti, ab 
16. monitor* in ti, ab 
17. #10or#11 or#12or#13or#14 
or #15 or #16 
18. outcome* in ti, ab 
19. #18 near3 #17 
20. #1 or #2 or #3 or #4 or #5 or #6 
or #7 or #8 or #9 
21. #19 or #20 
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CINAHL 
Cinalhl is a commercially produced database which includes bibliographic details 
pertaining to nusrsing and allied care 
MENTAL HEALTH TERMS 
1. explode Wental- Health"/ all 
topical subheadings / all age 
subheadings 
2. explode "Psychiatry"/ all topical 
subheadings / all age 
subheadings 
3. explode Wental- Disorders"/ all 
topical subheadings / all age 
subheadings 
4. mental health in ti, ab 
5. mental* ill* in ti, ab 
6. mental* ill-health in ti, ab 
7. psychiatry in ti, ab 
8. psychiatric in ti, ab 
9. mental* disorder* in ti, ab 
OUTCOMES TERMS 
1. explode "Health-Status"/ all 
topical subheadings / all age 
subheadings 
2. explode "Health-Status- 
Indicators"/ all topical 
subheadings / all age 
subheadings 
3. explode "Outcome-Assessment"/ 
all topical subheadings / all age 
subheadings 
4. "Outcomes-(Health-Care)"/ all 
topical subheadings / all age 
subheadings 
5. explode "Quality-of-Life"/ all 
topical subheadings / all age 
subheadings 
6. health outcome* in ti, ab 
7. quality of life in ti, ab 
8. outcome measure* in ti, ab 
9. measure* in ti, ab 
10. assess* in ti, ab 
11. (score* or scoring) in ti, ab 
12. index in ti, ab 
13. indices in ti, ab 
14. scale* in ti, ab 
15. monitor* in ti, ab 
16. #9 or #10 or#1 1 or#12 or#13 or 
#14 or #15 
17. outcome* in ti, ab 
18. #17 near3 #16 
19. #1 or #2 or #3 or #4 or #5 or #6 
or #7 or #8 
20. #18 or #19 
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BNI/RCN 
MENTAL HEALTH TERMS 
1, mental health 
2. mental* ill* 
3. mental* ill-health 
4. psychiatry 
5. psychiatric 
6. mental* disorder* 
OUTCOMES TERMS 
1. health status 
2. status indicator* 
3. (outcome* or process*) near3 
assessment* 
4. health outcome* 
5. quality of life 
6. outcome* measure* 
7. assess* 





13. #7 or #8 or #9 or #10 or #11 or 
#12 
14. outcome* 
15. #14 near3 #13 
16. #1 or #2 or #3 or #4 or #5 or #6 
17. #16 or #15 
305 
CCTR 
The Cochrane controlled trials register contains bibliographic details of controlled trials 
identified fomr literature and hand searches of a number of electronic databases and 
journals 
MENTAL HEALTH TERMS 
1. MENTAL-HEALTH*: ME 
2. PSYCHIATRY*: ME 
3. MENTAL-DISORDERS*: ME 
4. MENTALTI NEAR HEALTH: Tl 
5. MENTALAB NEAR HEALTKAB 
6. MENTAL*: Tl NEAR ILLNESS: Tl 
7. MENTAL*: AB NEAR ILLNESS: AB 
8. MENTAL*: Tl NEAR ILLTI 
9. MENTAL*: AB NEAR ILLAB 
10. PSYCHIATRY: Tl OR 
PSYCHIATRY: AB 
11. MENTAL*: Tl NEAR DISORDER*: Tl 
12. MENTAL*: AB NEAR 
DISORDER*: AB 
13. PSYCHIATRIC: Tl OR 
PSYCHIATRIC: AB 
14. MENTAL*: Tl NEAR ILL-HEALTH: Tl 









4. QUALITY-OF-LIFE: ME 
5. OUTCOME: Tl AND MEASURE*: Tl 
6. OUTCOME: AB AND 
MEASURE*: AB 
7. HEALTH: Tl AND OUTCOME*: Tl 
8. HEALTH: AB AND OUTCOME*: AB 
9. QUALITY: Tl NEAR LIFE: Tl 
10. QUALITY: AB NEAR LIFE: AB 
11. MEASURE: Tl OR MEASURE: AB 
12. ASSESS*: Tl OR ASSESS*: AB 
13. SCORE*: Tl OR SCORING: Tl OR 
SCORE*: AB OR SCORING: AB 
14. INDEKTI OR INDEKAB 
15. INDICES: Tl OR INDICES: AB 
16. SCALE*: Tl OR SCALE*AB 
17. MONITOR*: Tl OR MONITOR*: AB 
18. #11 OR #13 OR #14 OR #15 OR 
#16 OR #17 
19. OUTCOME*: Tl OR OUTCOME*: AB 
20. #19 AND #18 
21. #1 OR #2 OR #3 OR #4 OR #5 OR 
#6 OR #7 OR #8 OR #9 OR #10 
22. #21 OR #20 
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Appendix 3: Survey questionnaire 
Please take a few minutes to complete 
National Outcomes Survey this survey - the answers that you give 
will be treated in strictest confidence 
and will not be attributed 200 Oil - Thank you for your help 
A. Please indicate your area(s) of 
Main Subspeciality 
General adult psychiatry 
Community psychiatry 
Rehabilitation psychiatry 
Old age psychiatry 
Child and adolescent 
Liaison psychiatry 
Psychotherapy 
Drugs and alcohol 
Academic psychiatry 
Other (please specffy) 
---- ------------ 
B. What type of hospital/trust do you work in? 
tick which applies 
Teaching hospital/Trust 
Lj 
District general hospital/non-teaching trust 
Other (please specify) 
I 
C. How long have you worked as a consultant psychiatrist? 
years 
D. In any one week, approximately how many 
patients are you responsible for? 
Inpatients patients 
Day hospital patients 
patients 
Outpatients (average seen per week) patients 
The following questions are about your use and experience of 
standardised outcomes measures. 
By standardised outcomes measures, we mean questionnaires designed to 
do any of the following: 
elicit or measure patients' symptoms, 
identify specific problems/needs 
measure quality of life/social functioning. 
1. Do you use standardised outcomes measures to check for any of 
the specific psychiatric problems outlined below? 
- tick which apply and specify any measures which you use 
never occasiona 
Ily 











problem (please --------------------- - 
2. Do you use standardised outcomes measures to check for deficits in 
social functioning, quality of life, or to assess patient needs? 
- indicate for which diagnostic groups you 
do this and specify any measures 
3. Do you use outcomes measures to measure change over time or 
therapeutic response? 
- please specify for which diagnostic groups of patients and which 
never occasional 
ly 






------------- -------------- - 
Drugs/alcohol 
problems 
Other (please specify) 
4. Do you use standardised outcomes measures as tools for clinical 
audit? 




Length of stay 
Re-admission rates 
Use of the mental health act 
Other - please specify 
Yes No - 
Indicate which., if any 
---------- 
6. Are you asked to routinely collect standardised outcomes measures by 
your hospital/trust? 
- indicate for which patients1diagnostic groups you do 
No Yes Which measures are you asked to this 
use? 






7. Are you required/asked by your hospital/trust to collect the 
following information on your patients? 
Yes No 




(e. g. using Camberwell Assessment of Needs; MRC Needs for 
Other (please specify) 




if yes, please indicate which measures 
9. Does your hospital/trust routinely collect any of the following data/ 
outcomes? 
Yes No 
Length of stay 
Readmission rates 
Use of the Mental Health Act 
Suicides 
Deaths 
Adverse/untoward events (please 







10. Are any of these data ever fed back to you? 
a 
Yes No 
Inj 1: 1 
11. Have outcomes measures ever been used in planning your 
services or allocating specific resources to your service? 
Yes No 
Iffij 
Please use this box to give 
examples 
12. Please indicate which (if any) of the following measures you use in your clinical practice 
- you may have indicated that you use one or more of these already, but 
please complete this section as we# 
Never Sometimes Routinely 
General Health Questionnaire (GHQ) 
Hospital Anxiety and Depression (HAD) 
Zung Depression Inventory 
Brief Psychiatric Rating Scale (BPRS) 
Short Form 36 
Anxiety and Depression Outcome Scale 
Lancashire Quality of Life Scale 
MRC Needs for Care Assessment 
HoNOS 
HoNOS 65+ 
Symptom Check List (SCL) - 60 
Positive and Negative Syndrome Scale 
Abbreviated Mental Test Score (AMTS) 
Camberwell Assessment of Need (CAN) 
Hamilton Depression Rating Scale 
Beek Depression Inventory (BDI) 
Mini Mental State Examination (MMSE) 
Quality of Life Index 
Other (please indicate 
13. Please use this space to tell us more about your experience in 
using outcomes in the routine care of your patients and in planning 
your clinical services - continue over the page if necessary. 
Thank you for completing this questionnaire - please use the stamped addressed 
this questionnaire should be returned to: 
Dr. Simon Gilbody 
NHS Centre for Reviews and Dissemination 
University of York 
YOI 0 5DD 
Appendix 4: Covering letters for questionnaire survey 
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Appendix 5- Covering lefter #1 
1 1 
2 0 0 0 
Dr (flnitials)) ((Surname)) 
(<Address line 1)) 
oAddress line 2)) 
(<Adress-line_3)) 
(Jown)) ((County)) (<Postcode)) 
Dear Dr oSurname)) 
Mobile Phone 07940 576699 
e-mail smg5@york. ac. uk 
I am writing to ask for your help in an important survey funded by the Medical 
Research Council. 
You will no doubt be aware that psychiatrists in the United Kingdom are 
encouraged to record the outcomes of care for their patients. The purpose of 
our survey is to ask clinicians who work in the real world what (if anything) they 
use in the way of standardised measures. We also want to know your thoughts 
on their value. 
The attached brief questionnaire should not take more than a couple of minutes 
of your time. Your answers will help provide the first complete picture of current 
practice in the NHS, and will hopefully be useful in formulating future policy. We 
have provided a stamped addressed envelope in which to return the form. 
In recognition of your contribution, respondents will be entered into a prize draw 
to win a copy of the new Oxford Textbook of Psychiatry. Your returned 
questionnaire will automatically be entered into this draw. 
Please do not hesitate to contact me on the above number (or by fax or e-mail) if 
you require any further information or help completing this survey. 
With many thanks in anticipation. 
Yours sincerely 
Dr Simon Gilbody MRCPsych 
MRC Clinical Fellow in Health Services Research 
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Covering lefter #2 
1 
0 
Dr <dnitials)) oSurname)) 
oAddress line 1 )) 
oAddress line 2)) 
oAdress line 3)) 
oTown)) oCounty)) oPostcode)) 
02 January 2002 
Dear Dr oSurname)) 
Mobile Phone 07940 576699 
e-mail smg5@york. ac. uk 
I am writing again to ask for your help with the Medical Research Council 
sponsored survey of the use of outcomes measures by UK Psychiatrists. A 
questionnaire was sent, which you might not have had time to complete. 
We hope to gain the first really comprehensive picture of psychiatrists' 
experiences in using these measures. Your contribution to this project will help 
ensure that our results are valid and representative of those who provide mental 
health care in the real world. 
Respondents will be entered into a prize draw to win a copy of the new Oxford 
Textbook of Psychiatry. Your returned questionnaire will automatically be 
entered into this draw. 
I apologise if you have already returned the questionnaire, and these letters 
have 'passed' in the post. 
With many thanks in anticipation. 
Yours sincerely 
sz-lmuý 4jz 
Dr Simon Gilbody MRCPsych 




+[N Iý ý 
7.! N! 
ation atior al Ou tco mes Sur vey 
1 
2 0 0 0 
Dr <dnitials>> ((Surname>) 
oAddress line 1 >) 
oAddress line 2 >> 
((Adress - 
line_3>> 
<<Town>) (<County)) ((Postcode>) 
02 January 2002 
Dear Dr oSurname)) 
Mobile Phone 07940 576699 
e-mail smg5@york. ac. uk 
I am writing again to ask for your help with the Medical Research Council 
sponsored survey of the use of outcomes measures by UK Psychiatrists. 
We hope to gain the first really comprehensive picture of psychiatrists' 
experiences in using these measures. Your contribution to this project will help 
ensure that our results are valid and representative of those who provide mental 
health care in the real world. 
I have enclosed a further copy of the questionnaire and a pre-paid reply 
envelope, in case you need this. Respondents will be entered into a prize draw 
to win a copy of the new Oxford Textbook of Psychiatry. Your returned 
questionnaire will automatically be entered into this draw. 
I apologise if you have already returned the questionnaire, and these letters 
have 'passed' in the post. 





Dr Simon Gilbody MRCPsych 
MRC Clinical Fellow in Health Services Research 
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Appendix 5: Quality scoring instruments for randomised trials 
Jadad Scale 
Randomisation 
ci yes C no 
Extra point 10 yes 10 no 
Randomisation - trials that report using the following methods are to receive 
one point: reporting that the trial was a 'randomised' one. Trials that describe 
(and was appropriate) the method of randomisation, such as random table 
numbers, computer generated, receive an additional point. However, if the 
report described the trial as randomised, and it was appropriate, such as date of 
birth, hospital numbers, a point is deducted. 
Double blinding 
C] yes C] no 
Extra point C] yes n no 
Double blinding - trials that report using the following methods are to receive 
one point: reporting that a trial was double blind. Trials that describe (and was 
appropriate) the method of double blinding, such as identical placebos, receive 
an additional point. However, if the report described the trial as double blind, 
and it was inappropriate, a point is deducted. 
Withdrawals and dropouts 
ci yes iri no 
Withdrawals and dropouts - trials that report using the following methods are to 
receive one point: the number and reasons for dropouts and withdrawals in 
each group must be stated. However, if there is no statement on withdrawals, 




Adequately stated? El yes 10 no 
Randomisation generation - trials that report using the following methods are to 
receive a point: trials that report using either a random number table, computer 
random number, coin tossing, dice throwing or shuffling. 
Allocation concealment 
Adequately stated? 0 yes 10 no 
Allocation concealment - trials that report using either central randomisation, 
numbered or coded bottles or containers, or a statement indicating that drugs 
were prepared by a pharmacy. Serially numbered, opaque, sealed envolopes is 
another example of adequate allocation concealment. Reports using 'sealed 
envelopes' without mention of opaque are not to receive a point. 
Double blinding 
no i yes r 
Adequately stated 
Double blinding - trials that report using the following methods are to receive a 
point: trails purporting to be accounts of double blinding trials. 
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